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THESIS ABSTRACT 
 
KCNE1 (E1) peptide is the founding member of the KCNE family (1-5), which is 
a class of type I transmembrane β-subunits.  KCNE1 peptides assemble with and 
modulate the gating, ion conducting properties and pharmacology of a variety of voltage-
gated K+ channel α-subunits, including KCNQ1 (Q1).  Mutations that interfere with the 
function of either E1 and/or Q1 and disrupt the assembly and trafficking of KCNE1-
KCNQ1 channel complexes give rise to diseases such as Romano-Ward (RW) and Jervell 
Lange Nielsen Syndrome (JLNS), two different forms of Long QT Syndrome (LQTS).    
Using enzymatic deglycosylation assays, immunofluorescence techniques and 
quantitative cell surface labeling, we showed that KCNE1 peptides are retained in the 
early stages of the secretory pathway as immaturely N-linked glycosylated proteins.  
KCNE1 co-assembly with KCNQ1 leads to E1 progression through the secretory 
pathway and glycan maturation, resulting in cell surface expression.   
N-linked glycosylation of some membrane proteins is critical for proper folding, 
co-assembly and subsequent trafficking through the biosynthetic pathway.  Previous 
studies have shown that genetic mutations that disrupt one of the two N-linked 
glycosylation sites on KCNE family members lead to LQTS (T7I, KCNE1 and T8A, 
KCNE2) (Schulze-Bahr et al., 1997; Sesti et al., 2000a; Park et al., 2003).  Having 
confirmed that KCNE1 proteins acquire N-linked glycans, we examined the kinetics and 
efficiency of N-linked glycan addition to KCNE1.  We showed that KCNE1 has two 
distinct N-linked glycosylation sites.  The N-terminal sequon is a traditional co-
 viii 
translational site.  The internal sequon (which is only ~ 20 residues away from the N-
terminal sequon) acquires N-linked glycans primarily after protein synthesis (post-
translationally).  Surprisingly, mutations that prevent N-glycosylation at the co-
translational site also reduce the glycosylation efficiency of post-translational 
glycosylation at the internal sequon, resulting in a large population of unglycosylated 
KCNE1 peptides that are retained in the early stages of the secretory pathway and do not 
reach the cell surface with their cognate K+ channel.  We showed that KCNE1 post-
translational N-glycosylation in the endoplasmic reticulum is a cellular mechanism that 
ensures E1 proteins acquire the maximal number of glycans needed for proper channel 
assembly and trafficking.  Our findings provide a new biogenic mechanism for human 
disease by showing that the JLNS mutation, T7I, not only inhibits glycosylation of the N-
terminal sequon, but also indirectly prevents the glycosylation of the internal sequon, 
giving rise to a large population of assembly incompetent hypoglycosylated KCNE1 
peptides.   
To further investigate the two N-linked glycosylation sites on KCNE1, we 
generated structure-function deletion scans of KCNE1 and performed positional 
glycosylation scanning mutagenesis.  We examined the glycosylation pattern of 
glycosylation mutants in an effort to define the glycosylation window important for 
proper KCNE1 assembly and trafficking.  Our findings suggested a nine amino acid 
periodicity to serve as a desirable glycosylation site and a better substrate for N-
glycosylation.   
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Appendix II shows work on the characterization of the C-terminally HA-tagged 
KCNE1 protein, which was used throughout the experiments presented in Chapter II, 
Chapter III and Chapter IV.  Analysis of the C-terminally HA-tagged KCNE1 protein 
revealed that in heterologous expression systems KCNE1 had an internal translational 
start site, a methionine at position 27.  A  proteolytic cleavage site was also identified at 
the arginine cluster spanning residues 32 through 38 bearing the two known Long QT 
mutations (R32H and R36H) (Splawski et al., 2000; Napolitano et al., 2005).   
My work in Professor Craig C. Mello’s lab during the first four years of my 
graduate study is presented in Appendix I.  The highly conserved Wnt/Wingless 
glycoproteins regulate many aspects of animal development.  Wnt signaling specifies 
endoderm fate by controlling the fate of EMS blastomere daughters in 4-cell stage 
Caenorhabditis elegans embryos.  A suppressor genetic screen was performed using two 
temperature sensitive alleles of mom-2/Wnt to identify additional regulators of the 
Wnt/Wingless signaling pathway during C. elegans endoderm specification.  Five 
intragenic suppressors and three extragenic suppressors of mom-2/Wnt embryonic 
lethality were identified.  We cloned ifg-1, eIF4G homologue, as one of the extragenic 
suppressors suggesting an intriguing connection between the Wnt signaling pathway and 
the translational machinery.   
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PREFACE 
 
In Chapter II, C-terminally HA-tagged KCNE1 protein was used to examine 
intracellular localization of KCNE1 peptides in the whole cell immunofluorescence 
studies.  I constructed and characterized the C-terminally HA-tagged KCNE1 protein 
(Appendix II).  Kshama Chandrasekhar conducted the biochemistry and 
immunofluorescence experiments and showed that KCNE1 subunits require co-assembly 
with K+ channels for efficient trafficking and cell surface expression.  The work 
presented in Chapter II has been published in a peer-reviewed journal.   
In Chapter III, Kshama Chandrasekhar provided the preliminary observations for 
the work presented and is credited with the second authorship.  Dr. Anatoli Lvov is 
credited authorship for the electrophysiology experiments.  Yuan Gao is credited 
authorship for the proteosomal inhibitor experiment.  Professor Reid Gilmore has been 
our guide on glycosylation work.  I characterized KCNE1 N-glycosylation through 
extensive biochemical analysis and described a novel mechanism for the biogenesis of 
Long QT syndrome.  The experimental work has been written up as a manuscript for 
publication.   
In Chapter IV, I performed structure-function deletion scans and positional 
glycosylation mutagenesis to elucidate the differential behavior of the two N-linked 
glycosylation sites on KCNE1.  Yuan Gao provided the immunoblot for a glycosylation 
mutant and she will be pursuing this project.   
 xxi 
In Appendix I, I present my work in Mello Lab.  I performed suppressor screens 
of mom-2/Wnt and I was able to isolate both intragenic and extragenic suppressors.  Dr 
Takao Ishidate helped me with conducting the suppressor screens. Dr Soyoung Kim 
pursued and completed the project with the help of Rita Sharma and Dr Masaki 
Shirayama.  Dr Soyoung Kim and I will be co-authors in the soon to be published work.  
The experimental work has been written up as a manuscript for publication.   
In Appendix II, I characterized the C-terminally HA-tagged KCNE1.  Trevor 
Morin, Steven Gage and Jessica Rocheleau helped with electrophysiology experiments.   
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CHAPTER I 
INTRODUCTION 
 
 
Part I: Voltage-gated potassium channels 
 
Historia:  
 
The plasma membrane is a biological barrier that confines the interior of the cell 
from the outside environment.  Cells can exhibit a voltage difference across their plasma 
membrane through the selective separation of ions and creating an electrochemical 
gradient.  This voltage difference, also known as membrane potential, is important for 
proper functioning of the cell (Alberts et al., 2002; Hunte and Richers, 2008).  Membrane 
potential is also essential for signal transmission between different parts of a cell in 
electrically excitable cells, such as neurons.  The membrane potential is held at a 
relatively stable value called the resting potential, which stays in -40 to -90 mV range for 
most cell types.  The membrane potential arises from the interaction of ion pumps and ion 
channels embedded in the membrane (Hille, 2001; Levitan and Kaczmarek, 2002).   
Ion pumps are transmembrane proteins that are able to move ions across the 
plasma membrane against their concentration gradient.  In contrast, ion channels are 
membrane-embedded proteins that allow the passive diffusion of ions down their 
electrochemical gradient; therefore they establish the voltage gradient across the plasma 
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membrane (Hille, 2001).  Other than this very fundamental function, ion channels have 
additional physiological roles and if they fail to function properly they can cause a broad 
range of diseases known as channellopathies (Hubner and Jentsch, 2002; Marban, 2002).   
Generally, ion channels are composed of several proteins that assemble, creating a 
water-filled pore through the plane of the membrane.  This water-filled pore allows ions 
to diffuse passively and often selectively depending on the type of the channel 
(Ackerman and Clapham, 1997; Hille, 2001).  Thus, one way to classify channels is 
according to the ions that they permeate: namely, chloride channels; sodium channels; 
calcium channels; proton channels; non-selective cation channels and potassium 
channels.   
Potassium channels are found in most cell types in practically all living 
organisms.  Beside this central role in maintaining the membrane potential, potassium 
channels have many other functions, from shaping the action potentials to regulating 
cellular processes like hormone secretion (Ackerman and Clapham, 1997; Hille, 2001; 
Levitan and Kaczmarek, 2002).  Therefore, their malfunction can lead to diseases like 
diabetes and even in some cases life threatening cardiac arrhythmias (Lehmann-Horn and 
Jurkat-Rott, 1999).   
There are four major classes of potassium channels: calcium activated potassium 
channels, inwardly rectifying potassium channels, tandem pore-domain potassium 
channels and voltage-gated potassium channels.  Calcium activated potassium channels 
open in response to the presence of intracellular calcium ions and voltage changes.  
Inwardly rectifying potassium channels pass positive charges (current) more easily in the 
 3 
inward direction (into the cell) at negative membrane potentials and do not allow 
potassium efflux at positive membrane potentials; unlike other potassium channels where 
potassium currents are preferentially carried outward at depolarized membrane potentials.  
Tandem pore-domain potassium channels are also known as two-pore-domain potassium 
channels.  They are responsible for baseline or leak currents.  Voltage-gated potassium 
channels open and close in response to the changes in membrane voltage (Hille, 2001).   
 
Voltage-gated potassium channels:  
 
Voltage-gated potassium channels are composed of four transmembrane subunits 
which can form either homo- or heterotetramers.  These subunits, also known as α-
subunits, are arranged around a central conducting pore, Figure 1.1A.  Each α-subunit has 
6 transmembrane domains (S1-S6) with both amino and carboxy termini facing the 
cytoplasm.  The narrowest part of the pore is formed by a loop between S5 and S6 and it 
is called the selectivity filter (Doyle et al., 1998; Zhou et al., 2001; Williamson et al., 
2003; Miloshevsky and Jordan, 2008).  Selectivity and high conductance rates are crucial 
factors for the biological function of the channels and voltage-gated potassium channels 
are indeed highly selective with the ions they permeate.  In addition, ion transport rates 
are close to the aqueous diffusion limit (Hille, 2001).   
Voltage-gated potassium channels are expressed in both non-excitable and 
excitable cells.  Excitable cells are cell types capable of changing their membrane   
 4 
A 
 
 
B 
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Figure 1.1:  (A)  The K+ channel family transmembrane architecture.  Top left: Four 
similar 6-transmembrane subunits (S1-S6) surround a central pore (P), forming a voltage-
gated potassium channel.  Both N- terminus (purple) and C- terminus (green) are facing 
the cytoplasm.  S4 region bears positive charges and serves as the voltage sensor (S1-S4, 
blue).  S5 and S6 form the pore region (light green).  Tetramerization domain (purple) is 
in the N-terminus.  Top right: The prototype for the pore forming domain of bacterial 
KcsA K+ channel with only two transmembrane helices (homologous to S5 and S6).  
Dark green is the interior of the protein, grey is the water exposed surface.  The four 
spheres represent the four K+ ion binding sites.  The water-filled ―cavity‖ resides between 
the selectivity filter and bundle crossing.  B.  Structural requirements of K+ channel 
ion permeation.  Left: Diagram of an open K+ channel based on the crystal structure of 
the MthK channel (Jiang et al., 2002b). Intracellular vestibule is wide-open. Pore helix 
dipoles are highlighted. Right: A view derived from the high resolution structure of the 
KcsA channel (Zhou et al., 2001).  A narrower (probably closed) access to a water-filled 
cavity in the middle of the membrane protein is shown. Purple sphere, a trapped K+ ion;  
green spheres are eight water molecules; red spheres, backbone oxygens of the selectivity 
filter; and orange spheres, side chain oxygen atoms (Yellen, 2002).   
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potentials, and include neurons and cardiomyoctes.  The canonical change in membrane 
potential is an action potential.  An action potential is a transient change in the voltage 
across the cell membrane.  During an action potential a cascade of events commences, 
resulting in signal transmission within the cell, Figure 1.2 (Kleber and Rudy, 2004).  
During the final steps of the action potential voltage-gated potassium channels are the 
main players that bring the membrane potential to its resting level.  Every α-subunit 
possesses a voltage sensor with multiple charged amino acids on the S4 transmembrane 
helix (Figure 1.1A).  Charge repulsion within this region is responsible for sensing the 
changes in membrane potential (Gandhi and Isacoff, 2002).  The time required for 
voltage-gated potassium channels to bring the depolarized membrane potential from 
positive to its resting state, a process known as hyperpolarization, is determined by the 
voltage sensitivity and gating kinetics.  During hyperpolarization, voltage-gated 
potassium channels are activated by positive voltage and this results in the outward flow 
of potassium ions to reduce the positive charge inside the cell and terminate (or prevent) 
excitation.  In some cases channels can begin opening within milliseconds.  An open 
channel can pass millions of ions per second making it a high throughput and highly 
selective system (Morais-Cabral et al., 2001; Levitan and Kaczmarek, 2002; Yellen, 
2002).   
The merits of this highly efficient system come from its architectural features that 
were provided by the crystal structures of the pores of two different bacterial potassium 
channels, KcsA and MthK Figure 1.1B (MacKinnon et al., 1998; Morais Cabral et al., 
1998; Long et al., 2005).  Stabilization of potassium ions are achieved in two ways: First,   
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Figure 1.2:  Top: The major ion channels and an electrogenic transporter in cardiac 
cells.  K+ channels (green) mediate K+ efflux from the cell; Na+ influx is achieved 
through Na+ channels (purple) and Ca2+ influx through Ca2+ channels (yellow). The 
Na+/Ca2+ exchanger (red) transports three Na+ ions for each Ca2+ ion across the plasma 
membrane.  Bottom: Ionic currents and genes underlying the cardiac action 
potential.  The top three currents are: INa, ICa,L and INa/Ca are depolarizing currents shown 
as functions of time, followed by their corresponding genes. Underneath the depolarizing 
currents is a ventricular action potential.  Repolarizing currents and their corresponding 
genes are presented below the action potential (Marban, 2002).   
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part of the permeation pathway is broad enough to accommodate a large amount of water 
to stabilize the potassium ion.  Second, electrostatic influence of helix dipoles stabilizes 
the cations near the entrance to the narrow selectivity filter within the center of the lipid 
bilayer Figure 1.1B.  In addition, the selectivity filter of the potassium channel mimics 
the water structure around a potassium ion making it more like a custom made polar 
oxygen cage for potassium ions, enhancing selectivity.  Finally, potassium ions pass 
through with simultaneous occupancy by multiple ions in the selectivity filter Figure 
1.1B.  This creates electrostatic repulsion between the adjacent potassium ions helping 
the rapid permeation and allowing high transport rates (Doyle et al., 1998; Zhou et al., 
2001; Yellen, 2002).   
There is an enormous variety in voltage-gated potassium channels.  They are 
encoded by at least 40 different genes in mammals.  Alternative splicing, 
posttranslational modifications and heteromultimerization increase this variety (Wulff et 
al., 2009).  The α-subunits of voltage-gated potassium channels have been grouped into 
12 classes labeled Kvα1-12 according to the sequence homology of the transmembrane 
domain (Gutman et al., 2005).  Other than this broad nomenclature, many subfamilies of 
voltage-gated potassium channels have been discovered exhibiting typical structural 
features including voltage sensor, toxin binding sites, and a single ion-conducting pore 
(Hille, 2001).  Also, voltage-gated potassium channels enhance channel diversity further 
through the association with auxiliary subunits, known as β-subunits.  β-subunits do not 
conduct current on their own; instead they modulate the activity of voltage-gated 
potassium channels via changing the kinetic properties, regulation, pharmacology, and 
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structure of the channel (Isom et al., 1994; Adelman, 1995; Catterall, 1995; Trimmer, 
1998; Pongs et al., 1999; Deutsch, 2002; Hanlon and Wallace, 2002; Yellen, 2002).   
The KQT-like channels, also known as the KCNQ family, encode voltage-gated 
potassium channels with unusual features.  Unlike the other voltage-gated six 
transmembrane helix channels, KQT-like channels do not have an N-terminal 
tetramerization domain (Deutsch, 2002).  Accordingly, they depend on the interactions 
with accessory subunits.  They also form heterotetramers with other members of the 
family.  Initially, these channels were cloned in a genetic screen searching for the 
proteins involved in cardiac arrhythmia (Wang et al., 1996).  There are five members of 
the KCNQ family known to date, namely KCNQ1-5.  KCNQ channels are widely 
distributed in the body and they are expressed in the heart, ear, cochlea, brain, eye, 
kidney, lung, pancreas, breast, testis, small intestine, colon, rectum and placenta 
(Robbins, 2001; Gutman et al., 2005).   
 
 
Part II: KCNQ1: Voltage-gated potassium channel, KQT-like subfamily, member 1 
 
The original name of KCNQ1 was ―potassium voltage-gated channel, KQT-like 
subfamily, member 1‖.  KCNQ1 is the official symbol of the gene.  KCNQ1 is a 676 
amino acid protein.  Like other members of the voltage-gated potassium channel family, 
KCNQ1 has six transmembrane helices, with both amino- and carboxy-termini facing the   
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Figure 1.3.  A:  Topology of KCNE and KCNQ1 proteins.  Some of the domains 
important for regulation of the KCNQ1 channel and topology of the KCNE proteins are 
indicated. All five KCNE proteins have a single transmembrane domain with different 
lengths of NH2 and COOH termini. B:  Channel architecture of KCNQ1 α-subunit 
with KCNE proteins.  Four KCNQ1 α-subunits assemble with two KCNE β-subunits 
resulting in β-subunit-specific currents (Jespersen et al., 2005; Morin and Kobertz, 
2008a).   
 
 
 
 
  
 13 
cytoplasm and a single pore-loop-helix motif Figure 1.3A (Robbins, 2001).  KCNQ1 has 
a relatively short N-terminal domain where it bears a PKA phosphorylation site at S27.  
KCNQ1 also has a large C-terminal domain where it harbors interaction sites for several 
cell signaling molecules including two PKC phosphorylation sites at T381 and S399 
(Busch et al., 1992; Lo and Numann, 1998; Kurokawa et al., 2003; Chen et al., 2005).  
KCNQ1 has a potential glycosylation site, N289, at the region connecting the 
transmembrane domains S5 and S6 (Figure 1.1A and Figure 1.3A).  Up until very 
recently, there was no information about the functional significance of this site (Freeman 
et al., 2000).  However, a group showed that changing N289 to a glutamic acid reduced 
current density by 56% with no further evidence showing its relation to hypo-
glycosylation (Zaika et al., 2008).   
KCNQ1 proteins are expressed in the inner ear and heart (Panaghie et al., 2006).  
In the inner ear, these channels are responsible for the transport of potassium ions out of 
the cells and maintain ionic homeostasis required for normal hearing (Nicolas et al., 
2001; Wangemann, 2002).  In the heart, they form Iks channels responsible for the slow 
delayed outwardly-rectifying cardiac potassium current.  These currents are essential for 
the rhythmicity of the heart (Bendahhou et al., 2005; Lundquist et al., 2005).  Also, the 
KCNQ1 protein is involved in transport of molecules across cell membranes in the 
kidney, lung, stomach and intestine (Lehmann-Horn and Jurkat-Rott, 1999; Jespersen et 
al., 2005).  The currents arising from homotetrameric KCNQ1 channels in over 
expression systems do not match any observed physiological potassium currents.  
KCNQ1 channel shows rapid activation and a large degree of inactivation.  In order to 
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present the physiologically observed gating properties KCNQ1 channels require co-
assembly with KCNE peptides (Melman et al., 2002b).   
 
Part III: KCNE Family - A family of voltage-gated potassium channel β-subunits 
 
The KCNE family members function as ancillary subunits (β-subunits) of 
voltage-gated potassium channels.  These proteins control the surface expression, voltage 
dependence, ion selectivity, unitary conductance, gating kinetics, and pharmacology of 
several channels (Abbott and Goldstein, 1998; Trimmer, 1998; Pongs et al., 1999).  The 
hallmark of the KCNE family of peptides is that they assemble with and modulate 
KCNQ1 channels in heterologous expression systems (McCrossan and Abbott, 2004).  
Until now, there are 5 known members of the KCNE family:  KCNE1 (MinK/IsK), 
KCNE2 (MiRP1), KCNE3 (MiRP2), KCNE4 (MiRP3) and KCNE5 (KCNE1L) (Takumi 
et al., 1988; Abbott and Goldstein, 1998; McCrossan and Abbott, 2004).  These small 
glycoproteins (100 to 170 amino acids) are type I transmembrane peptides; they have a 
single transmembrane domain where the N-terminus is facing outside and the C-terminal 
is facing the inside of the cell (Figure 1.3A and Figure 1.4A).  All KCNE peptides have at 
least one N-linked glycosylation site located within the first 30 amino acids of the N-
terminus (Figure 1.4A).  The C-terminal and transmembrane domains of KCNE peptides 
are mainly α-helical and interact with KCNQ1 in a bipartite manner, dramatically 
modulating the channel complex function (Mercer et al., 1997; Gage and Kobertz, 2004; 
Rocheleau et al., 2006; Chen and Goldstein, 2007; Liu et al., 2007).    
 15 
 
 
A 
 
 
 
B 
 
 
 
  
 16 
 
 
Figure 1.4:  (A).  The N-terminal glycosylation site is conserved among KCNE 
family members (1-5).  The first glycosylation site is underlined red and the internal 
glycosylation sites are underlined blue.  Asparagines (n) and serines (s) or threonines (t) 
are in red.  Cylinders denote transmambrane domains.  (B)  Sequence alignment of 
KCNE1 N-terminus.  The two N-linked glycosylation sites on KCNE1 are conserved 
among species.  h: human, bt: bos taurus (cattle), ss: sus scrofa (pig); fc: felis catus 
(domastic cat), mm: mus muculus (house mouse), xl: xenopus laevis (African clawed 
frog).   
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All known KCNEs are expressed in the heart; KCNE2-5 in CNS; KCNE2-4 in 
kidney and lung; KCNE2-3 in stomach; KCNE1 in inner ear; KCNE3 in small intestine, 
colon, skeletal muscle (Abbott and Goldstein, 2001).  The wide distribution of KCNE 
peptides in the body shows their diverse roles from controlling the excitability of the 
heart and CNS, to facilitating potassium recycling in the gastrointestinal tract, to 
modulating vascular tone in blood vessels (McCrossan and Abbott, 2004).  Recently, it 
has been shown that all KCNEs are expressed in the immune system (Sole and Felipe, 
2010).  Mutations in KCNE genes can lead to acquired and/or congenital diseases of 
cardiac muscle, skeletal muscle and inner ear (Abbott and Goldstein, 2001; McCrossan 
and Abbott, 2004). 
KCNE peptides are highly promiscuous regulatory subunits.  Each has been 
shown to interact with several different voltage-gated potassium channel α-subunits such 
as Kv2.1, Kv3.1, Kv3.2, Kv4.2K, KCNQ1 (Kv7.1), HERG (Kv11.1) (Sanguinetti et al., 
1996; McDonald et al., 1997; Melman et al., 2001; Zhang et al., 2001; Finley et al., 2002; 
Ohya et al., 2002a; Lewis et al., 2004; McCrossan and Abbott, 2004; Gordon et al., 2006; 
Um and McDonald, 2007).  Also, some KCNEs assemble with the same α-subunit in a 
tissue specific manner.  One example would be assembly with α-subunit KCNQ1.  
KCNQ1-KCNE complexes have known roles in physiological processes including 
cardiac repolarization through Iks current (KCNE1) (Barhanin et al., 1996; Sanguinetti et 
al., 1996), acid-secretion in the gut (KCNE2), K+ homeostasis in the lung and colon 
(KCNE3), maintaining ion equilibrium in inner ear (KCNE1) (Marban, 2002; 
Wangemann, 2002), and possibly regulation and diversification of Iks (KCNE4 and 
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KCNE5) (Angelo et al., 2002; Grunnet et al., 2002; Bendahhou et al., 2005; Lundquist et 
al., 2005).   
 
Part IV: KCNE1: Voltage-gated potassium channel, Isk-related family, member 1 
 
The official name of KCNE1 gene is ―potassium voltage-gated channel, Isk-
related family, member 1‖.  KCNE1 is the gene’s official symbol.  KCNE1, the founding 
member of KCNE family, is a type I transmembrane protein.  KCNE1 is a 129 amino 
acid glycoprotein.  It has two N-linked glycosylation sites in the extracellular N-terminal 
side, N5 and N26 (Figure 1.4A and Figure 1.4B).  There is no high resolution crystal 
structure of KCNE1.  Serial perturbation studies of KCNE1 suggest that the C-terminal 
domain of KCNE1 is mainly α-helical (Rocheleau et al., 2006; Chen and Goldstein, 
2007; Liu et al., 2007).  In addition, fourier transform infrared (FTIR) and circular 
dichrosim (CD) spectroscopy studies show that the transmembrane domain of KCNE1 
forms an α-helical conformation in lipid or detergent environments, which is consistent 
with biochemical perturbation scans (Mercer et al., 1997; Rocheleau et al., 2006; Chen 
and Goldstein, 2007).   
KCNE1 has been shown to form complexes with Kv3.1, Kv3.2, Kv4.3, HERG K+ 
channels (McDonald et al., 1997; Bianchi et al., 1999; Deschenes and Tomaselli, 2002; 
Lewis et al., 2004).  KCNE1 subunits also associate with KCNQ1 α-subunits in a tissue 
specific manner and modify channel gating, ion selectivity, single-channel conductance, 
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pharmacology (channel’s sensitivity to small molecule activators and inhibitors) and 
regulation (Barhanin et al., 1996; Sanguinetti et al., 1996; Abbott and Goldstein, 1998).   
KCNE1 is widely expressed in mammalian tissues.  It is expressed in heart 
cardiac muscle (Zhang et al., 2001; Finley et al., 2002); in smooth muscle and epithelia in 
the stomach (Ohya et al., 2002a; Ohya et al., 2002b), kidney, uterine endometrium, 
submandibular duct (Sugimoto et al., 1990), inner ear (Sakagami et al., 1991; Nicolas et 
al., 2001).  In addition, KCNE1 mRNA is found in the small intestine, lung, leukocytes, 
testis and ovaries (Chouabe et al., 1997); pancreas (Demolombe et al., 2001), uterus 
(Folander et al., 1990) and brain (Ohya et al., 2002b).   
 
 
Part V: KCNQ1 - KCNE1 channel complex and disease:  
 
Historia:  
 
KCNQ1 was cloned in a genetic study searching for a mutation that is responsible 
for inherited cardiac arrhythmia (Wang et al., 1996).  However, this six transmembrane 
voltage-gated potassium channel with a classical pore-forming P loop gave rise to 
rapidly-activating, non-inactivating K+ current that did not match any known native 
cardiac myocyte current.  When KCNQ1 and KCNE1 were coexpressed in mammalian 
cells native IKs channel currents were observed (Figure 1.5A and Figure 1.5B) (Barhanin 
et al., 1996; Sanguinetti et al., 1996; Sesti and Goldstein, 1998).    
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Figure 1.5:  Current properties of KCNQ1 channels change when co-expressed with 
KCNE1.  (A)  Representative families of IQ1 and IKs traces were recorded from CHO 
cells.  Cells were transfected only with KCNQ1 (KCNQ1) or cotransfected with KCNE1 
(+E1).  The currents were evoked by 3-s depolarization prepulses from a holding 
potential of -80 mV in 10-mV increments at an interpulse interval of 30 s to test voltages 
-70 to +60 mV.  To monitor the tail currents the depolarization prepulses were followed 
by repolarization to -30 mV for 2 s.  (B)  Relative mean peak currents (I/Imax) were 
normalized to the maximal IKs (Q1/E1) and plotted as a function of the prepulse voltage 
(V).  n = 3 – 5, mean ± S.E.M.  Figure 1.5 was kindly generated by Dr Anatoli Lvov. 
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The IKs channel currents have slower activation rates, slower deactivation rates 
compared to KCNQ1 channel currents.  KCNE1 modulates KCNQ1 channel by changing 
the unitary conductance (Romey et al., 1997; Sesti and Goldstein, 1998); effecting the 
channel gating by slowing activation and deactivation and decreasing the voltage 
sensitivity (Barhanin et al., 1996; Sanguinetti et al., 1996; Sesti and Goldstein, 1998); 
changing ion selectivity by selecting more effectively against Cs+ and NH4
+ ions (Sesti 
and Goldstein, 1998); modifying the pharmacology by influencing the block or activation 
by some drugs such as Class III anti-arrhythmic agents, mefenamic acid and DIDS (4,4-
diisothiocyanato-stilbene-2,2'disulphonate) (Busch et al., 1997; Abitbol et al., 1999; 
Lerche et al., 2007).   
A tethered blocker strategy allowed the assessment of the number and 
composition of KCNE subunits assembling with KCNQ1 α-subunits (Morin and Kobertz, 
2008b).  The stoichiometry of the KCNQ1-KCNE1 complex is shown to be 4:2 (Figure 
1.3B) (Morin and Kobertz, 2008a).  Though the KCNQ1-KCNE1 protein-protein 
interaction is a controversial topic, one model suggests that KCNE1 subunits are 
intimately associated with the channel pore; therefore they are positioned close to the 
residues forming the conduction pathway (Melman et al., 2004; Jespersen et al., 2005).  
All KCNE peptides share a conserved 20 amino acid stretch in the cytoplasmic domain 
neighboring the transmembrane domain.  For KCNE1 this region is required for KCNQ1 
channel modulation (Takumi et al., 1991; Tapper and George, 2000).  Also, it has been 
shown that a triplet of amino acids located in the transmembrane domain is essential for 
current modulation (Melman et al., 2001).  In addition, the specificity of the β-subunit 
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(KCNE1, T58 and KCNE3, V72) is dictated by a single residue within this triplet 
(Melman et al., 2002a).  Structure-function studies defined the minimal KCNE1 segment 
required for proper function.  The deletion of residues 10-39 had no noticeable effect; yet 
residues between 4-25 and 4-39 were crucial for proper KCNE1 function.  Further 
truncation studies involving the C-terminus showed that the minimal functional KCNE1 
spanned residues 1-9 and 40-94 including the transmembrane domain  (Takumi et al., 
1991; Abbott and Goldstein, 1998; Tapper and George, 2000).   
 
KCNQ1-KCNE1 channel complex and disease:  
 
KCNE1 co-assembles with KCNQ1 K+ channels in some epithelial tissues and the 
heart.  In epithelia KCNQ1/KCNE1 channels take part in transepithelial transport by 
recycling potassium across the basolateral membrane, maintaining the resting potential 
and regulating Cl- secretion and/or Na+ absorption (Figure 1.6) (Jespersen et al., 2005).  
In murine tracheal epithelial cells, KCNE1 plays a role in regulatory volume decrease 
response (Grahammer et al., 2001).  In kidney, KCNE1 and KCNQ1 are found in the 
proximal tubule and the distal tubule of the nephron (Demolombe et al., 2001).  Though 
the function of KCNQ1/KCNE1 channel in kidney epithelia is not clear, the KCNE1 
knockout mice suffer from renal problems such as hypokalemia, volume depletions, 
urinary and fecal salt wasting (Vallon et al., 2001; Attali, 2002).   
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Figure 1.6:  The role of KCNQ1 channels in epithelial function.  In a prototype 
secretory epithelial cell, KCNQ1 channels are essential for recycling potassium across the 
basolateral membrane for transepithelial secretion of the chloride ions and maintaining 
ionic homeostasis (Jespersen et al., 2005).   
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In epithelial cells from the inner ear, KCNQ1 channels are coexpressed with 
KCNE1 in the apical membranes of the marginal cells of the stria vascularis and 
vestibular dark cells (Nicolas et al., 2001; Wangemann, 2002).  In the inner ear, 
endolymph is the fluid that fills the membranous labyrinth enclosed by the heterogenous 
epithelium.  The major salt in endolymph is KCl and potassium ion (K+) is the major 
charge carrier for the sensory transduction (Figure 1.7).  KCNQ1/KCNE1 channels are 
responsible for K+ release into endolymph and for the formation of endolymph in the 
cochlear and vestibular labyrinth, which is essential for hearing (Vetter et al., 1996; 
Tyson et al., 1997; Marban, 2002).  Mice that lack either KCNE1 or KCNQ1 after 
postnatal day 3 have collapsed endolypmhatic space due to lack of potassium secretion 
from strial marginal cells and vestibular dark cells (Vetter et al., 1996).  In vestibular dark 
cells of KCNE1 null mutant mice, KCNQ1 remains in the cytoplasm rather than being 
trafficked to the apical membrane (Nicolas et al., 2001).  Therefore, KCNE1 may be 
necessary for KCNQ1 trafficking, suggesting a posttranslational interaction between 
KCNE1 and KCNQ1 (Wangemann, 2002).  Patients with Jervell and Lange-Nielsen 
syndrome who lack either KCNE1 or KCNQ1 suffer from sensorineural deafness that is 
due to the collapsed endolymphatic space (Neyroud et al., 1997; Schulze-Bahr et al., 
1997).   
In heart KCNQ1/KCNE1 channels give rise to cardiac IKs currents (Figure 1.2 and 
Figure 1.5).  IKs current is the slowly activating component of the cardiac delayed 
repolarization (Barhanin et al., 1996; Sanguinetti et al., 1996).  These currents activate 
and deactivate very slowly.  IKs channels (KCNQ1/KCNE1 channels) are in part   
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Figure 1.7: Potassium recycling in the inner ear.  The high K+ concentration and 
positive potential of endolymph of the scala media is maintained through the inconcert 
function of ion channels and ion pumps.  Bottom right shows the model for K+ secretion 
from the stria vascularis.  A basolateral Na+/K+-ATPase pumps K+ in and Na+ out of the 
marginal cells and creates a gradient to drive Cl- into the cell in a co-transport process.  
K+ is then secreted apically by KCNQ1/KCNE1 K+ channels, allowing a net secretion 
into the endolymph in spite of its high K+ concentration.  Chloride is recycled through 
basolateral Cl- channels.  Bottom left is the the diagram of an outer hair cell.  Potassium 
enters through apical mechanosensitive channels and leaves the cell through KCNQ4 K+ 
channels present in the basal membrane.  Then, K+ is recycled back to the stria vascularis 
through supporting cells and fibrocytes of the spiral ligament for another round of 
secretion (Jentsch, 2000).   
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responsible for the duration of the action potential in cardiac muscle, which can be 
followed by the time interval between the Q and T peaks on an electrocardiogram 
(ECG/EKG).  Genetic mutations in either E1 or Q1 give rise to delayed repolarization of 
the heart following a heartbeat, which can be reflected as the prolongation of the Q-T 
interval (Figure 1.8A and Figure 1.8B).  This irregularity might lead to torsade de pointes 
(a form of arrhythmic heartbeat that originates from the ventricles) that may cause 
palpitations, fainting, seizures and sudden death due to ventricular fibrillation.  Inherited 
diseases of the cardiac rhythm are Romano-Ward, a form of autosomal dominant long-
QT syndrome (LQTS) and Jervell-Lange-Nielsen Syndrome (JLNS), the inherited 
autosomal recessive LQTS accompanied with congenital deafness (Figure 1.8C) 
(Splawski et al., 2000; Tyson et al., 2000).   
There are over 90 KCNQ1 and 10 KCNE1 mutations that can cause Long-QT 
Syndrome including mutations in the following frequencies: missense mutations, splice-
site mutations, nonsense mutations, in-frame deletions and frameshift mutations 
(Splawski et al., 2000).  For KCNQ1, most mutations reside in intracellular and 
transmembrane domains followed by the pore region (Splawski et al., 2000; Napolitano 
et al., 2005).  For KCNE1, mutations are located in the intracellular domain followed by 
the transmembrane and the extracellular domains (Schulze-Bahr et al., 1997; Splawski et 
al., 2000).  KCNQ1 and KCNE1 mutations can interfere directly with function, 
regulation, assembly and/or trafficking and lead to prolonged action potentials and long-
QT syndrome (Keating and Sanguinetti, 2001; Dahimene et al., 2006).    
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Figure 1.8:  A healthy heart vs an unhealthy heart.  (A).  A schematic representation 
of a four-chambered heart (RA:right atrium, LA:left atrium, RV:right ventricle, LV:left 
ventricle).  Specialized cells act as a pacemaker (the sino-atrial node, SAN).  Conducting 
tissues are the atrio-ventricular node (AVN) and the right and left bundle branches (RBB, 
LBB).  (B)  Normal electrocardiogram (ECG) and an ECG with QT interval 
prolongation.  The P wave shows atrial depolarization, QRS complex reflects ventricular 
depolarization and the T wave represents ventricular repolarization.  A normal QT 
interval takes about 0.40 s.  Abnormal cardiac repolarization gives rise to QT interval 
prolongation.  (C)  ECG showing a normal sinus rhythm turning into torsades de pointes 
ventricular tachycardia and ventricular fibrillation (Keating and Sanguinetti, 2001) .    
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Part VI:  Post-translational modifications of proteins 
 
Historia:  
 
Gene expression starts with transcription of DNA into RNA.  The transcript 
encoding for a protein is a messenger RNA (mRNA).  During protein synthesis, also 
known as translation, mRNA is decoded into canonically 20 different amino acids to 
produce an amino acid chain (the list of endogenous amino acids has been extended to 22 
through the recent addition of selenocysteine and pyrrolysine (Hao et al., 2002)).  In 
every gene, a nucleotide triplet code of the DNA encodes an amino acid that is added to 
the growing polypeptide chain.  Translation is followed by protein folding where the 
nascent polypeptide chain folds into its characteristic and functional three-dimensional 
structure (Rossmann and Argos, 1981).   
After translation most proteins go through a variety of chemical modifications 
known as post-translational modifications (PTMs).  These covalent changes follow the 
translation of mRNA nucleotide sequences into amino acid based protein sequences at the 
ribosome (Wold, 1981).  Posttranslational modifications alter the function of proteins by 
changing their activity, trafficking and localization, turnover and interactions with other 
proteins.  These modifications increase proteome diversity through covalent 
modifications of the side chains of amino acids and peptide linkages.  About 5 % of the 
human genome is dedicated to expanding diversity by encoding the necessary enzymes 
needed for posttranslational modifications (Walsh, 2006).  An enzyme particular for a 
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certain posttranslational modification shows a great deal of promiscuity for its substrates. 
This increases the number of modified proteins.  The enzymes are also the ultimate 
decision makers for the type of amino acid side chains modified and the type of covalent 
chemical modifications introduced.   
There are more than 200 kinds of posttranslational modifications of proteins.  
These modifications can be divided into two major classes: The first one is the covalent 
addition of one or more groups on a protein; the second one is the hydrolytic cleavage of 
one or more peptide bonds.  In the first group, through the catalytic activity of enzymes 
groups like phosphoryl, acetyl, or glycosyl are covalently attached to the amino acid side 
chains of proteins.  In the second group, enzymes known as proteases (protein 
hydrolyses) catalyze the cleavage of the peptide bonds.  There are hundreds of enzymes 
encoded in the human genome that take part in these modifications.  A single protein can 
have several of these posttranslational modifications through the enzyme selectivity for 
the correct region and sequence on the modified side chains.  This is done with great 
precision, allowing large numbers of combinations and increasing the proteome diversity.   
Posttranslational modifications empower proteins in many ways.  Introducing 
negative charges can change the conformation of the microenvironment of the protein.  
This might effect the overall conformation of the protein in ways unimaginable without 
posttranslational modifications (Johnson and Lewis, 2001).  For example, 
phosphorylation of two sites might end up creating docking sites for partner proteins that 
can specifically recognize the tetrahedral phosphate dianionic side chains.  
Posttranslational modifications may also enhance the catalytic capacity of the modified 
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proteins.  Conversion of inactive apo forms of proteins to holo forms by covalent 
modifications like protein lipoylation, biotinylation and phosphopantetheinylation 
increases the catalytic efficiency of the protein considerably.  Finally, posttranslational 
modifications such as ubiquitylation, acylation, glycosyl phosphatidylinositol (GPI) 
anchoring, farnesylation/ geranylgeranylation, and glycosylation all guide trafficking and 
subcellular localization of the proteins.   
The posttranslational modifications can be examined under eight major 
categories: protein phosphorylation by protein kinases, sulfuryl transfers, protein 
methylation, protein N-acetylation, protein lipidation, ubiquitination, proteolytic post-
translational modification of proteins and protein glycosylation.  Some of the 
posttranslational modifications are mentioned in detail to provide sufficient background 
for the upcoming Data Chapters and Appendix II.   
Protein phosphorylation by protein kinases:  Phosphorylation, like other 
posttranslational modifications, changes the function of the target protein.  The changes 
effect the protein’s association with other proteins, enzyme activity and/or location.  
Protein kinases are the enzymes that catalyze the transfer of the γ-PO3
2- group from ATP 
onto the nucleophilic –OH group of the amino acid side chain of serine/threonine or 
tyrosine.  A little more than 500 protein kinases are encoded in the human genome 
(Manning et al., 2002) and more than 30% of all human proteins are substrates for protein 
kinases (Cohen, 2000).  Overall phoshorylation plays an important role in the regulation 
of the majority of the cellular pathways, mainly in signal transduction (Cohen, 2002).   
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Proteolytic Post-translational Modification of Proteins:  Proteases are the 
enzymes that catalyze the hydrolysis of peptide bonds of select target proteins and can 
modify their activity (Walsh, 2006).  This posttranslational modification of the protein 
can be biosynthetic (activation and/or inhibition of the substrate) or degradative.  
Controlled proteolysis plays many roles in cellular processes; defense responses like 
antigen processing, programmed cell death, shedding of cell surface proteins; 
developmental processes like the proteolytic action of sperm enzymes penetrating into an 
egg; and signaling pathways like the Notch signaling are some of the many cellular 
processes that are triggered by proteolytic processing (Thornberry and Lazebnik, 1998; 
Ye and Fortini, 2000; Walsh, 2006).   
The hydrolytic cleavage of the peptide bond is thermodynamically favored (Keq is 
about 105) under physiological conditions.  Therefore, proteolysis is an irreversible 
posttranslational modification that is tightly controlled spatially and temporally.  Failure 
of proper regulation leads to apoptotic cell death intracellularly and tissue destruction 
extracellularly.   
Proproteins are synthesized as the inactive precursors of proteins and undergo 
proteolytic post-translational modifications for proper function.  Proproteins that are 
synthesized in one compartment are transported to another compartment for activation, 
where they undergo proteolytic processing by a specific protease.  The mechanism of 
proteolytic cleavage depends on the substrate, location and the protease.  There are more 
than 11,000 proteases among species and most of them are highly specific for their 
substrates.  Proteases can be classified according to their site of action (attacking amino 
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terminus, carboxy terminus or inter peptide bonds of substrates) or by their catalytic 
mechanism.  According to the catalytic mechanism classification there are four major 
categories: aspartic acid proteases, metallo proteases, cysteine proteases, serine proteases 
(Puente et al., 2003).   
One major group of serine proteases is the proprotein convertase (PC) family.  
They are calcium dependent serine endoproteases with conserved signal peptides, pro-
regions, catalytic and P-domains.  Their C-terminal regions play a role in subcellular 
routing.  Proprotein convertases are activated by the autocatalytic cleavage of the N-
terminal propeptide followed by the release of prodomain and proper folding for their 
enzymatic activity.  They assist protein maturation through proteolytic cleavage as 
proteins pass through the secretory pathway.   
Proprotein convertases cleave at multibasic recognition sites with the general 
motif (K/R)-(X)n-(K/R) ↓ , where X is any amino acid except Cys, and n = 0, 2, 4, or 6.  
There are seven proprotein convertases known to date, namely: PC1/3, PC2, Furin, 
PACE4, PC4, PC5/6, and PC7 (Nakayama, 1997; Seidah and Chretien, 1999).  It is 
predicted that still many unidentified proteases participate in the proteolytic cleavage of 
proteins (Zhou et al., 1999).  Hopefully, their discovery will reveal the underlying 
reasons for many unexplained proteolytic cleavages.   
Among proprotein convertases, Furin is the best understood.  Furin is expressed in 
the trans-Golgi network, endosomal secretory compartments and plasma membrane.  
After the intramolecular cleavage of prodomain, furin exits the endoplasmic reticulum 
(ER).  When furin reaches the trans-Golgi network (TGN) the calcium-enriched, acidic 
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pH conditions lead to a second cleavage that releases the prodomain and activates the 
enzyme (Anderson et al., 1997; Thomas, 2002).   
Proprotein convertases are ubiquitously expressed in many tissues such as gut, 
liver, kidney, brain and neuroendocrine system.  Among many of their physiological 
roles, malfunctioning of the proprotein convertases leads to disease states such as cancer, 
diabetes, lipid disorders, obesity, atherosclerosis, infectious diseases and 
neurodegenerative diseases (Scamuffa et al., 2006).  Proprotein convertases have a 
variety of functions and show promise as therapeutic targets (Seidah and Chretien, 1999).   
 
 
Part VII:  N-linked Glycosylation of Proteins 
 
Historia:  
 
Protein glycosylation is the covalent attachment of mono-, oligo-, or 
polysaccharides to proteins, forming glycoconjugates called glycoproteins.  The sugar 
containing portion of a glycoprotein is made up of complex heteropolymers known as 
glycans.  Glycans are composed of monosaccharides with related chemical structure like 
hexoses that include glucose (Glc), mannose (Man), galactose (Gal), N-
acetylglucosamine (GlcNAc), N-acetylgalactosamine (GalNAc) in the D configuration 
and other modified forms of simple hexoses like glucuronic acid (GlcA), xylose (Xyl), 
fucose (Fuc) and sialic acids like N-acetylneuraminic acid (NeuAc).  These monomers 
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form oligo- or polysaccharides through glycosidic linkages.  A glycosidic linkage is 
formed when a monosaccharide at the hemiacetal of the ring conformation reacts with a 
hydroxyl group of another monosaccharide.  Glycosidic bond formation is an 
energetically unfavorable process and the free energy required is generated by coupling 
the reaction to the energetically favorable hydrolysis of nucleotide triphosphate and with 
the help of glycosyltransferases (GTFs).  A glycosyltransferase is specific for the 
nucleotide sugar donor and the acceptor.  Both making and breaking of glycosidic 
linkages are parts of the glycosylation process.  Glycosidases catalyse the hydrolysis of 
glycosidic linkages and this reaction is energetically favorable.  Glycosidases are also 
specific for glycosidic linkages involving a particular sugar.  To date there is no 
established structure-function relationship for glycan addition to proteins.  Glycans are 
assembled without any template and they do not have a unique folded structure (Taylor 
and Drickamer, 2006).   
Glycans modify the structure and function of membrane proteins and secreted 
proteins.  In eukaryotes, the majority of proteins that are synthesized in the rough 
endoplasmic reticulum are glycosylated.  Also, certain glycans are added to proteins in 
the cytoplasm and nucleus.  For some proteins, these carbohydrate side chains are 
essential for proper folding, and with some secreted glycoproteins they enhance protein 
stability.  In addition to these structural roles, glycans serve as tags in glycoprotein 
trafficking, target glycoproteins to the appropriate luminal compartments and play a part 
in a series of quality-control checks.  They also modulate protein-protein interactions and 
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protect against proteolysis.  Glycosylation of some membrane proteins can be essential 
for cell-cell adhesion.   
1–2% of the total number of human genes encode oligosaccharyltransferases, 
glycosyltransferases, glycosidases, lectins, and many other proteins directly involved in 
glycan assembly (Kikuchi and Narimatsu, 2006; Narimatsu, 2006).  To date over 40 
human congenital diseases have been associated with glycogene mutations and many 
more remain to be discovered (Schachter and Freeze, 2009).  Inherited diseases related to 
glycan biosynthesis are quite heterogeneous.  Patients with carbohydrate-deficient 
glycoprotein syndromes (CDGS), leukocyte adhesion deficiency syndrome II (LAD II), 
congenital dyserythropoietic anemia type II (HEMPAS), galactosemia, and abnormalities 
in proteoglycan synthesis suffer from malfunction of multiple organ systems (Varki et al., 
2009).  In cancer cells, glycosylation is altered and these changes are used as markers for 
tumor progression (Dall'olio, 1996).   
There are three classes of glycosylation: C-linked glycosylation where glycans are 
attached to a carbon on a tryptophan side chain; O-linked glycosylation - glycans are 
attached to the hydroxy oxygen of serine, threonine, tyrosine, hydroxylysine or 
hydroxyproline side chains; N-linked glycosylation where glycans are attached to the 
nitrogen of asparagine (and very rarely to the nitrogen of arginine side chains).  C-linked 
glycosylation (C-mannosylation): The C-1 atom of a single mannose residue is added in 
an α-linkage to the C-2 atom of the indole ring of tryptophan at specific sites in proteins 
(Furmanek and Hofsteenge, 2000).  Potentially there are over 335 mammalian proteins 
that are C-mannosylated  (Krieg et al., 1998).  Though C-mannosylation is a highly 
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common protein modification, not much is known about its function.  O-linked 
glycosylation: O-glycosylation occurs in the Golgi apparatus.  The hydroxyl side chain of 
serine and threonine residues of proteins serve as nucleophiles to form a sugar-O-protein 
bond.  In higher eukaryotes the donors for O-linked proteins are sugar nucleotides like 
UDP-Gal, UDP-GalNAc, GDP-Fuc, UDP-Glc, UDP-GlcNAc (Ten Hagen et al., 2003).  
O-linked glycan addition is catalyzed by a family of glycosyltransferases.  There are two 
major groups of proteins that are heavily O-glycosylated: mucins and proteogylcans.  
Mucins are large proteins that hold water.  They are present at the surfaces of the 
digestive and genital tracts and respiratory system (Taylor and Drickamer, 2006).  
Proteoglycans like mucins are heavily O-glycosylated proteins.  Proteoglycans give 
strength to the extracellular matrix and they serve as co-receptors for growth factors on 
the plasma membrane (Taylor and Drickamer, 2006).  O-linked glycans provide 
resistance to thermal change, protect from proteolytic attack; assist protein sorting and 
function as ligands for receptors (Ten Hagen et al., 2003).   
 
N-linked glycosylation of Proteins:   
 
N-linked glycosylation is a form of co-translational and a series of post-
translational modifications.  In eukaryotes N-Glycosylation starts with the addition of a 
14-sugar precursor to the asparagine residue in the protein as the growing nascent 
polypeptide chain comes out of the translocon (Figure 1.9 and Figure 1.10).  In the 
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human genome, more than half of all the proteins are N-glycosylated (Apweiler et al., 
1999).   
Much of the N-linked glycosylation machinery is conserved in eukaryotes.  N-
glycosylation has an assembly pathway and a processing pathway.  Three cellular 
compartments are involved in N-glycan addition and maturation: the cytosol, the 
endoplasmic reticulum (ER) and the Golgi.  In the cytoplasmic face of the ER membrane 
the precursor glycan donor is made through a complex set of reactions in which the 14 
monosaccharide residues (the two GlcNAcs and five mannoses) are put together with the 
help of membrane enzymes, UDP-GlcNAc and GDP mannose donors.  These sugars are 
assembled on dolichol, a polyisoprenoid lipid carrier, which anchors the growing sugar 
chain to the ER membrane.  Later, this heptasaccharyl-PP-dolichol intermediate is flipped 
to the ER membrane lumenal side by the Rft1 protein (Helenius et al., 2002).  The next 
seven sugars are added on the lumenal side of the ER membrane.  Sugar donors are 
mannose-P-dolichol and glucose-P-dolichol; the Alg (Asparaginyl-linked-glycan) 
enzymes catalyze the incremental build up of core lipid-linked oligosaccharide, 
Glc3Man9GlcNAc2-PP-dolichol (Burda and Aebi, 1999).  The structure of these core 
glycans are conserved in most eukaryotes (Figure 1.9).  High mannose oligosaccharides 
of the Glc3Man9GlcNAc2-PP-dolichol are then transferred onto selected asparagines of 
the nascent protein as it is translocated into the ER lumen.  The transfer is catalyzed 
through the enzymatic action of the oligosaccharyltransferase (OST) complex that 
recognizes the consensus glycosylation site (sequon) on the protein.    
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Figure 1.9:  The N-linked core oligosaccharide ( Glc3Man9GlcNAc2-  ).  In the ER, the 
core oligosaccharides are transferred onto proteins through formation of an N-glycosidic 
bond with the side chain of an asparagine that is part of the Asn-X-Ser/Thr consensus 
sequence on the protein. Glucosidases remove the terminal glucose residues and 
mannosidases remove central terminal mannose residue in the ER.  The symbols for the 
different sugars are indicated on the right (Helenius and Aebi, 2001).  
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Figure 1.10:  Synthesis and maturation of N-linked core oligosaccharides in the 
secretory pathway.  Oligosaccharide synthesis starts on the cytosolic surface of the ER 
membrane.  ALG7 catalyzes the addition of GlcNAc-P to Dol-P.  Next 6 more sugars are 
added to this Dol-PP-carrier.  After the addition of two N-actetylglucosamines and five 
mannoses, the oligosaccharides are flipped to the lumenal side of the membrane and four 
more mannose residues are attached followed by the addition of three glucoses forming 
the core glycan (Figure 1.9).  Oligosaccharyltransferase enzyme complex catalyzes the 
transfer of the core oligosaccharide complex onto the asparagine residues of the nascent 
polypeptide chains.  After a series of deglucosylation and reglucosylation steps properly 
folded proteins leave the ER and traffic through the secretory pathway.  In the Golgi 
oligosaccharides undergo further trimming and terminal glycosylation steps.  Unlike the 
ER homogeneous ER glycoforms, Golgi-generated glycoforms are highly diverse 
(Helenius and Aebi, 2001).  The symbols for the different sugars are: red triangle: 
glucose, pink circle: mannose, blue square: N-Acetylglucosamine, white triangle: fucose, 
green circle: galactose, black diamond: sialic acid.   
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Traditionally, N-linked glycosylation was believed to be a cotranslational process.  
As the nascent peptide chain passes through the translocation channel (Sec61 complex) 
and enters the lumen of rough endoplasmic reticulum (RER), the OST complex 
recognizes the sequon, NXT/S (where X can be any amino acid other than proline).  
Then, OST complex transfers the high mannose oligosaccharides cotranslationally as 
long as the sequon is 65-75 residues away from the peptidyl-transferase site on the large 
ribosomal subunit (Chen et al., 1995; Whitley et al., 1996).  Recently, posttranslational 
N-glycosylation of human coagulation factor VII (FVII) was shown in several 
mammalian cell lines (Bolt et al., 2005).   
Mammalian OST is a heteromultimeric complex that is made up of eight proteins.  
In yeast the OST complex is made up of single copies of the following proteins: Ost1p, 
Ost2p, Ost3p or Ost6p, Ost4p, Ost5p, Wbp1p, Swp1p, and Stt3p (Kelleher and Gilmore, 
2006).  Vertebrate, plant, and insect genomes encode two STT3 isoforms: STT3A and 
STT3B (Kelleher et al., 2003).  The STT3 proteins are directly involved in the catalytic 
activity of the OST complex (Yan and Lennarz, 2002).  Recently, it has been 
demonstrated that STT3A is primarily responsible for the cotranslational glycosylation of 
the nascent polypeptide chain as it enters to the ER lumen; whereas STT3B is important 
for both cotranslational glycosylation, and it can mediate posttranslational glycosylation 
(Ruiz-Canada et al., 2009).   
After the transfer of the oligosaccharide core onto the Asn residues, the newly 
formed glycoprotein is further processed in the ER (Walsh, 2006).  ER lumen 
glucosidases, glucosidase I and glucosidase II, act sequentially to remove the three 
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terminal glucoses and transfrom the initial N-glycan chain (Glc3Man9GlcNAc2- Asn-
Protein) to Man9GlcNAc2-Asn-Protein (Parodi, 2000b).  During this hydrolytic trimming 
process, the intermediate form GlcMan9GlcNAc2- Asn-Protein serves as a handle for 
soluble ER protein chaperone, calreticulin and the ER membrane-associated protein 
chaperone, calnexin.  Calreticulin and calnexin act in an ER quality control mechanism 
and monitor proper protein folding by recognizing the terminal glucose of the 
oligosaccharide (Parodi, 2000b).  At this point the glycoproteins enter a cycle of 
deglucosylation (glucosidase II) and reglucosylation (UDP-glucose glycoprotein 
glucosyltransferase) ensuring the proper folding of the glycoproteins during the process 
(High et al., 2000; Parodi, 2000a; Roth, 2002).  During this cycle, hopelessly misfolded 
proteins are shipped to the cytoplasm and their glycans are removed by protein glycanase 
N.  Next, misfolded proteins are ubiquitinylated and sent to the proteasome for 
degradation.  Meanwhile, properly folded Man9GlcNAc2-Asn-proteins are passed on to 
Golgi complex for further processing (Figure 1.10) (High et al., 2000; Trombetta and 
Parodi, 2003; Walsh, 2006).   
In the cis Golgi compartment, hydrolytic trimming of the core glycans continues 
by mannosidases and Man3GlcNAc2-(Asn-proteins) is the final dominant oligosaccharide 
in higher eukaryotes at this stage (Trombetta, 2003).  In the medial- and trans-Golgi, 
trimming ceases and re-building starts.  Glycosyltransferases residing in these 
compartments build the outer branches of the glycans by adding monosaccharides such as 
N-acetylglucosamines, galactoses, N-acetylgalactosamines, fucoses and sialic acids, 
producing diverse final products.  A glycoprotein can have different compositions of 
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glycans, known as glycoforms, leading to a heterogeneous population of a single 
polypeptide.  Though the extent of this heterogeneity varies from protein to protein, a 
glycoprotein with multiple glycosylation sites can have as many as 100 glycoforms, yet 
only a few of them predominate (Taylor and Drickamer, 2006).   
The core glycan assembly and trimming reactions in the ER are highly conserved 
in higher eukaryotes; and the differences among species are observed in the late stages of 
glycan chain maturation.  There are three main classes of N-linked glycans resulting from 
the core oligosaccharides, Glc3Man9GlcNAc2- (Asn-Protein): high-mannose 
oligosaccharides, complex oligosaccharides and hybrid oligosaccharides (Taylor and 
Drickamer, 2006).  High-mannose oligosaccharides have many mannose residues in 
addition to the two N-acetylglucosamines just like the core glycans.  Complex 
oligosaccharides contain many other types of saccharides. Hybrid oligosaccharides are 
the combination of both.  After the initial trimming in the ER, the fate of the core glycan 
is determined by its accessibility to the glycan modifying enzymes in the Golgi 
compartments.  The more accessible the saccharides are the more modifications they will 
get; hence they will become more complex.   
The functions of N-linked glycosylation can be divided into two broad categories: 
physico-chemical functions and biological functions.  Physico-chemical functions 
(Shental-Bechor and Levy, 2009) include altering the glycoprotein’s electrical charge, 
mass, size and viscosity in solution; effecting protein solubility; controlling protein 
folding; stabilizing protein conformation; providing thermal stability and protecting 
against proteolysis.  Biological functions are regulating intracellular trafficking and 
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localization of glycoproteins; determining the lifetime of glycoproteins in circulation; 
modifying immunological properties; modulating activity of enzymes and hormones; 
participating in cell-cell interactions and acting as cells surface receptors for lectins, 
antibodies and toxins, etc.  (Lis and Sharon, 1993).   
Disturbances in the assembly or processing of N-glycans lead to diseases that 
belong to the congenital disorders of glycosylation (CDG).  The mutant CDG genes 
discovered thus far lead to a reduction in the amount of fully assembled Dol-PP-
GlcNAc2Man9Glc3, causing abnormalities in a large group of glycoproteins (Jaeken and 
Carchon, 2000).  Congenital disorders of glycosylation are multisystem diseases and 
allele severity effects the patient phenotype immensely.  The list of CDGs is growing and 
some of the known disorders of N-glycan assembly include: CDG-Ia, 
(phoshomannomutase (PMM) deficiency); CDG-Ib (phoshomannose isomerase 
deficiency); CDG-Ic (glucosyltransferase I deficiency); CDG-1d (mannosetransferase VI 
deficiency); CDG-Ie (dolichol-phosphate-mannose synthase-1 deficiency); CDG-If.  
CDG-1a, CDG-1c, CDG-1d, CDG-1e are all neurological diseases.  CDG-Ib is a hepatic-
intestinal disease. CDG-If results in developmental problems and neurological defects.  
Disorders of N-glycan processing include: CDG-IIa (N-acetylglucosaminyltransferase II 
deficiency); CDGIIb (Glucosidase I deficiency); GDP-fucose transporter defect.  CGG-
IIa results in neurological diseases; CDG-IIb causes severe developmental problems, 
generally with a fatal outcome in newborns. GDP-fucose transporter defect causes 
developmental problems and neurological defects (Jaeken and Matthijs, 2001).    
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Part VIII:  N-linked glycosylation and KCNE1 
 
Asparagine-linked (N-linked) glycosylation is important for assembly, trafficking 
and stability of some K+ conducting subunits.  Most ion channels and their auxiliary 
subunits are N-glycosylated and the functional role of N-glycan addition varies 
dramatically among proteins.  Glycosylation can modify the elementary properties of 
some channels and increase functional diversity (Watanabe et al., 2003) .  At the same 
time glycosylation can modulate channel function through effecting its assembly and 
trafficking (Khanna et al., 2001; Khanna et al., 2004; Cotella et al., 2010; Egenberger et 
al., 2010; Hegle et al., 2010).   
The extracellular N-terminus of KCNE peptides contain at least one and up to 
three consensus sequences for N-linked glycosylation (Figure 1.4A) (Abbott and 
Goldstein, 2001; McCrossan and Abbott, 2004).  The glycosylation site nearest to the N-
terminus (within 10 residues) is absolutely conserved in all mammalian KCNE peptides.  
E1 has two N-linked glycosylation consensus sites at residues N5 and N26, both of which 
are glycosylated in native tissues (Finley et al., 2002).  Structure-function studies have 
shown that the minimal KCNE1 includes the first glycosylation site, which is essential 
for KCNQ1-KCNE1 complex formation and function (Takumi et al., 1991; Abbott and 
Goldstein, 1998; Freeman et al., 2000).  Moreover, the JLNS mutation, T7I, prevents 
glycosylation at the first N-linked glycosylation site on E1 (Schulze-Bahr et al., 1997).  
An SNP in the equivalent threonine in KCNE2 (T8A) provokes drug-induced LQTS with 
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the commonly prescribed antibiotic, sulfamethoxazole (Sesti et al., 2000b; Park et al., 
2003).   
The two glycosylation sites on KCNE1 (N5 and N26) are conserved in all 
mammals (Figure 1.4B).  However, only mutations in the first sequon (first sequon is also 
conserved among the KCNE family (Figure 1.4A)), are capable of causing Long QT 
Syndrome.  Structure-function deletion scans have demonstrated residues between 1-9 
(encompassing the first sequon) and 40-94 are indispensable for KCNE1 function.  
Surprisingly, despite the intriguing possible role of the first N-linked glycosylation site in 
KCNQ1/KCNE1 channel trafficking and function, little is known about either of the 
KCNE1 sequons.  I will present the requirements for KCNE1 trafficking and cell surface 
expression in Chapter II and Appendix II.  I will then explain the relative importance of 
the two consensus N-linked glycosylation sites on KCNE1 in Chapter III.  Finally, I will 
present additional structural and functional data showing a likely pattern that could 
explain the relative importance of the first glycosylation site in Chapter IV.   
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CHAPTER II 
 
KCNE1 subunits require co-assembly with K+ channels for efficient trafficking and 
cell surface expression* 
 
 
Contributors to the work presented in Chapter II: 
 
The author of this thesis, Tuba Bas constructed and characterized the C-terminally 
HA tagged KCNE1 peptide that allowed the authors to observe the cell surface 
expression and membrane localization of KCNE1 in immunostaining experiments.  
Kshama D. Chandrasekhar performed the experiments.   
 
 
 
 
 
*  Chandrasekhar, K. D., Bas, T., and Kobertz, W. R. 2006. KCNE1 subunits require co-assembly with K+ 
channels for efficient trafficking and cell surface expression. J Biol Chem. 281: 40015-40023.   
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ABSTRACT 
 
 
KCNE peptides are a class of type I transmembrane β-subunits that assemble with 
and modulate the gating and ion conducting properties of a variety of voltage-gated K+ 
channels.  Accordingly, mutations that disrupt the assembly and trafficking of KCNE-K+ 
channel complexes give rise to disease.  The cellular mechanisms responsible for 
ensuring that KCNE peptides assemble with voltage-gated K+ channels have yet to be 
elucidated.  Using enzymatic deglycosylation, immunofluorescence, and quantitative cell 
surface labeling experiments, we show that KCNE1 peptides are retained in the early 
stages of the secretory pathway until they co-assemble with specific K+ channel subunits; 
co-assembly mediates E1 progression through the secretory pathway and results in cell 
surface expression.  We also address an apparent discrepancy between our results and a 
previous study in human embryonic kidney cells, which showed wild type KCNE1 
peptides can reach the plasma membrane without exogenously expressed K+ channel 
subunits.  By comparing KCNE1 trafficking in three cell lines, our data suggest that the 
errant E1 trafficking observed in human embryonic kidney cells may be due, in part, to 
the presence of endogenous voltage-gated K+ channels in these cells.   
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INTRODUCTION 
 
 
Voltage-gated K+ channels have diverse physiological roles ranging from 
repolarization of excitable tissues to salt and water homeostasis in epithelial cells.  To 
achieve such functional diversity, many K+ channels function as membrane-embedded 
complexes made up of pore-forming α-subunits and tissue-specific regulatory β-subunits.  
The KCNE type I transmembrane peptides are a class of small β-subunits that assemble 
with and modulate the function of several types of voltage-gated K+ channels 
(McCrossan and Abbott, 2004).  KCNE1 (E1) is the founding member of the family and 
has been shown to form complexes with Kv3.1, Kv3.2, Kv4.2, Kv4.3, HERG, and 
KCNQ1 (Q1) K+ channels (Barhanin et al., 1996; Sanguinetti et al., 1996; McDonald et 
al., 1997; Zhang et al., 2001; Deschenes and Tomaselli, 2002; Lewis et al., 2004).  When 
E1 assembles with Q1, the complex produces the slowly activating cardiac IKs current 
and is the exclusive pathway for endolymphatic K+ recycling in apical membranes of 
strial marginal and vestibular dark cells (Marban, 2002; Wangemann, 2002).  Conversely, 
unpartnered Q1 channels are ill-equipped to perform either function because they open 
and close too quickly to maintain the rhythmicity of the heartbeat and are significantly 
inactivated and nonconducting at the resting membrane potential of inner ear cells (Pusch 
et al., 1998).  The biological importance of the proper Q1-E1 complex formation is 
further underscored by the inherited mutations in either Q1 or E1 that disrupt the 
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assembly and/or trafficking of the complex and give rise to cardiac arrhythmias, most 
notably long QT syndrome (Splawski et al., 2000).  An autosomal recessive form of long 
QT syndrome also causes neural deafness (Tyson et al., 2000).   
Although proper K+ channel function requires completely assembled complexes 
at the plasma membrane, the cellular mechanisms that ensure K+ channel α-subunits 
combine with membrane-embedded β-subunits are starting to be elucidated.  For the 
ATP-sensitive K+ channels (Kir6.1 and 6.2), which assemble with sulfonylurea receptors 
(sulfonylurea receptors 1/2A/2B) in a 4:4 stoichiometry, unpartnered channel and 
receptor subunits are stringently held in the endoplasmic reticulum (ER) via a RXR 
retention signal (Zerangue et al., 1999).  Once an octameric complex is formed, the KATP-
sulfonylurea receptor complex is permitted to exit the ER and traffic to the cell surface.   
In contrast, E1 subunits in complexes with voltage-gated K+ channels may traffic 
differently than their KATP counterparts. Two different studies suggest that Q1-E1 
complex formation occurs at the plasma membrane, which would require both proteins to 
traffic through the secretory pathway independently (Romey et al., 1997; Grunnet et al., 
2002).  More recently, it was proposed that Q1-E1 assembly occurs in the ER because 
mutant E1 proteins could retain Q1 channels there (Krumerman et al., 2004).  However, 
unpartnered wild type E1 proteins freely exited the ER and migrated to the cell surface, 
an observation inconsistent with an ER-based assembly.  A significant caveat with all of 
the above studies was that KCNE trafficking was studied in either Xenopus oocytes or 
human embryonic kidney (HEK) 293B cells, both of which possess endogenous 
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transcripts of voltage-gated K+ channels that have been shown to assemble with KCNE 
subunits (Sanguinetti et al., 1996; Jiang et al., 2002a).   
Here, we examine the assembly and trafficking of wild type E1 subunits in the 
presence and absence of Q1 channels in Chinese hamster ovary (CHO) and African green 
monkey kidney (COS-7) cells, both of which are revered for their ―electrical tightness‖ or 
lack of measurable endogenous K+ currents (Lesage et al., 1993).  Using these cells, we 
find that the majority of E1 protein is localized to the ER when expressed alone. Co-
expression with Q1 subunits promotes E1 protein trafficking through the secretory 
pathway, resulting in robust cell surface expression.  Moreover, these results demonstrate 
that Q1-E1 complex formation occurs early in the secretory pathway and that unpartnered 
E1 subunits do not efficiently progress past the ER and cis-Golgi compartments until they 
assemble with Q1 channel subunits.   
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RESULTS 
 
Active retention of unassembled membrane protein subunits is one mechanism by 
which a cell ensures that membrane-embedded K+ channel complexes are properly 
assembled before the proteins arrive at their final cellular destination (Ellgaard and 
Helenius, 2003).  Distinguishing cellular markers for ER-resident proteins are immature 
N-linked glycans.  The ER utilizes these high mannose oligosaccharide handles to 
promote protein folding, oligomerization, quality control, retention, and trafficking 
(Helenius and Aebi, 2001).  Once N-linked glycoproteins reach the Golgi, however, they 
are no longer subject to the rigorous quality control systems of the ER and migrate 
through medial and trans-Golgi compartments relatively unabated while acquiring 
complex modifications to their N-linked glycans (Helenius and Aebi, 2001).  Because 
KCNE peptides have two well conserved N-linked glycosylation consensus sites, we 
utilized this hallmark of ER residency to determine the cellular locales of E1 peptides 
expressed alone, with Q1, and with KCNQ4 (Q4), a K+ channel previously shown not to 
assemble with E1 (Figure 2.1) (Melman et al., 2004).  Transient expression of E1 alone in 
CHO cells gave rise to two strong bands at 16 and 22 kDa (though faint, higher molecular 
mass bands can be seen on this intentionally well developed, but not overexposed 
Western blot). When expressed with Q4, a similar banding pattern was observed with an 
additional band at 19 kDa. In contrast, expression with Q1 affords an additional, higher 
molecular mass band at ∼40 kDa. The presence of this 40-kDa band was independent of  
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Figure 2.1: KCNE1 peptides migrate differently on denaturing gels when expressed 
with specific K+ channel subunits.  Immunoblots of HA-tagged E1 peptides from 
solubilized CHO cells or COS-7 cells transfected with Q1, E1, Q1/E1, or Q4/E1 DNA. 
Expression of E1 alone or with Q4 yields two intense bands at 16 and 22 kDa in CHO 
cells and one band at 22 kDa in COS-7 cells. Q1/E1 co-expression results in the 
appearance of an equally strong band at ~40 kDa. Q1 was transfected alone to serve as a 
negative control. 
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the detergent lysis mixture used but only occurred in abundance when E1 was co-
expressed with Q1. The abundance of the higher molecular mass form of E1 was 
dependent on the ratio of Q1-E1 DNA used for transient transfection. Limiting amounts 
of Q1 DNA yielded all three forms of E1 protein as shown in Figure 2.1; optimizing the 
Q1-E1 DNA ratio (Experimental Procedures) afforded primarily the higher molecular 
mass species (Figure 2.2; see also (Figure 2.4). We also observed the same gel banding 
patterns for E1 in COS-7 cells (Figure 2.1).   
The multiple bands and differences in gel shift mobility suggested that E1 
peptides were differentially glycosylated depending on the presence of specific K+ 
channel subunits.  We therefore determined whether the gel shift mobility difference that 
was observed with Q1-E1 co-expression was due to maturation of the glycans on E1.  
The maturity of N-linked glycoproteins can be readily determined using two different 
glycosidases.  Endo H is a glycosidase that removes the high mannose (immature) glycan 
found on ER and cis-Golgi proteins but is unable to process the complex (mature) 
glycoform once the protein reaches the medial Golgi in the biosynthetic pathway.  In 
contrast, PNGase F is an endoglycosidase that removes all N-linked oligosaccharides.  
Treatment of the E1 samples with either Endo H or PNGase F reduced the 22-kDa band 
to 16 kDa, consistent with the loss of two immature glycans (Figure 2.2).  Thus, when E1 
is expressed alone, the majority of the N-linked glycan is immature; indicating that 
unpartnered E1 is localized to the ER and/or cis-Golgi.  Enzymatic deglycosylation of the 
Q1-E1 sample afforded a different result.  Treatment with Endo H had no effect on the 
higher molecular mass band. However, the two faint bands centered at ~20 kDa collapsed   
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Figure 2.2: KCNE1 glycopeptides are predominantly immature until they assemble 
with KCNQ1 subunits.  Immunoblot of enzymatic deglycosylation of E1 N-linked 
glycopeptides in the presence and absence of expressed Q1. The samples were left 
untreated (–), heat-treated (Δ) to 95°C for 5 min, digested with Endo H, or PNGase F and 
separated by SDS-PAGE (15%). Mature, immature, and unglycosylated (unglyc) samples 
are indicated as determined by enzymatic deglycosylation. Asterisks (*) denote PNGase 
F digestion products that consistently migrated slower than immature and unglycosylated 
protein, which may be due to an additional post-translational modification. 
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to the unglycosylated form (16 kDa), identifying these two bands as E1 glycoproteins 
with one and two immature glycans.  Heating the samples (95 °C for 5 min) did not effect 
any of the bands, suggesting that the higher molecular mass band was not due to protein 
aggregation.  All of the glycosylated forms of E1, however, were susceptible to PNGase 
F treatment, indicating that the higher molecular mass form of E1 possessed mature N-
linked oligosaccharides.  Because maturation of N-linked glycoproteins occurs in the 
medial and trans-Golgi, the presence of mature glycans in only the Q1-E1 sample shows 
that co-assembly with Q1 facilitates E1 peptide progression through the secretory 
pathway.  Although the PNGase F-treated E1 protein was deglycosylated, several 
residual bands were observed (indicated by the asterisks).  Prolonged treatment with 
PNGase F, the addition of more enzyme, varying the concentration of SDS in the gel 
loading buffer, or heat denaturation did not change the intensity or mobility of these 
bands (data not shown).  The residual banding is not partial digestion of the individual N-
linked glycans because PNGase F directly cleaves the oligosaccharide from the peptide 
backbone (Lemp et al., 1990). It is possible that one of the two mature N-linked glycans 
on E1 is totally inaccessible to the enzyme; however, we have observed these similar 
bands with PNGase F-treated E1 mutants that possess only one N-linked glycosylation 
site (data not shown).  These bands do not correspond to immature E1, because they have 
a slightly slower mobility that can be readily observed in either the E1 or the Q1-E1 
PNGase F-treated samples.  Moreover, PNGase F treatment of the E1 sample 
demonstrates that this enzyme cleaves both immature N-linked glycans efficiently. These 
additional bands were also resistant to a subsequent phosphatase or neuraminidase (to   
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Figure 2.3: Cell surface expression of KCNE1 requires co-expression with K+ 
channel subunits that assemble with KCNE peptides.  Cell surface immunostaining of 
E1 expressed alone or with Q4 or Q1 in CHO cells is shown. The cells were fixed and 
left intact to visualize cell surface staining or permeabilized to visualize total cellular 
staining. The images shown are single 0.4-μm planes through the center of each cell. 
Differential interference contrast (DIC) images show both untransfected and transfected 
cells. Green fluorescent protein (GFP) images identify transfected cells. Alexa 594 
images show E1 protein staining with Alexa 594-conjugated antibodies. The fluorescent 
images were captured using the same exposure time and rendered identically to 
qualitatively compare the fluorescent intensities between panels. Note the strong cell 
surface staining for the Q1/E1 panels (non-permeabilized and permeabilized), whereas 
the E1 and Q4/E1 permeabilized panels show mostly punctate staining, indicative of 
intracellular distribution. 
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remove sialic acid residues from O-linked glycans) treatment (data not shown) and may 
be due to the presence of another type of post-translational modification.   
Because maturation of N-linked glycans on E1 requires co-expression with Q1, 
we determined whether cell surface expression of E1 was also dependent on expression 
with specific K+ channel subunits.  Cell surface expression of E1 protein was visualized 
by immunofluorescence with permeabilized and nonpermeabilized cells using an 
extracellularly HA-tagged version of E1 (Wang and Goldstein, 1995).  In 
nonpermeabilized cells, no cell surface labeling of E1 was observed when E1 was 
expressed alone or with Q4 (Figure 2.3, E1 and Q4/E1 panels).  Co-transfection with 
green fluorescent protein DNA verified that the absence of cell surface staining was not a 
result of untransfected cells.  Permeabilization of the cells confirmed that the majority of 
the E1 protein was intracellular, as evidenced by the punctate staining.  In contrast, co-
expression with Q1 resulted in striking cell surface staining of E1 in intact and 
permeabilized cells (Figure 2.3, Q1/E1 panels).   
The plasma membrane protein levels of E1 were then quantitated by cell surface 
biotinylation.  To minimize labeling of intracellular proteins and membrane recycling, 
cells expressing E1 with or without Q1 were labeled with a membrane-impermeant, 
amine-reactive biotin derivative at 4 °C.  When co-expressed with Q1, E1 shows robust 
cell surface expression Figure 2.4A.  Moreover, no immature E1 was ever observed on 
the plasma membrane, which is consistent with the enzymatic deglycosylation assays 
Figure 2.2.  Little to no protein was observed at the cell surface when E1 was expressed 
alone.  To account for cell rupture during biotinylation, the ER-resident protein calnexin  
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Figure 2.4: Quantification of the KCNE1 plasma membrane protein by cell surface 
biotinylation.  (A) a representative immunoblot of E1 expressed in CHO cells with and 
without Q1 channel subunits. Transfected cells were labeled with a membrane-
impermeant biotin reagent and subsequently lysed, and the biotinylated proteins were 
isolated from 75μg of total protein. Lanes identified as one-fifth of the total input are 
15μg of each sample lysate that was set aside to quantitate the total amount of 
biotinylated proteins. Biotinylated lanes are the streptavidin-bound proteins that were 
eluted from the beads and separated by SDS-PAGE (15%). The calnexin (CNX) 
immunoblot shows that the majority of the cells remained intact during the biotinylation 
procedure. (B) quantification of the biotinylated E1 proteins. The percentage of 
biotinylated protein was calculated by dividing the band intensities in the biotinylated 
lane by the band intensities in the one-fifth total input lane, which were multiplied by 
five. There was no significant difference between background calnexin labeling and cell 
surface labeling of E1 when the peptide was expressed alone. Co-expression with Q1 
results in 34±11%E1 protein on the cell surface after subtracting for background cell lysis 
(calnexin control).The error bars are standard error measurement (S.E.M.) from three 
immunoblots. The dotted line indicates background biotinylation, which was calculated 
from calnexin staining (4±1%). 
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was used as an internal control in all experiments.  The percentage of E1 protein at the 
cell surface was quantitated as a ratio of biotinylated proteins over the total protein input 
shown in Figure 2.4B.  For Q1-E1, ~35% of E1 protein was at the cell surface after 
background subtraction.  For E1 alone, the percentage of protein detected on the cell 
surface by biotinylation was within error of background calnexin labeling.   
Because E1 does not reach the plasma membrane when it is expressed alone, we 
determined its intracellular localization.  Results from enzymatic deglycosylation (Figure 
2.2) narrow the spectrum of intracellular locales to the ER and/or cis-Golgi because the 
glycans on E1 were predominately immature.  Initial examination of the intracellularly 
localized E1 protein by immunofluorescence afforded weak overall staining.  The 
strongest signals were punctate in nature and not reminiscent of ER staining, as can be 
seen in the E1 permeabilized cells in Figure 2.3.  Accordingly, E1 did not co-stain with 
ER markers (data not shown). These observations did not correlate with the strong 
protein expression seen in Western blots (Figure 2.1).  We wondered whether antibody 
accessibility to the E1 HA tag was being prevented by lumenal proteins binding to the E1 
N terminus because this extracellular tag is positioned between the two N-linked 
glycosylation consensus sequences (Wang and Goldstein, 1995).  Thus, we repositioned 
the HA tag to the intracellular C terminus of E1 (Appendix II).  This C-terminal construct 
behaved similarly to the extracellularly tagged construct in all aspects; it assembled with 
Q1 channel subunits to afford the cardiac IKs current and required co-expression with Q1 
to reach the cell surface with mature N-linked glycans (Appendix II).  In contrast to the 
extracellularly tagged E1 construct, visualization of the C-terminally HA-tagged E1   
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Figure 2.5: Intracellular distribution of KCNE1 peptides in CHO cells.  (A) co-
localization of E1 with intracellular markers. CHO cells expressing E1 alone were 
labeled for E1 along with an ER marker, calnexin (CNX), a cis-Golgi network marker 
(β’-COP), or a trans-Golgi network marker, EYFP-Golgi (YFP-Golgi). (B) co-
immunoprecipitation (IP) of E1 with anti-Q1 antibody. Digitonin-solubilized CHO cells 
expressing E1 alone (E1) or co-expressed with Q1 (Q1/E1) were incubated with (+) or 
without (–) anti-Q1 antibody. One-fifth of the total detergent solubilized lysate (1/5th 
Input) and the precipitates were analyzed by SDS-PAGE. 
 
 
  
 69 
protein by immunofluorescence gave strong perinuclear staining (Figure 2.5A).  
Counterstaining with calnexin and overlaying the images showed that the majority of E1 
protein co-stains with this ER marker, although some E1 protein did not.  E1 also co-
stained with the cis-Golgi marker, β′COP (Palmer et al., 1993); however, the majority of 
the E1 protein stained in a pattern similar to calnexin.  Little to no co-staining was 
observed when E1 was expressed with EYFP-Golgi, which localizes to the trans-Golgi 
network.   
The intracellular staining of E1 showed that the majority of the protein resides in 
the ER when it is expressed alone.  We determined whether Q1 subunits could co-
assemble with the immature glycoforms of E1 found in the ER.  Figure 2.5B shows that 
all glycoforms, mature, immature, and unglycosylated, co-immunoprecipitate with Q1.  
Immunoprecipitation of E1 required co-expression with Q1 because no bands were 
observed when E1 was expressed alone.   
To verify that there are inherent differences in cellular trafficking of E1 in HEK 
cells versus CHO and COS-7 cells and not variability in experimental design, reagents, or 
constructs, we also examined E1 protein expression and trafficking in HEK cells.  Unlike 
in CHO and COS-7 cells, expression of E1 in HEK cells primarily afforded the higher 
molecular mass species when it was expressed alone or with Q1 (Figure 2.6).  Treatment 
with Endo H and PNGase F confirmed that this species contained mature N-linked 
glycosylation.  As we observed with CHO and COS-7 cells, PNGase F digestion of E1 
peptides from HEK cell lysates resulted in bands (indicated by the asterisks) that 
migrated slower than both immature and unglycosylated protein.  Nonetheless, these   
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Figure 2.6: KCNE1 glycopeptides in HEK cells mature when expressed with or 
without K+ channel subunits.  Shown is an immunoblot of enzymatic deglycosylation 
of E1 peptides from SDS-solubilized HEK cells transfected with E1, Q1/E1, or Q1 
(negative control) DNA. Expression of E1 with or without Q1 channel subunits results in 
robust expression of a 37 kDa band that was identified as the mature N-linked glycan 
after enzymatic deglycosylation. The samples were left untreated (–), heat-treated (Δ) to 
95 °C for 5 min, digested with Endo H or PNGase F, and separated by SDS-PAGE 
(15%). Mature (mat), immature (imm), and unglycosylated (un) samples are indicated as 
determined by enzymatic deglycosylation. The asterisks (*) denote PNGase F digestion 
products that consistently migrated slower than unglycosylated or immature, which was 
also observed in CHO (Figure 2.2) and COS-7 (data not shown). 
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results show that the N-linked glycans on E1 peptides in HEK cells mature without 
transiently expressed K+ channel subunits.   
Given that E1 peptides in HEK cells exit the ER and traffic through the Golgi 
without co-expressed K+ channel subunits, we determined whether these peptides were 
reaching the plasma membrane.  Using immunofluorescence, some cell surface staining 
was observed for E1 when expressed alone (Figure 2.7A).  However, the number of 
fluorescent cells and the intensity of cell surface staining were noticeably less than what 
was observed for Q1-E1.  Quantitation of the cell surface proteins using biotinylation 
confirmed this qualitative observation.  When E1 was expressed alone, 4 ± 2% of the 
protein was at the cell surface after calnexin subtraction; co-expression with Q1 increased 
the E1 cell surface protein to 22 ± 3%.   
The combination of weak cell surface expression and the overwhelming 
maturation of the N-linked glycans on E1 when it is expressed in HEK cells prompted us 
to examine its intracellular distribution.  The C-terminally HA-tagged version of E1 was 
expressed in HEK cells and overlaid with a panel of intracellular markers (Figure 2.7B).  
Negligible co-staining was observed with the ER marker, calnexin.  Modest co-staining 
was observed with β′COP, but a substantial amount of E1 co-localized with EYFP-Golgi 
in the trans-Golgi network.  However, in all merged images, there was some E1 protein 
that did not co-stain with any of the markers used.  In total, these results in HEK cells 
demonstrate that the E1 protein traffics through the ER and to the Golgi apparatus 
without an exogenously expressed K+ channel.   
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Figure 2.7: Solitary KCNE1 peptides traffic to the trans-Golgi in HEK cells and 
depend on KCNQ1 K+ channel subunits for cell surface expression.  (A) cell surface 
immunostaining of E1 in HEK cells. Intact cells transfected with E1 or Q1-E1 DNA were 
fixed, labeled with Alexa 594-conjugated antibodies, and visualized by wide field 
microscopy. The images shown are single 0.4-μm planes through the center of each cell. 
Differential interference contrast (DIC) panels show both transfected and nontransfected 
cells. Green fluorescent protein (GFP) panels identify transfected cells. Alexa 594 panels 
show cell surface staining of E1. (B) co-localization of E1 with intracellular markers. 
HEK cells expressing E1 alone were labeled for E1 along with an ER marker, calnexin 
(CNX), a cis-Golgi network marker (β’-COP), or a trans-Golgi network marker, EYFP-
Golgi (YFPGolgi). Note that the calnexin/E1 panels have two cells, but only the bottom 
cell expresses E1. 
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DISCUSSION 
 
We studied the trafficking of E1 peptides through the biosynthetic pathway by 
following the maturation of the oligosaccharides on E1 because N-linked glycan 
processing is intimately tied to cellular compartmentalization (Helenius and Aebi, 2001).  
By expressing E1 alone, with Q1, or with Q4 (a K+ channel that does not assemble with 
E1), we determined that E1 glycoproteins do not mature unless they are co-expressed 
with K+ channel subunits that assemble with KCNE peptides.  In addition, cell surface 
expression of E1 was also co-dependent on Q1 subunit expression, which was 
demonstrated in both qualitative and quantitative cell surface labeling experiments. 
Moreover, only the mature form of E1 was ever observed at the cell surface, indicating 
that the immature E1 protein bands observed at ∼20 kDa do not correspond to E1 protein 
in functioning Q1-E1 complexes at the plasma membrane.  Our results in CHO and COS-
7 cells recapitulate what has been observed in Caenorhabditis elegans where a KCNE 
homolog requires its corresponding K+ channel subunits to reach the cell surface (Bianchi 
et al., 2003).   
The presence of immature N-linked glycans on E1 indicates that these proteins 
have yet to traffic beyond the cis-Golgi in the biosynthetic pathway and strongly suggests 
that unpartnered E1 peptides are actively prevented from trafficking past these early 
compartments in the secretory pathway.  Co-localization experiments using a panel of 
intracellular markers place the majority of the E1 protein in the ER and a small fraction in 
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the cis-Golgi. Although these results cannot rule out Q1-E1 complex assembly in the cis-
Golgi, the sheer abundance of unpartnered E1 peptides in the ER and co-
immunoprecipitation of the immature and unglycosylated E1 with Q1 strongly suggest 
that Q1-E1 complex assembly occurs in the ER.  An ER-based assembly for Q1-E1 
complexes directly contradicts two previous functional studies where it was proposed that 
complex assembly occurs at the plasma membrane (Romey et al., 1997; Grunnet et al., 
2002).  The basis for this proposal was that Xenopus oocytes expressing unpartnered Q1 
K+ currents could be converted to KCNE-modulated currents within 24 h by a subsequent 
injection of KCNE mRNA.  However, this functional change was the only evidence in 
support of this hypothesis.  The cell surface and ER lifetimes of Q1 protein were not 
measured, nor was it directly shown that previously unpartnered, plasma membrane Q1 
channels acquired newly synthesized KCNE peptides.  The fact that the majority of the 
unassembled E1 peptides reside in the ER, possess immature N-linked glycans, and do 
not reach the cell surface in the absence of Q1 channel subunits eliminates a plasma 
membrane-based assembly mechanism for Q1-E1 complexes.   
Enzymatic deglycosylation assays also revealed that E1 peptides potentially 
possess another post-translational modification, because we routinely observed digestion 
products that migrated slower than unglycosylated E1 (Figures 2.2 and 2.5) in all three 
cell lines: CHO, COS-7, and HEK. These bands appeared whether the E1 peptide 
possessed either or both N-linked glycosylation sites.  In addition, changing the detergent 
composition used for cell lysis or the concentration of SDS in the loading buffer did not 
change the migration or intensity of these bands.  The modification may be specific to E1 
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because PNGase F treatment of KCNE3 peptides co-expressed with Q1 channels in 
Xenopus oocytes (Gage and Kobertz, 2004), and CHO cells are completely digested to 
unglycosylated peptides (Gage and Kobertz, unpublished results).  The retarded 
migration is not due to phosphorylation because treatment with phosphatase had no effect 
on the mobility of these bands.  These residual bands were also resistant to a subsequent 
neuraminidase treatment, suggesting that if O-linked glycans are present on E1, the 
removal of terminal sialic acids does not change the mobility of the protein on a 
denaturing gel.  Neuraminidase treatment of the N-linked glycans on Q1-E1, however, 
did show a subtle redistribution of the heterogenous E1 mature bands consistent with the 
removal of sialic acid residues (data not shown).   
Previous studies of E1 trafficking in HEK cells observed that wild type E1 
peptides could readily exit the ER with or without a co-expressed K+ channel 
(Krumerman et al., 2004).  In light of our contrasting results using CHO and COS-7 cells, 
we re-examined the cellular processing of E1 protein in HEK cells.  As was previously 
reported, E1 peptides exited the ER without the exogenous expression of K+ channels 
subunits. Using immunofluorescence, E1 protein could be detected at the plasma 
membrane in some cells; however, quantitative analysis of the cell surface population by 
biotin labeling revealed that the expression of E1 alone was barely detectable after 
background subtraction (4 ± 2%) and was considerably lower when compared with co-
expression with Q1 (22 ± 3%).  Visualization of the intracellular distribution of E1 in 
HEK cells by immunofluorescence showed that the majority of the protein has trafficked 
past both the ER and cis-Golgi.  Some E1 protein is localized to the trans-Golgi network; 
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however, a fair amount of E1 does not co-stain with any of the secretory pathway 
markers used.  The presence of E1 protein in the ER and cis- and trans-Golgi leaves open 
the possibility that Q1-E1 complex assembly in HEK cells may not be confined to the 
early compartments of the secretory pathway.  This series of experiments suggests that 
the majority of the E1 protein in HEK cells exits the ER but is trapped in the trans-Golgi 
or is trafficked to another compartment in the cell. Redistribution of E1 peptides to 
intracellular vesicles may be an ancillary mechanism that occurs in HEK cells to redirect 
unassembled, mature E1 peptides to recycling and degradation compartments.   
These contrasting results suggest that there are inherent differences in KCNE 
trafficking in HEK versus CHO or COS-7 cells.  Traditionally, the biochemical 
investigation of K+ channel α- and β- subunits has been performed in HEK cells because 
copious amounts of protein can be generated; however, these cells have been avoided for 
electrophysiological studies because endogenous voltage-gated K+ currents can be 
measured (Jiang et al., 2002a).  It is now known that some of these K+ channels can 
assemble with KCNE peptides, including E1 (Lewis et al., 2004).  The presence of native 
K+ channels in HEK cells could explain the enigmatic trafficking of E1.  In HEK cells, 
E1 peptides do not reach the plasma membrane unaccompanied but assemble with 
endogenous K+ channel subunits in the secretory pathway.  This inference harkens back 
to the initial discovery of E1 by expression cloning in Xenopus oocytes, where 
exogenously introduced E1 peptides assembled with endogenous Q1 channel subunits 
and trafficked to the plasma membrane producing the cardiac IKs current (Takumi et al., 
1988; Folander et al., 1990).  The low cell surface expression of E1 supports the idea that 
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it forms complexes with limiting amounts of endogenous K+ channel subunits.  However, 
the lack of immature E1 observed in our immunoblots suggests that protein 
overexpression may also contribute to the artificial ER exit of E1 in HEK cells.  Whether 
cell surface expression of E1 is mediated by endogenous K+ channels or by 
overwhelming the retention/retrieval machineries of the cell, studying the assembly and 
trafficking of KCNE peptides in HEK cells should be avoided.   
The ER has two well known mechanisms for retaining misfolded and 
unassembled protein subunits: recognition of ER retention/retrieval signal sequences and 
chaperone-mediated retention of N-linked glycoproteins.  The best studied ER retention 
signal to date is the RXR motif, which has been shown to regulate the ER exit of KATP 
channel subunits and sulfonylurea receptors (Zerangue et al., 1999).  ER retention 
through this motif is a stringently controlled mechanism because neither protein can 
escape the ER with this signal sequence exposed.  E1 peptides do not possess such a 
motif nor are they exquisitely retained in the ER when overexpressed in CHO or COS-7 
cells, because faint bands that corresponded to mature glycoprotein were always observed 
with solitary expression of E1 (Figures 2.1 and 2.2).  Because we also observe some E1 
protein in the cis-Golgi, it is possible that E1 is subject to ER retrieval. E1 does possess a 
KKXX sequence, which is a known ER retrieval signal sequence (Ellgaard and Helenius, 
2003); however, the juxtaposition of this motif to the transmembrane domain suggests 
that it may function only as a membrane stop transfer signal (Shikano and Li, 2003). It is 
likely that E1 peptides are, in part, retained in the ER via their N-linked glycans through 
the calnexin/calreticulin quality control pathway, which has been shown to aid in the 
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stability and ER exit of K+ channel α-subunits (Khanna et al., 2004).  A 
calnexin/calreticulin association with the E1 N terminus would also explain the lack of 
ER staining that we observed with the extracellularly HA-tagged E1 construct, which 
necessitated repositioning of the tag. If E1 peptides are retained in the ER by calnexin or 
calreticulin, this mechanism would be applicable to all KCNE peptides because the N-
linked consensus site closest to the N terminus is conserved throughout the family.  It is 
also feasible that multiple retention/retrieval machineries are acting on unassembled E1 
peptides or that Q1-E1 co-assembly promotes active export of the complex from the ER.   
The goal in preventing unassembled K+ channel α- and β- subunits from leaving 
the ER is to ensure the formation of fully assembled K+ channel complexes because 
unpartnered K+ channels would have inappropriate gating and ion conducting properties.  
Although our results show that unpartnered E1 peptides reside primarily in the ER, 
homotetrameric Q1 channels have been shown to exit the ER and function at the plasma 
membrane in several different ion channel expression systems, including CHO and COS-
7 cells (Pusch et al., 1998; Tinel et al., 2000; Melman et al., 2001).  In E1 knock-out 
mice, however, Q1 channels do not traffic to the apical membranes of vestibular dark 
cells, where they would normally be found with E1 in wild type cells (Nicolas et al., 
2001).  In addition, RNA interference experiments in C. elegans suggest that the stability 
of the K+ channel complex is dependent on the presence of both pore-forming and 
KCNE-like subunits (Bianchi et al., 2003).  The discordant observation of unpartnered 
Q1 channels at the cell surface in expression systems may be due to Q1 channels leaking 
from the ER as a result of overexpression.  Consistent with swamping the ER with 
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overexpressed protein is the fact that the majority of the Q1 protein in expression systems 
is intracellular (Schroeder et al., 2000).  Moreover, Q1 expressed in Xenopus oocytes or 
CHO cells is not N-linked glycosylated (Gage and Kobertz, unpublished results) and thus 
not subject to glycosylation-dependent ER retention.  An alternative explanation for the 
ER exit of unpartnered Q1 channels is that E1 protein synthesis always precedes Q1 
subunit expression in native tissues.  With this temporal control, the ER is always chock 
full of E1 peptides that can readily assemble with newly synthesized K+ channel subunits.  
This mechanism alleviates the need to retain unpartnered Q1 channels as long as the rate 
of co-assembly with E1 is faster than ER exit of the homotetrameric channel.  There is 
some in vivo evidence in the developing ear to support this notion, because E1 protein is 
expressed in embryonic mouse vestibular dark cells 24 h before the Q1 protein (Nicolas 
et al., 2001).   
Many studies have shown that modulation of voltage-gated K+ channels by 
KCNE peptides provides the functional diversity required for these complexes to work in 
the nervous system, muscle, colon, ear, and heart; however, for proper biological function 
these complexes must reach the plasma membrane fully assembled.  Our results show 
that E1 peptides cannot advance past the cis-Golgi until they assemble with Q1 channel 
subunits, which is the first step in the assembly and trafficking of KCNE-K+ channel 
complexes.  Given that mutations in KCNE peptides effect the assembly and trafficking 
of the entire K+ channel complex and cause long QT syndrome, identifying the cellular 
machineries that directly ensure the proper assembly and trafficking of healthy KCNE-K+ 
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channel complexes will be critical for following and interpreting the aberrant assembly 
and trafficking of diseased complexes.   
This study laid the foundation of the next chapter where we investigated the N-
linked glycosylation behavior of the two sequons on KCNE1.   
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EXPERIMENTAL PROCEDURES 
 
Plasmids and cDNAs.  Human Q1 and E1 were subcloned into pcDNA3.1(-) 
(Invitrogen).  Two hemagglutinin A (HA)-tagged versions of E1 were used.  For cell 
surface immunofluorescence experiments, an extracellular HA tag (YPYDVPDYA) was 
incorporated in the E1 N terminus between residues 22 and 23 (Wang and Goldstein, 
1995).  For intracellular immunolocalization experiments, an HA tag was appended to the 
E1 C terminus via a SGSG linker.  Biochemical experiments were performed with both 
HA constructs.  For consistency, only the data from the extracellularly tagged version is 
shown.   
Cell Culture and Transfections.  Chinese Hamster Ovary-K1 (CHO) cells were 
cultured in F-12K nutrient mixture (Invitrogen).  HEK cells and African green monkey 
kidney (COS-7) cells were cultured in Dulbecco's modified Eagle's medium (Sigma). All 
of the media were supplemented with 10% fetal bovine serum (Hyclone) and 100 
units/ml penicillin/streptomycin (Invitrogen).  For biochemical analysis, the cells were 
plated at 60-75% confluency in 35-mm dishes.  After 24 h, the cells were transiently 
transfected at room temperature with E1 alone, Q1-E1, or Q4-E1 at a ratio of 0.5 μg/1.5 
μg with 8 μl of Lipofectamine (Invitrogen) for CHO cells or at a ratio of 0.25 μg/0.25 μg 
(COS-7 cells), 1.25 μg/2.5 μg (HEK cells) with 10 μl of Lipofectamine 2000 
(Invitrogen).  Empty pcDNA 3.1(-) plasmid DNA (0.5 μg for CHO, 0.25 μg for COS-7, 
and 1.25 μg for HEK) was co-transfected in samples containing only E1 DNA to keep the 
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total transfected DNA constant in all wells.  To increase the amount of E1 protein with 
complex glycans in CHO cells, 0.75 μg of Q1 DNA was used in the co-transfection.  For 
immunofluorescence studies, the cells were plated at 50% confluency onto sterile 12-mm 
glass coverslips (untreated for CHO cells, poly-d-lysine treated for HEK cells) in 24-well 
plates. For cell surface immunofluorescence, the cells were transiently transfected with 
E1 alone, Q1-E1, or Q4-E1 by scaling down the DNA (optimized ratio for CHO cells) 
and lipid levels by one-fifth; 0.2 μg of a vector containing green fluorescent protein was 
co-transfected to serve as a transfection control.  For co-localization with ER and cis-
Golgi markers, 0.3 μg of E1 was transfected; to visualize trans-Golgi, 0.3 μg of EYFP-
Golgi (Clontech) was also transfected. Co-localization studies were performed 24 h post-
transfection. For all other experiments, the cells were used 48 h post-transfection.   
Cell Lysis and Western Blot Analysis.  The cells were washed in ice-cold PBS (3 
× 2 ml) and lysed at 4 °C in three different detergent buffers: 1% SDS lysis buffer (10 
mm Tris·HCl, pH 7.5, 150 mm NaCl, 1 mm EDTA, 1% SDS (w/v)), 1.5% digitonin lysis 
buffer (20 mm Tris·HCl, pH 7.4, 140 mm NaCl, 10 mm KCl, 1 mm MgCl2, 1.5% 
digitonin), and RIPKA lysis buffer (10 mm Tris·HCl, pH 7.4, 140 mm NaCl, 10 mm KCl, 
1 mm EDTA, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate).  All of the 
detergent buffers were supplemented with protease inhibitors, 1 mm 
phenylmethylsulfonyl fluoride, and 1 μg/ml each of leupeptin, pepstatin, and aprotinin. 
For expression gels, CHO cells were lysed in 300 μl of 1% SDS buffer, and COS-7 cells 
were lysed in 250 μl of RIPKA buffer.  Cell debris was pelleted in a microcentrifuge 
(16,100 × g for 10 min at room temperature).  The supernatants were diluted with SDS-
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PAGE loading buffer containing 100 mm dithiothreitol, separated on a 15% SDS-
polyacrylamide gel, and transferred to nitrocellulose (0.2 μ; Schleicher & Schuell).  The 
membranes were blocked in Western blocking buffer (5% nonfat dry milk in Tris-
buffered saline containing 0.2% Tween 20 (TBS-T)) for 30 min at room temperature and 
then incubated with rat anti-HA (Roche Applied Science) (1:750) in Western blocking 
buffer overnight at 4 °C.  The membranes were washed in TBS-T (four times for 5 min) 
and incubated with goat anti-rat horseradish peroxidase-conjugated antibody (Santa Cruz 
Biotechnology, Inc.) (1:2000) in Western blocking buffer for 45 min at room 
temperature.  The membranes were subsequently washed with TBS-T (four times for 5 
min).  Horseradish peroxidase-bound proteins were detected by chemiluminescence using 
SuperSignal West Dura Extended Duration Substrate (Pierce) and a Fujifilm LAS-3000 
CCD camera.   
Endo H and PNGase F Deglycosylation Analysis.  The cell lysates (30 μl) were 
diluted to 0.5% SDS with water and raised to 1% Nonidet P-40 (for PNGase F analysis 
only), 1% β-mercaptoethanol, 50 mm sodium citrate, pH 5.5 (for Endo H analysis) or 50 
mm sodium phosphate, pH 7.5 (for PNGase F analysis) and then digested with Endo Hf 
(1 μl) or PNGase F (2 μl) (New England BioLabs, Inc.) for 30 min at 37 °C.  The samples 
were then raised to 100 mm dithiothreitol and 3.5% SDS before resolving by SDS-PAGE 
(15% gel) and analyzed by Western blot.   
KCNE1 Co-immunoprecipitation.  The cells were washed in ice-cold PBS (3 × 2 
ml) and lysed at 4 °C in 250 μl of 1.5% digitonin buffer. The cell debris was pelleted in a 
microcentrifuge (16,100 × g for 15 min at room temperature).  30 μl of cell lysate was 
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incubated with 5 μl of anti-Q1 antibody (Santa Cruz Biotechnology, Inc.) for 2 h at room 
temperature.  The samples were bound to protein G beads (Pierce) for 2 h at room 
temperature to separate out antibody-bound protein complexes from the cell lysate.  The 
beads were washed (three times with 500 μl) in digitonin-free wash buffer (20 mm 
Tris·HCl, pH 7.4, 140 mm NaCl, 10 mm KCl, 1 mm MgCl2.  Co-immunoprecipitated 
proteins were eluted from the beads using 1× SDS-PAGE loading buffer with 200 mm 
dithiothreitol for 15 min at room temperature.  One-fifth of the total input used for the co-
immunoprecipitation assay and eluted proteins were resolved by SDS-PAGE (15% gel) 
and analyzed by Western blot.   
Immunofluorescence.  For visualization of intact cells, the cells were first labeled 
with rat anti-HA antibody (1:200) in culture medium for 30 min at 37 °C.  The cells were 
rinsed quickly in warm PBS (3 × 2 ml) before fixing in 4% paraformaldehyde (10 min at 
room temperature).  The cells were then blocked in blocking solution (PBS containing 
5% normal goat serum (Vector Laboratory, Inc.), 1% IgG-free bovine serum albumin 
(Sigma)) for 30 min at room temperature.  For permeabilized samples, the cells were first 
washed in PBS (3 × 2 ml) and then fixed in 4% paraformaldehyde (10 min at room 
temperature).  The cells were blocked in Triton blocking buffer (blocking solution 
containing 0.2% Triton X-100) and then incubated with rat anti-HA antibody (1:500) in 
Triton blocking buffer for 1 h at room temperature.  Nonpermeabilized and permeabilized 
samples were then washed with PBS (3 × 5 min) and incubated with goat anti-rat Alexa 
Fluor 594-conjugated antibody (Molecular Probes) (1:2000) in blocking solution or 
Triton blocking solution, respectively, for 45 min at room temperature.  The cells were 
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then washed with PBS (two times for 5 min; then for 1 h).  The coverslips were dried at 
37 °C for 45 min before mounting on slides with ProLong® Gold Antifade mounting 
solution (Molecular Probes).  For co-staining with intracellular markers, the cells were 
fixed in 100% methanol at -20 °C for 8 min, rehydrated in PBS for 5 min, and blocked 
overnight in SeaBlock Blocking buffer (Pierce).  The cells were first incubated with 
rabbit anti-calnexin (Stressgen) (1:500) or concentrated mouse serum from monoclonal 
antibody CM1A10 for β′ coatomer protein (anti-β′COP) (Palmer et al., 1993; Gomez et 
al., 2000) (1:10) in SeaBlock Blocking buffer at room temperature for 90 min.  The cells 
were then washed with PBS (3 × 10 min) and incubated with donkey anti-rabbit Alexa 
Fluor 488-conjugated antibody (1:500) or donkey anti-mouse Alexa Fluor 488-
conjugated antibody (1:250) (Molecular Probes) in SeaBlock blocking buffer at room 
temperature for 90 min.  The cells were washed in PBS (three times for 10 min) and 
labeled for E1 as described above with rat anti-HA (1:100) followed by goat anti-rat 
Alexa Fluor 594-conjugated antibody (1:500) in SeaBlock blocking buffer.  After a final 
set of PBS washes (three times for 10 min), the coverslips were mounted on slides with 
Vectashield® mounting medium (Vector Laboratories).  All of the cells were visualized 
using a Zeiss Axiovert 200M microscope with a 63 × 1.4 N.A. oil immersion objective. z 
stacks were generated by obtaining optical sections through the samples 0.4 μm apart 
along the z axis.  Deconvolution of z stack images was performed with a constrained 
iterative algorithm on Slidebook 4.0 software (Intelligent Imaging Innovations) using a 
measured point spread function.  The images are displayed as single 0.4-μm planes 
through the center of each cell.   
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Cell Surface Biotinylation.  The cells were rinsed with ice-cold PBS2+ buffer (four 
times with 2 ml; PBS containing 1 mm MgCl2, 0.1 mm CaCl2) at 4 °C to arrest 
membrane internalization. The cells were then incubated with 1 mg/ml sulfo-NHS-SS-
biotin (Pierce) in PBS2+ buffer twice for 15 min at 4 °C.  To quench the excess 
biotinylation reagent, the cells were washed quickly (three times with 2 ml) with quench 
solution (PBS2+ containing 100 mm glycine) and then incubated with quench solution 
twice for 15 min at 4 °C.  The cells were lysed in RIPKA buffer for 30 min at 4 °C. Cell 
debris was removed by centrifugation (16,100 × g for 10 min at 4 °C). Total protein in 
each sample was quantitated by BCA analysis.  Of these samples, 75 μg of total protein 
was separated by affinity chromatography on 25 μl of Immunopure® immobilized 
streptavidin beads (Pierce) overnight at 4 °C, whereas 15 μg was saved as an input 
control to determine the percentage of biotinylated proteins.  The beads were washed 
(three times with 500 μl) in 0.1% SDS wash buffer (10 mm Tris·HCl, pH 7.4, 150 mm 
NaCl, 1 mm EDTA, 0.1% SDS).  Biotinylated proteins were eluted from the beads using 
2× SDS-PAGE loading buffer with 200 mm dithiothreitol for 15 min at 55 °C.  The 
inputs and eluted proteins were resolved by SDS-PAGE (15% gel) and analyzed by 
Western blot.  The images of nonsaturated bands were captured on a Fujifilm LAS-3000 
CCD camera, and the band intensities were quantitated using MultiGauge V2.1 software 
(FujiFilm).  An ER-resident protein, calnexin, was used as a control to determine the 
percentage of cell rupture that occurred during the labeling process.  Background cell 
lysis was quantitated as a ratio of biotinylated calnexin protein to total input calnexin.  
 89 
The percentage of E1 protein on the cell surface was calculated from the ratio of avidin-
bound protein to total input protein after background lysis subtraction.   
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CHAPTER III 
 
Post-Translational N-Glycosylation of Type I Transmembrane KCNE1 Peptides:  
Implications for Membrane Protein Assembly in the Endoplasmic Reticulum 
 
 
Contributors to the work presented in Chapter III: 
 
The author of this thesis, Tuba Bas performed all the experiments other than 
electrophysiological studies and the proteosomal inhibitor experiment.  Kshama 
Chandrasekhar did the preliminary work.  Anatoli Lvov provided electrophysiology data.  
Yuan Gao performed the proteosomal inhibitor experiment.   
 
 
 
 
 
 
*  Bas, T., Chandrasekhar, K. D., Lvov, A., Gao, Y, Gilmore, R., and Kobertz, W. R. 2010. Post-
Translational N-Glycosylation of Type I Transmembrane KCNE1 Peptides:  Implications for Disease.   
Manuscript in Preparation.   
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ABSTRACT 
 
N-linked glycosylation of membrane proteins is critical for their proper folding, 
co-assembly and subsequent matriculation through the secretory pathway.  Here we 
examine the kinetics and efficiency of N-linked glycan addition to type I transmembrane 
KCNE1 K+ channel β-subunits, where point mutations that prevent N-glycosylation give 
rise to disorders of the cardiac rhythm and congenital deafness.  We show that KCNE1 
has two distinct N-linked glycosylation sites:  a traditional co-translational site and a 
consensus site ~ 20 residues away that unexpectedly acquires N-linked glycans after 
protein synthesis (post-translationally).  Mutations that prevent N-glycosylation at the co-
translational site concomitantly reduce post-translational glycosylation, resulting in a 
large population of unglycosylated KCNE1 peptides that do not reach the cell surface 
with their cognate K+ channel.  This long range disruption of post-translational N-glycan 
addition directly explains how a single point mutation can prevent N-glycosylation at 
multiple consensus sites, providing a new biogenic mechanism for human disease.  These 
results demonstrate that post-translational N-glycosylation in the endoplasmic reticulum 
is a cellular mechanism that ensures type I transmembrane proteins acquire the maximal 
number of glycans needed for proper membrane protein assembly and trafficking.   
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INTRODUCTION 
 
Asparagine-linked (N-linked) glycosylation is a highly-conserved protein 
modification that eukaryotic cells utilize for the proper folding, assembly and trafficking 
of membrane and secreted proteins.  The initial attachment of N-linked glycans to 
polypeptides occurs in the endoplasmic reticulum (ER), where the 
oligosaccharyltransferase (OST) complex efficiently transfers a high mannose 
oligosaccharide onto asparagine residues within the primary sequence N-X-T/S-Y 
(sequon, where X and Y can be any natural amino acid other than proline) (Marshall, 
1972; Silberstein and Gilmore, 1996).  Although commonly referred to as a post-
translational protein modification, N-linked glycosylation in mammalian cells typically 
occurs during translation as the nascent polypeptide is threaded through the translocation 
tunnel into the ER lumen (Weerapana and Imperiali, 2006).  Recently, however, one of 
the mammalian isoforms (STT3B) of the active site subunit of the ER resident OST 
complex has been shown to mediate post-translational N-glycosylation of a secreted 
protein, human blood coagulation factor VII (Ruiz-Canada et al., 2009).  To date, factor 
VII is the only reported full-length protein that is post-translationally N-glycosylated in 
mammalian cells with intact N-glycosylation machinery (Bolt et al., 2005).  Factor VII 
curiously contains two distinct sequons:  one sequon is modified co-translationally 
whereas the second sequon is modified post-translationally, yet the biological 
significance of a protein harboring both a co- and post-translational sequon is unclear. 
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Besides the structurally-distorting proline residue, three other factors can reduce 
or eliminate N-glycosylation of sequons.  (1) Residues at the X-position:  NXS sequons 
with negatively-charged (Asp and Glu) and hydrophobic (Trp and Leu) at the X-position 
are poorer substrates for the OST complex (Shakin-Eshleman et al., 1996; Kasturi et al., 
1997).  (2) Proximity to the C-terminus:  sequons within ~ 60 residues of the C-terminus 
often elude the OST complex, as the chain-terminated protein is believed to more rapidly 
enter the ER lumen through the translocation tunnel (Nilsson and von Heijne, 2000). (3) 
Proximity to a transmembrane domain:  sequons that are less than 12 residues away from 
a transmembrane segment are inaccessible to the OST active site (Nilsson and von 
Heijne, 1993; Cheung and Reithmeier, 2007).  Bioinformatic interrogation of the residues 
flanking sequons (up to 20 residues) has not identified any other sequence motifs that 
have long range effects on N-glycosylation efficiency (Gavel and von Heijne, 1990; Ben-
Dor et al., 2004).   
KCNE1 (E1) is the founding member of a family type I transmembrane K+ 
channel β-subunits that have multiple sequons in their extracellular N-termini.  E1 
peptides have two sequons at N5 and N26, both of which are obligatorily glycosylated in 
native  tissues as well as in standard electrophysiological expression systems (Finley et 
al., 2002; Chandrasekhar et al., 2006; Teixeira et al., 2006).  E1 co-assembles with 
KCNQ1 (Q1) K+ channels to produce the slowly activating cardiac Iks current (Barhanin 
et al., 1996; Sanguinetti et al., 1996) and to recycle potassium in apical membranes of 
strial marginal and vestibular dark cells in the inner ear (Wangemann, 2002).  A mutation 
that disrupts the sequon at N5 (T7I), gives rise to an inherited autosomal recessive form 
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of Long QT Syndrome (LQTS), a disorder of the cardiac rhythm that is accompanied 
with neural deafness, Jervell-Lange-Nielsen Syndrome (JLNS) (Schulze-Bahr et al., 
1997).  An SNP in the equivalent threonine in KCNE2 (T8A) provokes drug-induced 
LQTS with the commonly prescribed antibiotic, sulfamethoxazole (Sesti et al., 2000a; 
Park et al., 2003).  However, the biogenic mechanism that underlies the importance for 
glycosylation at this absolutely conserved sequon remains to be elucidated.   
Given the genetic linkage between N-glycosylation and KCNE biology, we 
determined the efficiency and kinetics of N-glycosylation of the two closely-spaced 
sequons in E1 and the effects of N-glycan occupancy on co-assembly with K+ channel 
subunits and cell surface expression.  By comparing wild type to a panel of E1 
glycosylation mutants in metabolic labeling experiments, we found that the N-terminal 
sequon (N5) acquires its N-linked glycan during translation whereas the second glycan is 
primarily added to the internal sequon (N26) post-translationally.  Unlike co-translational 
glycosylation, post-translational glycosylation was significantly effected by long range 
mutations since ablation of the N-terminal sequon inhibited N-glycan attachment to the 
internal sequon.  Moreover, E1 subunits harboring the LQTS mutation, T7I, exit the 
translocational tunnel unglycosylated where co-assembly with Q1 inhibits post-
translational glycosylation.  These results provide a new biogenic mechanism for 
channelopathies and demonstrate a need for post-translational glycosylation of membrane 
proteins in the endoplasmic reticulum.   
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RESULTS 
 
N-glycan Occupancy of KCNE1 Sequons 
The addition of N-linked glycans via oligosaccharyltransferase (OST) to nascent 
polypeptides in the ER translocation tunnel is conserved from yeast to humans.  
Accordingly, the initial attachment of N-linked glycans to the two N-terminal sequons in 
E1 is identical in a wide range of cells from native (cardiomyocytes and inner ear cells) to 
traditional expression systems (Xenopus oocytes, HEK-293, CHO-K1 and COS-1 
mammalian cells) (Gage and Kobertz, 2004; Chandrasekhar et al., 2006; Teixeira et al., 
2006; Wu et al., 2006).  To examine the two N-linked glycoforms of E1 individually 
(Figure 1A), we made an initial panel of single glycosylation mutants that would result in 
glycan addition to either the N-terminal sequon (N26Q) or the internal sequon (N5Q, 
T7I) and compared them to wild type E1 (WT).  We first examined these E1 mutants 
without a cognate K+ channel in order to follow N-glycosylation without interference 
from co-assembly with K+ channel subunits.  To do this, we expressed these E1 
constructs in CHO cells since these cells lack endogenous voltage-gated K+ channel 
subunits that assemble with E1 peptides (Chandrasekhar et al., 2006).  Transient 
expression of a C-terminal, HA-tagged WT peptide yielded two strong bands at 17 and 
23 kDa on a Western blot (Figure 3.1B, left), which we confirmed with enzymatic 
deglycosylation (Figure 3.S1) were the unglycosylated and immaturely N-linked   
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Figure 3.1: Differential N-linked glycosylation of WT and mutant KCNE1 peptides.  
(A) Schematic representation of KCNE1.  The glycosylation mutants N5Q, T7I and 
N26Q are indicated by arrows.  TM, transmembrane domain.  (B) Immunoblots of WT 
and glycosylation mutant E1 peptides from solubilized CHO cells.  Immature and 
unglycosylated (unglyc) are denoted.  (C) Bar graph of the percentage of glycosylated 
WT and mutant E1 peptides.  Error bars are SEM from n = 3 – 6 immunoblots.   
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glycosylated peptides, respectively (Chandrasekhar et al., 2006).  Ablation of the N-
terminal sequon (N5Q, T7I) unexpectedly prevented glycosylation of the internal sequon, 
resulting in mostly unglycosylated protein.  In contrast, disruption of the internal sequon 
(N26) had no significant effect on glycosylation of the N-terminal sequon, though as 
expected, the mono-glycosylated protein migrated faster than doubly-glycosylated WT.   
Since there was a significance difference in hypoglycosylation between the 
hydrophilic N5Q and hydrophobic T7I mutants (Figure 3.1C), we disrupted the N-
terminal sequon with various residues to determine how mutations at the N-terminal 
sequon effect glycosylation at the internal site twenty residues away.  Substitution of 
asparagine for isoleucine (N5I) reduced glycosylation at the internal site similarly to T7I 
(Figure 3.1B, right).  Mutation to residues less hydrophobic than isoleucine (T7A or 
T7Q) afforded slightly more glycosylated E1 peptide than the isoleucine mutants; 
however, the differences were not statistically significant (Table 3.S1).  Distorting the N-
terminal sequon with proline (T6P) had an intermediate reduction of glycosylation, 
falling significantly between the isoleucine mutants and N5Q.  This trend (T7I, N5I > 
T6P > N5Q > WT) suggests that hydrophobic disruption of N-terminal sequon has a long 
range effect on glycosylation of the internal site, resulting in a bolus of unglycosylated 
E1 peptides.   
Cellular Stabilities of WT and Mutant KCNE1 Peptides 
To identify the cellular mechanism responsible for the large population of 
unglycosylated protein observed with the N-terminal sequon mutants (N5Q, T7I), we first 
determined whether the singly-glycosylated mutants had different protein stabilities.  
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Cells expressing WT and mutant peptides were metabolically-labeled with 35S for 10 
min, chased with cold media, and the E1 peptides were isolated by immunoprecipitation 
at various times (Figure 3.2A).  The total protein (unglycosylated and glycosylated) for 
each time point was normalized in a way to make each data set comparable to one 
another, plotted and fitted to a single exponential decay (Figure 3.2B).  Since the zero 
time point is diluted with partially synthesized peptides (Hershey, 1991), the 5 min chase 
point was defined as maximally-labeled protein for the glycosylation mutants; for WT, 
the 10 min time point was used due to the delay in protein decay (Figure 3.2B).  We also 
plotted the raw data for two WT data sets and calculated the decay rates individually and 
showed that the decay rates were within the range of the normalized average decay rate 
calculated for WT (Figure 3.S2A, Figure 3.S2B and Table 3.1).  Surprisingly, the WT and 
the single site glycosylation mutants had experimentally similar protein stabilities (Table 
3.1).  Moreover, this similarity in protein stability did not change when we measured the 
decay of just the singly-glycosylated form of N26Q.  These results show that protein 
stability does not significantly contribute to the glycosylation ratios observed with the 
single site glycosylation mutants. 
Co- and Post-translational N-Glycosylation of KCNE1 Peptides 
We next determined whether the N-glycosylation rates of WT and the mutant E1 
peptides were different.  To follow the rapid kinetics of N-linked glycosylation, we 
metabolically-labeled cells using 2 min pulses.  This shorter pulse allowed us to 
differentiate between co- and post-translational N-linked glycosylation since all of the E1 
polypeptides initiated during the pulse will be completed by the 5 min chase   
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Figure 3.2: Protein stability of WT and KCNE1 glycosylation mutants are similar.  
(A) Representative fluorographs for WT and glycosylation mutants.  Metabolically-
labeled CHO cells were chased for the indicated times and the E1 peptides were 
immunoprecipitated, separated by electrophoresis, and detected by autoradiography.  2-
Gly: doubly glycosylated; 1-Gly: singly glycosylated; 0-Gly: unglycosylated.  (B) Graphs 
of densitometric analysis.  The total protein at each time point was quantified by 
densitometry, normalized to the total protein at 5 min (except WT: 10 min) and plotted 
versus chase time.  WT: closed circles; N5Q: gray triangles; T7I: open triangles; N26Q: 
gray squares are mean ± SEM (n = 3 – 4) for each chase point for WT, N5Q, T7I and 
N26Q respectively.  Data were fitted to a single exponential and tabulated in Table 3.1.   
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Table 3.1.  Protein decay and post-translational glycosylation rates of KCNE1 
peptides1 
KCNE1 peptide  protein decay (min)
 
ns 
 
 post-translational 
glycosylation (min) ns 
WT 33 ± 4 8.5 ± 2.0    
N5Q 33 ± 5 15 ± 5 
T7I 46 ± 3  20 ± 4 
N26Q 38 ± 2  ND 
N26Q (1-gly) 37 ± 3 NA 
1Data are from 3 – 5 individual experiments.  Data were fitted to a single 
exponential.  Values are mean ± SEM.  nsIndicates that the rates were not 
significantly different from each other (one-way ANOVA with Tukey post-hoc 
analysis (p > 0.5))   ND, not detectable; NA, not applicable. 
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(Hershey, 1991).  Figure 3.3A shows a time course for WT and mutant E1 peptides.  At 
each chase time point, the different glycosylation states were plotted as a percentage of 
the total protein (Figure 3.3B).  For WT, the doubly-glycosylated form of the protein 
steadily increased whereas the singly- and unglycosylated forms decreased over the 
duration of the 20 min time course.  The increase in doubly-glycosylated E1 after the 5 
min chase indicates that N-linked glycans were attached after translation.  Therefore, we 
used the E1 mutants to determine which N-linked glycosylation site(s) were responsible 
for the slower, post-translational glycosylation of WT.  For N26Q, the singly 
glycosylated form was the most abundant within the first 5 minutes, consistent with N-
linked glycan addition to the N-terminal sequon during translation.  Conversely, N5Q and 
T7I were poorly glycosylated during the protein translation time window, resulting in 
predominately unglycosylated protein.  However, for both N5Q and T7I, the singly 
glycosylated form exponentially increased over 5 – 20 min whereas the glycosylation 
state of N26Q remained constant after 5 min (Figure 3.3B, Table 3.1).  This kinetic 
difference in N-linked glycan addition identified the internal glycosylation site as a 
source of the post-translational glycosylation observed with WT E1.  Moreover, the use 
of proteosomal inhibitors did not change this outcome, indicating that the kinetic 
differences in N-linked glycan addition were not due to protein decay (Figure 3.S3A and 
Figure 3.S3B).  We also plotted the raw data for each WT glycoform and showed that 
after 5 min, the fully glycosylated form of WT E1 increased (Figure 3.S4A and Figure 
3.S4B).  Overall, these results demonstrate that the glycosylation timing and efficiency at 
the two sequons on E1 are different:  N-linked glycans are readily added to the   
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Figure 3.3:  KCNE1 peptides are co- and post-translationally N-glycosylated.  (A, C) 
CHO cells were pulsed for 2 min, chased for the indicated times and the E1 peptides were 
immunoprecipitated, separated by electrophoresis, and detected by autoradiography.  
Representative fluorographs for WT and E1 mutants expressed alone (A) and with Q1 
channel subunits (C).  (B) Graphs of densitometric analysis for Fig. 3.3A.  The 
percentage of the different glycoforms with respect to total protein is plotted for each 
time point.  After 5 min, the fully glycosylated forms of WT, N5Q and T7I increased 
whereas N26Q remained constant.  The increase in glycosylation was fitted to a single 
exponential and tabulated in Table 3.1.  N26Q is a linear fit for comparison purposes.  
Data (n = 3 – 5) are mean ± SEM for each chase point.  (D) Graphs of densitometric 
analysis for Fig. 3.3C.  The percentage of the maximally glycosylated form of WT (two) 
and the E1 mutants (one) with respect to total protein is plotted for each time point.  The 
fits from Fig. 3.3B were scaled to compare the post-translational glycosylation rates in 
the presence of Q1 channel subunits.  Data (n = 3 – 5) are mean ± SEM for each chase 
point.  Glycosylation states in all panels are labeled:  2-Gly: open square; 1-Gly: closed 
square; 0-Gly: open circle.   
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N- terminal sequon during translation whereas glycosylation of the internal site is delayed 
and less efficient.   
Since KCNE peptides are regulatory subunits that co-assemble with K+ channel 
subunits in the ER (Krumerman et al., 2004; Chandrasekhar et al., 2006), we next 
determined whether the presence of K+ conducting subunits effected post-translational 
glycosylation of E1 peptides.  Cells co-expressing Q1 channel subunits with WT and 
mutant E1 peptides were pulsed for 2 min and chased at different times to observe post-
translational glycosylation (Figure 3.3C).  Although co-expression with Q1 channel 
subunits eventually leads to N-glycan maturation in the Golgi complex (vide infra), the 
chase time points needed to detect post-translational glycosylation are too short to 
observe maturely glycosylated E1.  Thus, in these experiments, the immature form of E1 
is predicted to be the end glycoform as shown in Figure 3.3C.  The maximally-
glycosylated form of the E1 peptides in the presence of Q1 was calculated from the pulse 
chase data in Figure 3.3C, plotted in Figure 3.3D, and compared to post-translational 
glycosylation of solitary E1 peptides by re-plotting the curves from Figure 3.3B.  Co-
expression with Q1 reduced the overall glycosylation efficiency of the E1 peptides; 
however, the rate of post-translational glycosylation of WT and N5Q was unaffected.  As 
expected, the glycosylation of N26Q was also relatively unaffected by Q1 co-expression 
since this mutant primarily acquires its N-glycans during translation.  In striking contrast, 
post-translational glycosylation of T7I was strongly inhibited, suggesting that co-
assembly with Q1 channel subunits prevents the OST from attaching an N-linked glycan 
to the T7I internal sequon.   
 107 
Consequences of KCNE1 Hypoglycosylation 
We subsequently determined whether the compounded hypoglycosylation of the 
E1 mutants altered their ability to traffic to the cell surface with Q1 subunits.  Given the 
contrasting differences in the current profiles between unpartnered Q1 channels and 
Q1/E1 complexes (Figure 3.4A), we initially used electrophysiology to measure the 
function of WT and mutant Q1/E1 complexes.  Unpartnered Q1 channels give rise to 
small currents that rapidly activate as well as inactivate with depolarization.  In contrast, 
Q1/E1 complexes have larger currents that slowly activate over many seconds and show 
no measurable signs of inactivation.  Thus, co-assembly with E1 bestows the Q1 channel 
with the appropriate properties to maintain the rhythmicity of the heartbeat and provide 
salt and water transport in the inner ear.  Co-expression of Q1 with the glycosylation 
mutants afforded currents that were an amalgam of unpartnered Q1 channels (Figure 
3.4B, arrowheads) and Q1/E1 complexes.  Since the amount of unpartnered Q1 currents 
varied from cell to cell for each individual mutant, we measured the currents from several 
cells and normalized current activity relationships for the E1 mutants to WT (Figure 
3.4C).  The systematic decrease in maximal current of the glycosylation mutants followed 
the hypoglycosylation trend (Figure 3.1C), consistent with fewer Q1/E1 complexes 
functioning at the cell surface.   
To directly measure the plasma membrane expression of the mutant E1 peptides 
co-expressed with Q1 channel subunits, we used cell surface biotinylation.  This 
biochemical approach also allowed for the identification of the E1 glycoforms present on 
the plasma membrane.  Cells expressing WT and mutant Q1/E1 complexes were labeled   
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Figure 3.4:  Current properties of KCNQ1 channels co-expressed with KCNE1 
glycosylation mutants.  (A) Representative families of IQ1 and IKs currents recorded from 
CHO cells using the following voltage protocol: the currents were evoked by 3-s 
depolarization pulses from a holding potential of -80 mV to test voltages –70 to +60 mV 
in 10-mV increments at an interpulse interval of 30 s.  The depolarization pulses were 
followed by repolarization to –30 mV for 2 s to monitor tail currents.  Cells were 
transfected with a KCNQ1 plasmid only (KCNQ1) or cotransfected with WT KCNE1 
(+E1).  (B) Representative families of currents recorded from cells expressing KCNQ1 
and the KCNE1 mutants (+N5Q, +T7I or +N26Q).  Arrow is showing the instantaneous 
current.  (C) Relative mean peak currents (I/Imax) were normalized to the maximal WT Iks 
(+E1) and plotted as a function of the pulse voltage (V).  Data (n = 3 – 5) are mean ± 
SEM. 
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with a membrane impermeant, amine-reactive biotin reagent at 4 ˚C to prevent membrane 
recycling and minimize labeling of intracellular proteins.  The biotinylated proteins were 
isolated with streptavidin beads (Beads) and normalized to their respective endogenous 
calnexin (CNX) signal (½ Input) to compare the cell surface expression of WT to the E1 
mutants (Figure 3.5).  To verify that the cells remained intact during biotinylation, we 
also monitored for labeling of the ER-resident protein, CNX (Beads), and subtracted out 
this background intracellular labeling to calculate the normalized cell surface expression 
in Figure 3.4B.  E1 peptides with a single glycan attached to the N-terminal sequon 
(N26Q) had cell surface expression that was similar to WT (Figure 3.5) and was 
dependent on co-expression with Q1 (Figure 3.S5).  In contrast, E1 mutants lacking the 
N-terminal sequon (N5Q, T7I) were challenging to detect at the plasma membrane even 
when they were co-expressed with Q1.   
We next used enzymatic deglycosylation to determine which glycoforms of the 
mutants were present at the plasma membrane.  As we have previously shown with WT 
Q1/E1 complexes, E1 peptides are post-translationally modified in the Golgi, resulting in 
a strong, but diffuse band centered between 37 and 50 kDa, which is due in part to the 
maturation of the N-linked glycans (Chandrasekhar et al., 2006).  Using deglycosylation 
enzymes (Figure 3.S1B), we identified the unglycosylated, immaturely and maturely N-
glycosylated forms of WT and mutant E1 peptides, which are denoted in Figure 3.5A.  
Although all three glycoforms of WT and the E1 mutants were present in the cells 
(Figure 3.5A, ½ Inputs), only maturely N-glycosylated protein was detected at the cell 
surface over background calnexin labeling.  Moreover, the abundance of intracellular,   
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Figure 3.5:  Mature KCNE1 glycopeptides reach the plasma membrane.  (A) 
Representative immunoblots of WT and the glycosylation mutants co-expressed with 
KCNQ1.  Transfected CHO cells were labeled with a membrane impermeable biotin 
reagent, lysed, and the biotinylated proteins were isolated with streptavidin beads.  Lanes 
denoted as (½ input) are half the sample lysate that was set aside to quantitate the total 
amount of biotinylated proteins.  (Beads) lanes represent the streptavidin-bound proteins 
that were isolated and separated by SDS-PAGE.  The calnexin (CNX) immunoblots were 
used both to determine the amount of background lysis and to compare the cell surface 
expression of the mutants to WT.  The mature (m), immature (im) and unglycosylated 
(un) forms of the E1 glycopeptides were identified by enzymatic deglycosylation (Figure 
3.S1).  (B) Quantification of the biotinylated E1 proteins on the cell surface.  Band 
intensities for biotinylated E1 proteins were calculated as described in the Experimental 
Procedures and normalized to input calnexin for the corresponding data set.  The error 
bars are SEM from n = 3 – 4 immunoblots.   
  
 113 
unglycosylated T7I peptides in the presence of Q1 channel subunits is consistent with 
inhibiting post-translational glycosylation of T7I in Figure 3.3D.  In total, these results 
demonstrate that cell surface expression of E1 peptides requires the acquisition of at least 
one N-linked glycan to reach the plasma membrane.  Thus, mutations that directly 
prevent co- and reduce post-translational N-glycosylation result in a large population of 
unglycosylated E1 peptides, which severely reduces the number of Q1/E1 channel 
complexes at the cell surface. 
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DISCUSSION 
 
Motivated by the genetic evidence that the N-terminal sequon in KCNE peptides 
plays an important role in cardiac biology (Schulze-Bahr et al., 1997; Sesti et al., 2000a; 
Park et al., 2003), we individually examined the kinetics and extent of N-linked 
glycosylation of the two E1 sequons.  The results from our investigation provide four 
mechanistic insights into the biogenesis and N-glycosylation of these type I 
transmembrane peptides.  (1) The two N-linked consensus sites on E1 are handled 
differently in the ER:   glycans are added to the N-terminal sequon during translation 
whereas the glycans are predominately attached to the internal site after translation has 
been completed.  (2) Post-translational glycosylation of E1 peptides lacking a co-
translational site is less efficient, compounding hypoglycosylation and resulting in a 
majority of unglycosylated peptides.  (3) Co-assembly with Q1 channel subunits 
additionally inhibits post-translational glycosylation of some mutant E1 peptides.  (4) 
Unglycosylated E1 peptides do not reach the cell surface with or without Q1 K+ channels.  
Thus, mutations that inhibit co-translational N-glycosylation reduce the population of 
functioning Q1/E1 complexes at the cell surface, providing a biogenic mechanism for 
Long QT and Jervell-Lange Nielsen Syndromes  
Post-Translational Glycosylation of Properly Folded KCNE subunits 
Post-translational glycosylation has been historically associated with cells that 
have compromised N-glycosylation machinery (Duvet et al., 2002) or that express 
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truncated glycoproteins (Kolhekar et al., 1998).  All E1 constructs used here are full-
length.  Moreover, post-translational glycosylation yields the predominant glycoform of  
E1—the doubly glycosylated form—which folds and assembles with Q1 subunits to 
afford K+ channel complexes that generate the hallmark cardiac IKs current (Figure 3.5).  
Similarly, post-translational glycosylation of E1 is neither a cell-specific artifact nor a 
result of depleting the key components of the N-glycosylation pathway.  Post-
translational glycosylation of E1 was observed in several standard mammalian cell lines 
(Figure 3.S6A and Figure 3.S6B), consistent with the conservation of the STT3B subunit, 
which has been recently shown to attach N-glycans to secreted proteins after translation 
(Ruiz-Canada et al., 2009).  We also tried to detect post-translational glycosylation in 
native cells (cardiomyocytes); however, the low endogenous expression of E1 combined 
with the short radioactive pulse (2 min) did not produce enough labeled protein from an 
entire rat heart (data not shown).  Although exogenous expression of E1 was needed to 
generate a detectable protein signal, it did not saturate the co-translational machineries or 
deplete the dolichol-linked oligosaccharides since co-translational glycosylation of 
endogenous cathepsin C was unaffected. (Figure 3.S6C).  Taken together, these results 
suggest that post-translational glycosylation of E1 is a native mechanism that affords 
assembly-competent regulatory subunits essential for proper electrical excitability.  
Proteins with Distinct Co- and Post-translational Sites 
To date, only one full-length protein has been identified that has distinct co- and 
post-translational N-linked glycosylation sites, yet the spacing between the two sites in 
this secreted, water soluble protein is over 170 residues (Bolt et al., 2005).  For a type I 
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transmembrane peptide with closely-spaced N-linked consensus sites, the cellular 
mechanisms that define co- and post-translational glycosylation sequons on E1 are likely 
to be different.  One possible explanation for distinct co- and post-translational sequons is 
that the E1 N-terminus is oriented in the ER translocation tunnel such that the OST 
complex has access to only the N-terminal sequon.  Similarly, the internal sequon could 
simply be occluded by the translocation tunnel.  Previous investigations have utilized the 
―rule of 14‖ for membrane proteins:  N-linked consensus sequences need to be at least 
12-14 residues away from a transmembrane domain to be a substrate for the OST 
complex (Nilsson and von Heijne, 1993; Cheung and Reithmeier, 2007).  However, the 
E1 internal sequon satisfies this rule, as it is 18 residues away from the predicted start of 
the transmembrane segment.  Moreover, the E1 internal sequon is glycosylated, it just 
occurs after translation.  Our results suggest the ER proteins responsible for post-
translational glycosylation have a different set of structural requirements that define 
which consensus sites are acceptable substrates.   
Post-Translational versus Post-Translocational N-glycosylation 
We have shown that the internal sequon of E1 acquires N-linked glycans after 
translation, but do these modifications occur outside of the protein translocation tunnel?  
Although we cannot rule out the possibility that some glycans are post-translationally 
added when the fully-synthesized peptide resides in the translocation tunnel, two 
experimental observations support a mechanism where post-translational glycosylation 
occurs after the transmembrane segment slides into the hydrophobic confines of the 
membrane.  Currently, there are two models for the timing of the lateral entry of a 
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transmembrane segment into the ER membrane based on photo-crosslinking studies.  The 
first model requires the completion of translation before exiting the transloction pore (Do 
et al., 1996), whereas the second model suggests that certain transmembrane segments 
can enter the lipid environment before translation is terminated  (Heinrich et al., 2000; 
McCormick et al., 2003).  Thus, the observation of N-glycosylation events 10 – 15 
minutes after translation of a ~ 150 residue type I transmembrane peptide (Figure 3.3B) is 
consistent with post-translocational glycosylation.  Moreover, post-translational 
glycosylation of the T7I mutant was inhibited by co-expressing Q1 channel subunits 
(Figure 3.3D) that co-assemble with E1 peptides in the ER (Krumerman et al., 2004; 
Chandrasekhar et al., 2006).  Since the protein translocation tunnel cannot simultaneously 
house a six transmembrane segment Q1 subunit and an E1 peptide, these data support the 
conclusion that post-translational glycosylation of type I transmembrane peptides occurs 
outside of the protein translocation tunnel.   
Efficiency of Post-Translational N-glycosylation of Type I Transmembrane Peptides 
The panel of E1 mutants that we examined revealed some basic structural 
requirements for post-translational glycosylation of type I transmembrane peptides.  First, 
unlike co-translational glycosylation, long range point mutations (~20 residues) effect 
post-translational glycosylation, as ablation of the N-terminal sequon with more 
hydrophobic residues led to less post-translational glycosylation (Figure 3.1C).  This 
trend is consistent with the best substrate for post-translational glycosylation, wild type 
E1, which is decorated with hydrophilic carbohydrates at its N-terminal sequon.   
Interestingly, we could not detect any post-translational glycosylation of the N26Q 
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mutant, which suggests that the N-terminal sequon is a poor substrate for post-
translational glycosylation.  This phenomenon has been previously observed with water 
soluble proteins where rapid protein folding sequesters the sequon from the OST complex 
(Ruiz-Canada et al., 2009).  However, the N-terminus of E1 is not predicted to have a 
globular fold nor does it possess any lumenal cysteines for disulfide bond formation.  
While we could not directly measure post-translational glycosylation of N26Q (Figure 
3.3B), the steady state populations (0 and 2 glycans) of WT peptides suggest that the N-
terminal sequon acquires N-linked glycans post-translationally when the internal sequon 
is glycosylated.  Differences in the degradation rates of the differently glycosylated WT 
peptides could also explain the lack of the singly glycosylated species; however, the 
degradation rates of WT and mutant E1 peptides were comparable in the absence of Q1 
channel subunits (Figure 3.2).  Nonetheless, these data hint that glycan occupancy 
directly effects post-translational glycosylation efficiency of type I transmembrane 
peptides.   
Cellular Advantages of Doubly-Glycosylated Type I Transmembrane Peptides 
The spacing of the N-linked glycosylation consensus sites in E1 is absolutely 
conserved among vertebrates.  Moreover, 4 out 5 human KCNE peptides have at least 
two N-linked sites and the spacing between the sequons is relatively consistent (16 – 23 
aa).  A potential benefit of having two sequons is to increase the probability that KCNE 
peptides are at least singly glycosylated in the ER.  KCNE peptides with only an N-
terminal sequon would mimic the N26Q mutant, resulting in 30% unglycosylated protein, 
which is not a substrate for post-translational glycosylation (Figure 3.3B).  Thus, 
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unglycosylated KCNE peptides having both sequons that elude the co-translational 
glycosylation machinery could still acquire at least one N-linked glycan post-
translationally, thereby increasing the total pool of glycosylated KCNE peptides in the 
ER.  Although we consistently observed ~ 5 – 10% more glycosylated wild type E1 
protein compared to N26Q for the latest chase time points (Figure 3.3), this difference 
was not experimentally significant.  Another potential advantage of a doubly-
glycosylated KCNE peptide is that it would improve the interactions (via multivalency) 
between the lectin family of chaperones in the ER (Helenius and Aebi, 2001), which have 
been hypothesized to interact with E1 (Chandrasekhar et al., 2006).  The initial delay in 
the decay of WT peptides that we observed is consistent with the notion that the 
chaperones that recognize N-linked glycans, calnexin and calreticulin, may be more 
avidly interacting with newly synthesized E1 peptides harboring two glycans (Figure 
3.2B).   
Biogenic Model for Long QT Syndrome 
From our results, we propose a model for E1 peptide biogenesis, co-assembly 
with Q1 channel subunits, and its implications for Long QT and Jervell-Lange Nielsen 
Syndromes (Figure 3.6).  In this model, WT peptides co-translationally acquire an N-
terminal glycan before exiting the translocon.  Once free from the proteinaceous 
environment of the translocon, post-translational glycosylation of E1 peptides either 
occurs before or after co-assembly with Q1 channel subunits (pathways a and b, 
respectively).  Once fully glycosylated, Q1/E1 complexes exit the ER and traffic to the 
plasma membrane.  For WT peptides, we cannot rule out either pathway a or b since co-
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expression with Q1 channel subunits had no significant effect on post-translational 
glycosylation.  In contrast, post-translational glycosylation of T7I was inhibited by Q1 
co-expression, which shunts the unglycosylated peptides towards co-assembly, resulting 
in a large population of unglycosylated Q1/T7I complexes that do not reside at the 
plasma membrane (Figure 3.6, T7I).  Therefore, the lack of N-linked glycosylated E1 
peptides in the heart would decrease the number of Q1/E1 complexes at the cell surface, 
leading to a reduction in the cardiac IKs current and a prolongation of the QT interval.  
Alternatively, a smaller population of assembly-competent E1 peptides could result in 
either unpartnered Q1 channels trafficking to the cell surface (as we observed in Figure 
3.4B) or assembly with different KCNE peptides since the mRNA for all five KCNE 
peptides is expressed in heart (Bendahhou et al., 2005; Lundquist et al., 2005).  Either 
scenario would result in ill-equipped Q1 channels, which would increase the probability 
of an arrhythmic event.  A similar reduction of Q1/E1 complexes in the developing ear 
would prevent the proper potassium flux into and thus formation of the endolymphatic 
space.  Given the absolute conservation of the N-terminal site in KCNE peptides, we 
predict that mutations that prevent N-linked glycosylation in other members of the KCNE 
family will also compromise K+ channel complex assembly and give rise to 
channelopathies.   
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Figure 3.6:  Model of KCNE1 biogenesis, N-glycosylation and co-assembly with 
KCNQ1 channels.  N-linked glycans are added to the N-terminal sequon (N5) of E1 
peptides during translation (Co-translational) and laterally exit the translocon into the 
membrane. Post-translational glycosylation of WT peptides at N26 occurs either before 
(a) or after (b) co-assembly with Q1 channel subunits.  Once fully glycosylated, the 
Q1/E1 complex exits the ER and traffics to the plasma membrane.  For the Long QT 
mutation, T7I, post-translational glycosylation is inhibited by co-assembly with Q1 
channel subunits resulting in Q1/E1 complexes that do not reside at the plasma 
membrane.  
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SUPPLEMENTARY MATERIAL 
 
 
 
Table 3.S1.  Statistical Analysis of Glycosylation Mutants1 
 WT N26Q N5Q T6P T7A T7Q N5I T7I 
WT  ns *** *** *** *** *** *** 
N26Q ns  *** *** *** *** *** *** 
N5Q *** ***  * *** *** *** *** 
T6P *** *** *  ns ns ** * 
T7A *** *** *** ns  ns ns ns 
T7Q *** *** *** ns ns  ns ns 
N5I *** *** *** ** ns ns  ns 
T7I *** *** *** * ns ns ns  
1Data are from 3 – 6 individual experiments.  Tukey’s multiple comparison test was used 
to determine the significantly differently glycosylated mutants as ***, p < 0.0001;  **, p 
< 0.01;  *, p < 0.05 (one-way ANOVA with Tukey post-hoc analysis).  ns indicates the 
E1 peptides were not significantly different from each other (p > 0.05). 
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Figure 3.S1:  Identification of the mature, immature and unglycosylated WT and 
N26Q KCNE1 peptides.  Immunoblots are from enzymatic deglycosylation of WT and 
N26Q KCNE1 peptides.  The samples were left untreated (–), digested with Endo H (Hf) 
or PNGase F (Pf).  (A) E1 peptides expressed alone.  Endo H susceptibility of the 23 kDa 
band (WT) and the 20 kDa band (N26Q) identified these bands as immaturely 
glycosylated E1 protein, which collapsed to the ~ 17 kDa unglycosylated form (unglyc).  
(B) E1 peptides co-expressed with Q1 subunits results in the appearance of higher 
molecular weight bands:  WT: ~40 kdD; N26Q: 25 – 30 kD.  Resistance to Endo H, but 
susceptibility to PNGase F identified these higher molecular weight bands as peptides 
with mature N-linked glycans (m).  As was previously reported (Chandrasekhar et al., 
2006), exhaustive digestion with PNGaseF results in a series of bands (denoted by 
asterisks) that are the result of an additional, as of yet unidentified post-translational 
modification.   
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Figure 3.S2: Protein stability of WT KCNE1.  A) Representative fluorographs for two 
WT KCNE1 data sets.  Metabolically-labeled CHO cells were pulsed for 10 min and 
chased for the indicated times.  E1 peptides were immunoprecipitated, separated by 
electrophoresis, and detected by autoradiography.  2-Gly: doubly glycosylated; 1-Gly: 
singly glycosylated; 0-Gly: unglycosylated.  (B) Graphs of raw data corresponding to the 
total protein (glycosylated and unglycosylated) from each data set (Figure 3.S2A) plotted 
as the total protein signal at each time point  (0 and 5 min are excluded, since zero time 
point is diluted with partially synthesized peptides and protein decay is delayed within 10 
min).  Each signal was quantified by densitometry and plotted versus chase time.  Data 
were fitted to a single exponential and the τ (min) value for Data Set1 is ―35.9‖ and Data 
Set2 is ―38.7‖ comparable to the WT τ value for the normalized average protein decay 
rate 33± 4 min (Table 3.1).    
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Figure 3.S3:  Proteosomal inhibitor, MG132, did not change co- and post-
translational N- glycosylation pattern of KCNE1 peptides.  (A) Representative 
fluorograph for WT KCNE1 protein. CHO cells were starved, pulsed and chased in 
media containing 10 µM MG132 to inhibit proteosomal degradation.  CHO cells were 
pulsed for 2 min, chased for the indicated times and the E1 peptides were 
immunoprecipitated, separated by electrophoresis, and detected by autoradiography.  (B) 
Graphs of densitometric analysis for Figure 3.S3A.  The percentage of the different 
glycoforms with respect to total protein is plotted for each time point.  After 3 min, the 
fully glycosylated form of WT increased.  Data (n = 5) are mean ± SEM for each chase 
point.  Glycosylation states are labeled:  2-Gly: open square; 1-Gly: closed circle; 0-Gly: 
open circle.    
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Figure 3.S4:  Raw data showing the co- and post-translational N-glycosylation of 
KCNE1 peptides.  (A) Representative fluorographs for WT E1 protein.  CHO cells were 
pulsed for 2 min, chased for the indicated times and the E1 peptides were 
immunoprecipitated, separated by electrophoresis, and detected by autoradiography.  (B) 
Graphs of raw data plotted as signal for Figure 3.S4A.  Signal is plotted for each time 
point.  After 5 min, the fully glycosylated forms of WT increased.  Glycosylation states in 
all panels are labeled:  2-Gly: open square; 1-Gly: closed circle; 0-Gly: open circle.   
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Figure 3.S5: Cell surface expression of WT and mutant E1 peptides requires Q1 
channels.  (A) Representative immunoblots of WT and the glycosylation mutants.  
Transfected CHO cells were labeled with a membrane impermeable biotin reagent, lysed, 
and the biotinylated proteins were isolated with streptavidin beads.  Lanes denoted as (½ 
input) are half of the sample lysate that was set aside to quantitate the total amount of 
biotinylated proteins.  (Beads) lanes represent the streptavidin-bound proteins that were 
isolated and separated by SDS-PAGE.  The calnexin (CNX) immunoblot was used to 
determine the amount of background lysis.  The mature (m), immature (im) and 
unglycosylated (un) forms of the E1 glycopeptides were identified by enzymatic 
deglycosylation (Figure 3.S1).   (B) Quantification of the biotinylated E1 proteins on the 
cell surface.  To obtain the percentage of E1 protein on the cell surface, the percentage of 
CNX labeling was subtracted from the percentage of biotinylated E1 protein, which was 
determined by dividing the band intensities in the beads lane by twice the band intensity 
in the corresponding half input lanes.  Statistically, there was no cell surface expression 
of E1 peptides when expressed alone:  WT:  2.3 ± 1.5 %; N5Q: 0.5 ± 2.2; T7I: 0.3 ± 1.9; 
N26Q: 0.5 ± 0.2 (open bars).  Cell surface expression of WT E1 protein co-expressed 
with Q1 is shown for comparison (Q1/E1: filled bar) where 20 ± 3 % of the E1 protein on 
the cell surface.  The error bars are SEM from n = 3 – 4 immunoblots. 
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Figure 3.S6:  Post-translational N-glycosylation of exogenously-expressed KCNE1 
peptides occurs in various cell types with fully functional co-translational 
machinery.  (A) Cells were pulsed for 2 min, chased for the indicated times and the E1 
peptides were immunoprecipitated, separated by electrophoresis, and detected by 
autoradiography.  Representative fluorograph for WT E1 expressed in CHO cells is 
shown for comparison.  (B) Graphs of densitometric analysis for Figure 3.S6A.  The 
percentage of the different glycoforms with respect to total protein is plotted for each 
time point.  After 5 min, the fully glycosylated forms of WT protein increased in all 
mammalian cell lines.  Glycosylation states in all panels are labeled:  2-Gly: open square; 
1-Gly: closed square; 0-Gly: open circle.  (C) Representative fluorograph for human 
cathepsin C.  HeLa cells transfected with empty vector (pcDNA3.1), WT or T7I were 
pulsed for 2 min, chased for the indicated times.  Endogenous cathepsin C was 
immunoprecipitated, separated by electrophoresis, and detected by autoradiography.  
Only the fully glycosylated protein (4-Gly) was observed at 0 and 10 min chase points, 
demonstrating that plasmid-based expression of E1 peptides does not compromise the co-
translational N-glycosylation machinery.  Endo (Hf) lane was used to identify the 
unglycosylated protein (0-Gly). 
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EXPERIMENTAL PROCEDURES 
 
Plasmids and cDNAs.  Human Q1 and E1 were subcloned into pcDNA3.1(-) 
(Invitrogen).  E1 constructs (wild type and mutants) possessed a C-terminal HA 
(YPYDVPDYA) epitope tag (Chandrasekhar et al., 2006).  To produce the N5Q, N5I, 
T6P, T7I, T7A, T7Q and N26Q mutants, site-directed mutagenesis was performed using 
the QuickChange system (Stratagene) and the mutations were confirmed by DNA 
sequencing of the entire gene.   
Cell culture and transfections.  Chinese Hamster Ovary (CHO-K1) cells were 
cultured in F-12K nutrient mixture (Gibco – Invitrogen).  HeLa cells and HEK Cells were 
cultured in Dulbecco's modified Eagle's medium (Sigma).  All of the media were 
supplemented with supplemented with 10% fetal bovine serum (Hyclone) and 102 U/mL 
penicillin/streptomycin (Gibco – Invitrogen).  Cells were plated at 60 – 75 % confluency 
in 35 mm dishes for all experiments except pulse-chase (60 mm).  After 24 h, cells were 
transiently transfected at RT with Lipofectamine (Invitrogen) 8 μl per mL of Opti-MEMI 
(Gibco - Invitrogen) for CHO cells or (HeLa cells and HEK Cells) with 10 μl of 
Lipofectamine 2000 (Invitrogen) per mL of Opti-MEMI  and returned to fresh media 
after 6 hr (2 hr for electrophysiology).  DNA ratios (in μg):  E1/empty pcDNA 3.1 
plasmid: 1.25/1.25; Q1/E1 (Western Blots): 1.25/1.25; Q1/E1 (Pulse-chase): 0.75/1.75; 
Q1/E1 + pEGFP-C3 (electrophysiology): 0.5/2 + 0.25. Cells were used 48 h post-
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transfection for Western Blots; 24 h for pulse-chase and electrophysiological 
experiments.   
Cell lysis and Western Blot Analysis.  Cells were washed in ice-cold PBS (3 × 2 
mL) and lysed at 4°C in RIPKA buffer (in mM):  10 Tris·HCl, pH 7.4, 140 NaCl, 10 KCl, 
1 EDTA, and 1% Triton-X, 0.1% SDS, 1% sodium deoxycholate and supplemented with 
protease-inhibitors: 1 mM phenylmethylsulfonyl fluoride (PMSF) and 1 µg/mL each of 
leupeptin, pepstatin and aprotinin (LPA).  Lysates were diluted with SDS-PAGE loading 
buffer containing 100 mM DTT, loaded on a 15% SDS-polyacrylamide gel, transferred to 
a nitrocellulose membrane, and blocked in Western blocking buffer (5% nonfat dry milk 
in Tris-buffered saline containing 0.2% Tween-20 (TBS-T)) for 30 min at RT.  
Membranes were incubated overnight at 4°C with rat anti-HA (Roche) (1:750) in 
Western blocking buffer and washed in TBS-T next day and incubated with goat anti-rat 
horseradish peroxidase (HRP)-conjugated antibody (Jackson Immunoresearch Labs, Inc.) 
(1:2000) in Western blocking buffer for 45 min at RT.  Membranes were washed with 
TBS-T and incubated with SuperSignal West Dura Extended Duration Substrate (Pierce) 
for 5min.  HRP-bound proteins were detected by chemiluminescence using Fujifilm 
LAS-3000 CCD camera and quantified using the Image Gauge V2.1 software (Fujifilm).   
Ezymatic deglycosylation assay.  NP-40, BME, and reaction buffer (G5 for Endo 
H; G7 for PNGase F) were added to the cell lysates (20 µL), which were diluted with 
water such that the final concentrations were 1% for NP40 and BME.  Endo Hf (2 µL) or 
PNGase F (1 µL) (New England BioLabs, Inc.) were added to the samples and incubated 
at 37°C for 30 min.  The samples were brought to a final concentration of 100 mM DTT 
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and 1.3% SDS and were separated on an SDS-PAGE (15% gel) and analyzed by Western 
Blot as described above.   
Cell surface biotinylation.  Transfected cells were rinsed with ice-cold PBS2+ 
buffer (PBS containing 1 mM MgCl2, 0.1 mM CaCl2), incubated with 1 mg/mL sulfo-
NHS-SS-biotin (Pierce) in PBS2+ buffer for 2 × 15 min at 4°C.  The biotin reagent was 
quenched by washing with (3 × 2 mL) with quench solution (PBS2+ containing 100 mM 
glycine) and then incubated with quench solution for 2 × 15 min at 4°C.  Cells were lysed 
in RIPKA buffer and cell debris was removed by centrifugation.  For each sample, 75 µg 
of total protein was quantitated by BCA analysis and incubated with 25 µL of 
Immunopure® Immobilized streptavidin beads (Pierce) overnight at 4°C.  One-half of the 
input (37.5 µg of total protein) was saved as a control for each sample.  Beads were 
washed 3 X with 0.1% SDS buffer (500 µL) and biotinylated proteins were eluted first 
with 30 µl 2× SDS-PAGE and 200 µM DTT mix for 15 min at 55°C, then with 30 µl 200 
µM DTT for 5 min at 55°C and the two elutions were combined to achieve 60 µl final 
volume.  Half of the input and bead-eluted proteins were separated by SDS-PAGE, 
analyzed by Western Blot as described above, and quantified in the linear range.  To 
compare the cell surface populations of WT to the mutant E1 peptides, the band 
intensities in the beads lanes were divided by twice the band intensity in the 
corresponding calnexin ½ input lanes and WT was normalized to 1.  Since some cell lysis 
and intracellular labeling of proteins occurs during biotinylation, the amount of calnexin 
(CNX) labeling was first subtracted from each biotinylated E1 sample. 
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Pulse-chase Experiments.  Cells were washed in PBS (2 × 2 mL) and starved in 
Dulbecco’s modified Eagle medium (DMEM) high glucose (Gibco - Invitrogen) 
supplemented with 10% fetal bovine serum (Hyclone) and 102 U/mL 
penicillin/streptomycin (Gibco – Invitrogen) and 2 mM glutamine (Invitrogen) for 1 hour 
at 37°C.  Then, 100 μCi/mL [35S] methionine and [35S] cysteine (MP Biomedicals, Inc.) 
was added to the starve media and the cells were pulsed 10 min for decay experiments 
and 2 min for post-translational glycosylation studies.  After the radioactive pulse, cells 
were washed in PBS (2 × 2 mL) and chased in standard medium at various times.  The 
cells were washed in PBS (2 × 2 mL) and lysed for 30 min at 4°C in 300 µL low salt lysis 
buffer consisting of (in mM): 50 Tris·HCl, pH 7.4, 150 NaCl, 20 NaF, 10 Na3VO4, and 
1% NP-40, 1% CHAPS supplemented with protease-inhibitors (PMSF and LPA).  To test 
proteosomal degradation 10 µM MG132 (Calbiochem) was used during 1 hour starvation 
and for the subsequent steps.   
Radioimmunoprecipitation assay.  Lysates were pelleted at 16,100 g for 10 min at 
RT and supernatant was precleared with a slurry of Immobilized Protein G Beads 
(Pierce) in lysis buffer rotating for 2 hours at 4°C.  The beads were pelleted and the 
precleared supernatants were rotated overnight at 4°C with 25 µl Protein G Beads/ (1 µl) 
rat anti-HA (Roche) antibody mix or with 25 µl Protein G Beads/ (1 µl) goat anti-human 
cathepsin C (R&D Systems) antibody mix.  The beads were pelleted at 16,100 g for 10 
min at RT and washed 2 X in low salt lysis buffer and then with 2 X in high salt buffer 
consisting of (in mM):  50 Tris·HCl, pH 7.4, 500 NaCl, 20 NaF, 10 Na3VO4, and 1% NP-
40, 1% CHAPS, followed by a final wash with low salt lysis buffer.  For cathepsin C 
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enzymatic deglycosylation assay beads were resuspended in 400 µl low salt lysis buffer 
with Endo Hf (20 µL) (New England BioLabs, Inc.) and incubated at 37°C for 1 hour 
followed by a final wash with low salt lysis buffer.  The washed and pelleted beads were 
eluted in 50 µL of 2 X SDS and 100 mM DTT mix at 55oC for 15 min.  Supernatants 
were separated by SDS-PAGE (15%) and visualized by autoradiography.  Signals were 
captured on a FLA-3000 phosphorimager and quantified using the Image Gauge V2.1 
software (Fujifilm).  The rates of protein decay and post-translational glycosylation were 
fitted to a single exponential.   
Perforated Patch Whole-Cell Recordings.  IKCNQ1 and IKs were recorded  in 
the whole-cell perforated patch configuration.  Briefly, on the day of the experiment cells 
were seeded on the surface of cover glass and placed to a custom recording bath filled 
with a modified Tyrode’s solution contained (in mM) 145 NaCl, 5.4 KCl, 10 HEPES, 5 
CaCl2 (pH 7.5 with NaOH).  Transfected (eGFP-expressing) cells were selected using an 
Axiovert 40 CFL inverted light microscope (Zeiss).  For the perforated patch 
configuration, a glass electrode (pipette resistance: 2.5-3.5 MΩ) filled with internal 
electrode solution contained (in mM) 126 KCl, 1 MgSO2, 0.5 CaCl2, 5 EGTA, 4 K2-ATP, 
0.4 GTP, 25 HEPES (pH 7.5 with CsOH), and 60 μg/ml Amphotericin B (Sigma; 
prepared in DMSO) was attached to the cell.  Once a GΩ seal was achieved and access 
resistance was dropped to the level enough to record membrane potential (<15 MΩ), 
Tyrode’s solution was replaced with the extracellular bath solution contained (in mM) 
160 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 8 glucose, and 10 HEPES (pH 7.5 with NaOH).  
Initially, the electrical access to the inside of the cell was monitored using 3-sec 
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depolarizing test pulse from the holding potential of -80 mV to +20 mV taken every 15 
sec.  Cells with pronounced rundown were discarded, and only those expressed stable 
currents were used.  The IQ1 and IKs currents were elicited using a family voltage protocol 
described in Figure legend 4.  All measurements were performed at room temperature 
(24±2°C).   
 
 
 
  
 139 
 
CHAPTER IV 
 
Investigating the Relative Importance of the two glycosylation sites on KCNE1: 
Structure-Function Deletion Scans and Positional Glycosylation Studies 
 
 
Contributors to the work presented in Chapter IV: 
 
The author of this thesis, Tuba Bas performed all the experiments, but the 
immunoblot for the the KCNE1 double mutant (N5Q;S28T) was kindly generated by 
Yuan Gao.   
 
 
 
 
 
 
 
  
 140 
ABSTRACT 
 
The KCNE peptides are a class of type I transmembrane N-linked glycoproteins 
that assemble with a variety of voltage-gated K+ channels in a tissue specific manner.  
KCNE β-subunits modulate the gating and ion conducting properties of K+ channels; 
formation of these heteromeric complexes enhances K+ current diversity.  In the heart and 
inner ear, KCNE1 co-assembles with KCNQ1 to form a voltage-gated K+ channel 
complex.  Genetic mutations in either KCNE1 or KCNQ1 give rise to inherited cardiac 
arrhythmicities and neural deafness, namely Romano-Ward and Jervell-Lange-Nielsen 
Syndrome (JLNS).  The JLNS mutation, T7I, indirectly prevents glycosylation at one of 
the two N-linked glycosylation sites on KCNE1.  In order to elucidate the positional 
importance of N-linked glycosylation of KCNE1, we constructed a C-terminally HA-
tagged KCNE1 that behaves like the wild type KCNE1 protein in terms of channel 
assembly and function.  Using this construct, we showed that the glycosylation site 
proximal to the KCNE1 N-terminus (N5) was critical for the formation of KCNE1 
protein, whereas removal of the second glycosylation site (N26) had no significant effect 
on KCNE1 protein expression and assembly.  To further investigate the structural 
requirements of KCNE1 glycosylation, we generated structure-function deletion scans of 
KCNE1 and performed positional glycosylation scanning mutagenesis.  Examination of 
the biogenesis and complex formation of these mutants with the channel partner KCNQ1, 
will define the glycosylation window that is important for proper KCNE1 assembly and 
trafficking.    
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INTRODUCTION 
 
Asparagine-linked (N-linked) glycosylation is the most common covalent 
modification in eukaryotic cells (Helenius and Aebi, 2004).  In the endoplasmic reticulum 
(ER), N-linked glycosylation involves the transfer of high-mannose oligosaccharides onto 
asparagine residues within the primary sequence N-X-T/S (Marshall, 1972; Silberstein 
and Gilmore, 1996).  This consensus sequence is recognized by oligosaccharyl-
transferase (OST) complex for glycosylation as the first 12-14 residues of the nascent 
protein appear from the translocation pore into the lumen of the ER (Nilsson and von 
Heijne, 1993).  The factors that effect the N-glycan transfer on the asparagine of N-X-T/S 
involve the residues at X-position, proximity to C-terminus and proximity to 
transmembrane domain.  Negatively-charged residues (Asp and Glu), hydrophobic amino 
acids (Trp and Leu) and proline at the X-position are poorer substrates for the OST 
complex (Marshall, 1972; Shakin-Eshleman et al., 1996; Silberstein and Gilmore, 1996; 
Kasturi et al., 1997).  The distance between the sequons and the C-terminus should be at 
least ~ 60 residues to give enough time for the OST complex to recognize sequon and for 
efficient co-translational glycosylation (Nilsson and von Heijne, 2000).  Also, N-linked 
glycosylation sites should be more than 12 residues away from the transmembrane 
segment to be accessible to the OST active site (Nilsson and von Heijne, 1993; Cheung 
and Reithmeier, 2007).  To date, there are no other identified sequence motifs that have 
long range effects on N-glycosylation efficiency (Gavel and von Heijne, 1990; Ben-Dor 
et al., 2004).   
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Although commonly referred to as a post-translational modification, N-linked 
glycosylation typically occurs during translation.  Recently, however, post-translational 
N-glycosylation of a secreted protein, human blood coagulation factor VII, has been 
observed in cells with intact N-glycosylation machinery (Bolt et al., 2005; Ruiz-Canada 
et al., 2009).  Factor VII has two sequons that are ~170 amino acids apart.  Surprisingly 
the sequon closest to the N-terminus is modified co-translationally, whereas the second 
sequon is modified post-translationally.  Unfortunately, the requirements of this relative 
behavior of the two N-linked glycosylation sites on Factor VII are not clear.   
KCNE1 is a K+ channel β-subunit that modulates the function of its partnering α-
subunits in a tissue specific manner.  In the heart, KCNE1 co-assembles with KCNQ1 
(Q1) K+ channels to produce the slowly activating cardiac IKs current (Barhanin et al., 
1996; Sanguinetti et al., 1996).  In the inner ear, the KCNE1/KCNQ1 channel complex 
recycles potassium (Wangemann, 2002).  KCNE1 is a type I transmembrane glycoprotein 
with two sequons at N5 and N26 facing the extracellular media.  Both glycosylation sites 
satisfy the known N-linked glycosylation rules: they are more than ~60 residues away 
from the C-terminus and more than ~12 residues away from the transmembrane domain.  
Only the sequon that is closest to the N-terminus is conserved in all KCNE family 
members (1-5) (Figure 1.4A).  Patients with genetic mutations effecting the first sequon 
in KCNE proteins give rise to congenital or acquired Long QT Syndrome (LQTS) 
(Schulze-Bahr et al., 1997; Abbott and Goldstein, 2001; McCrossan and Abbott, 2004). 
Our studies showed that the first N-linked glycosylation site in KCNE1 is indespensible 
for proper protein expression and function (Chapter III).  Moreover, the sequon closest to 
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the N-terminus is modified co-translationally and the internal N-linked glycosylation site 
is modified post-translationally just like Factor VII (Chapter III).  Factor VII is a 
secreted, water soluble protein; therefore KCNE1 is the only known transmembrane 
protein that acquires glycans posttranslationallly.  When comparing the two proteins it is 
hard to deduce any patterns for posttranslational glycosylation since the distance between 
the two sequons in Factor VII is ~170 residues, whereas in KCNE1 they are only 21 
amino acids apart.  What determines the differential N-linked glycosylation behavior of 
the two closely-spaced N-linked consensus sites on KCNE1 remains to be uncovered.   
In this study, I have changed the microenvironments of the two N-linked 
glycosylation sites on KCNE1 in order to understand the relative importance of sequon 
position.  In the structure-function deletion scans, I had two sets of mutants.  In the first 
group I truncated the N-terminus, bringing it closer to the internal sequon (N26).  In the 
second group I systematically brought the first sequon (N5) closer to the transmembrane 
domain through internal deletions.  I also repositioned the internal sequon (N26) in a 
KCNE1 null glycosylation background (N5Q; N26Q) by sliding this consensus sequence 
(N26) closer to the N-terminus and away from the transmembrane domain.  These 
experiments revealed a likely pattern that could reflect the differential glycosylation of 
the two sequons on KCNE1.  Lastly, in order to make the internal glycosylation site (the 
post-translational glycosylation site) a more desirable substrate for OST complex (Kasturi 
et al., 1997), we changed the serine of the second sequon to a threonine (S28T).  
Surprisingly, we found that this change was enough to convert the post-translational 
glycosylation site to a co-translational glycosylation site on KCNE1.    
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RESULTS 
 
 
N-terminal truncations 
In Chapter III, we discovered that the N-terminal sequon is co-translationally 
glycosylated; whereas glycans are attached to the internal sequon predominantly post-
translationally.  What distinguishes the behavior of the two sequons remains to be 
elucidated.  Therefore, in order to investigate the difference between the two sequons, we 
constructed a series of N-terminal truncation mutations of the KCNE1 protein (Figure 
4.1A).  We systematically brought the internal glycosylation site (N26) closer to the N-
terminus to find the optimal distance required to rescue E1 protein expression.  In order 
to prevent the interference of a probable internal start site, we used a mutant KCNE1 
background, M27V, and confirmed that M27V had no effect on KCNE protein 
expression and function (Figure A2.5A, Appendix II).  The expression and glycosylation 
state of the resultant mutant proteins were tested in CHO cells (Figure 4.1B).   
Figure 4.1B shows that E1 and Δ(2-4) bear two glycosylation sites when fully 
glycosylated, yielding a strong band at 23 kDa on a Western blot corresponding to the 
immaturely N-linked glycosylated peptides.  N26Q;M27V both lacking the second 
sequon, served as positive control to follow monoglycosylated KCNE1.  Unglycosylated 
E1 protein appears at ~17 kDa on a western blot, which was confirmed by enzymatic 
deglycosylation assays (Figure 3.S1, Chapter III).  Unexpectedly, none of the N-terminal 
truncation mutants, Δ(2-10), Δ(2-16), Δ(2-22), were able to rescue the E1 protein 
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expression; therefore bringing the internal glycosylation site (N26) closer to the N-
terminus was not sufficient for proper glycosylation.  Elimination of the first 
glycosylation site by deletion has the similar effect as T7I mutation.   
 
Internal deletions 
Having demonstrated that the distance from the N-terminus was not the main 
criteria for efficient glycosylation of the internal sequon (N26) on KCNE1, we altered the 
distance from the transmembrane domain to determine the minimal distance required to 
keep the N-terminal sequon (N5) glycosylated.  We made a panel of internal deletion 
mutants, systematically bringing the N-terminal glycosylation site (N5) closer to the 
transmembrane domain (Figure 4.2A).  All constructs possessed N26Q, since we have 
previously shown that ablation of the internal sequon (N26) had no significant effect on 
glycosylation of the N-terminal sequon (Figure 3.1, Chapter III).  48 hours post- 
transfection, expression and glycosylation of E1 internal deletion mutants were analyzed 
on a western blot (Figure 4.2B).  We used E1 and N26Q as positive controls, where we 
could follow the unglycosylated (17 kDa), monoglycosylated (20 kDa) and doubly 
glycosylated (23 kDa) forms of the E1 protein.   
All internal deletion mutants, Δ(8-10), Δ(8-16), Δ(8-22), Δ(8-28) showed a 
reduction in glycosylation efficieny at N5 (Figure 4.2B).  Unlike the expected strong 
band observed at 20 kDa corresponding to the monoglycosylated form of N26Q, the 
internal deletion mutants resolved as a smear above the unglycosylated band.  
Interestingly, even the three amino acid deletion Δ(8-10), was not tolerated, and resulted  
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Figure 4.1:  KCNE1 N-terminal truncation mutants were not efficiently glycosylated 
as N26Q.  A.  A panel of truncation mutants was made using PCR methods.  The internal 
glycosylation site (N26) was systematically brought closer to the N-terminus in M27V 
background.  The deletion mutants were named as the residue numbers of deleted amino 
acids in parenthesis following the mark ―Δ‖.  B.  CHO were cells transiently transfected 
with N26Q;M27V and the N-terminal truncation mutants ( Δ(2-4), Δ(2-10), Δ(2-16), Δ(2-
22) ).  After 48 hours, cells were lysed and samples were resolved on an SDS-PAGE.  
N26Q;M27V and Δ(2-4) served as positive controls, where we could follow the double 
and single glycosylated forms of the E1 protein. A ~23 kDa band, Δ(2-10), corresponds 
to the double glycosylated protein, ~20 kDa band (N26Q;M27V) monoglycosylated 
protein and ~17 kDa unglycosylated form (Figure 3. S1).   
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in an abundance of unglycosylated proteins corresponding to the 17 kDa band (Figure 
4.2B).  Moreover, the Δ(8-10) showed the most severe phenotype, which may be due to 
bringing the consensus N-linked glycosylation site right next to the structurally-distorting 
proline residue, P11 (vide infra).  When co-expressed with the channel partner, KCNQ1, 
all mutants but Δ(8-10) showed a faint banding pattern between 25 and 37 kDa (data not 
shown).  However, these bands did not exactly match the maturely monoglycosylated E1 
protein (N26Q) and might be due to O-linked glycosylation of the KCNE1 peptides 
(personal communication with Kshama Chandrasakher).   
Since large internal deletions were not well tolerated, and the smallest deletion 
Δ(8-10) may have been distrupted by P11, we decided to check the effect of small 
internal deletions on N5 while keeping the sequon farther from P11 (Figure 4.2C).  We 
brought the N-terminal sequon one residue closer to the transmembrane domain in the Δ8 
mutation and two residues closer with the Δ(8-9) deletion.  We found that these small 
internal deletions were well tolerated. We observed an unglycosylated band at ~17 kDa 
and a monoglycosylated band at ~20 kDa (Figure 4.2D).  Both Δ8 and Δ(8-9) behaved 
like N26Q.   
Up to now our data implied that the exact position of N5 was critical for efficient 
glycosylation and within the protein sequence only small changes were tolerated for 
proper N-linked glycosylation.    
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Figure 4.2:  Only single, Δ8 or double amino acid deletions, Δ(8-9) were allowed for 
effective glycosylation at N5.  (A) & (C).  A panel of internal deletion mutants was 
made using PCR methods.  Transmembrane domain was brought closer to the N-terminal 
sequon (N5) systematically in N26Q background.  The internal deletion mutants were 
named as the residue numbers of deleted amino acids in parenthesis following the mark 
―Δ‖.  (B) & (D).  CHO cells were transiently transfectedwith WT, N26Q, and the internal 
deletion mutants ( Δ(8-9), Δ(8-10) Δ(8-16), Δ(8-22), Δ(8-28) ).  After 48 hours, cells 
were lysed and samples were resolved on an SDS-PAGE.  WT and N26Q served as 
positive controls, where we could follow the double and single glycosylated forms of the 
E1 protein when expressed alone (~23 kDa band (WT), double glycosylated protein; ~20 
kDa band (N26Q) monoglycosylated protein; ~ 17 kDa (WT and N26Q) unglycosylated 
protein).   
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Positional glycosylation mutants 
Since the N-terminal truncation mutants and the internal deletion mutants did not 
significantly improve our understanding of the differential behavior of the two N-linked 
glycosylation sites on KCNE1, we made a panel of positional glycosylation mutants to 
investigate the effect of changes in the microenvironment of the sequon (Figure 4.3A & 
C).  Within the N5Q;N26Q;M27V background, we repositioned the sequon at residues 
26-28, sliding this consensus sequence in triplets within the N-terminus.  M27 was 
mutated to a valine in order to prevent replacing a probable internal translational start site 
(Figure A2.5A, Appendix II).   
We examined the expression and glycosylation of the mutant E1 proteins (Figure 
4.3B & D) 48 hours post-transfection.  We observed a ~17 kDa band for unglycosylated 
E1 for all the positional glycosylation mutants (P1 through P6); however, only mutants 
P3 and P6 resolved to the 20 kDa monoglycosylated E1 protein (Figure 4.3B & D).    
Knowing that one or two residue deletions were tolerated (vide supra), we wanted 
to test the effect of small amino acid changes on the first glycosylation site, rather than 
sliding the internal sequon (-NVS-) in triplets.  Therefore, we constructed two more 
positional glycosylation mutants, P1a and P1b (Figure 4.3E).  P1a and P1b resolved as 
monoglycosylated protein (Figure 4.3F), yet surprisingly the signal level was nowhere 
near that of the monoglycosylated glycoforms of P3 or P6 (Figure 4.3 B & D).    
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Figure 4.3:  Positional glycosylation mutants presented a 9 amino acid periodicity 
for efficient glycosylation.  (A) & (C) & (E).  A panel of positional glycosylation 
mutants were made and named as numbers indicating the position of the internal sequon 
(-NVS-) relative to the N-terminus following the mark ―P‖.  PCR methods were used to 
systematically move the consensus glycosylation sequence (-NVS-) in triple mutant 
background (N5Q;N26Q;M27V) towards the transmembrane domain.  (B) & (D) & (F).  
CHO cells were transiently transfected with WT, N26Q and the positional glycosylation 
mutants ( Po, P1, P2, P3, P4, P5, P6, P1a, P1b ).  After 48 hours, cells were lysed and 
samples were resolved on an SDS-PAGE.  WT, Po and N26Q served as positive controls, 
where we could follow different glycoforms of the E1 protein.   
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Changing the serine of the second sequon to a threonine 
We wanted to test whether the internal sequon (N26) would be glycosylated more 
efficiently if S28 was replaced with a threonine residue (Figure 4.4A) (Kasturi et al., 
1997).  We expressed the N5Q; S28T double mutant in CHO cells alone and with 
KCNQ1.  After 48 hours, we examined the cell surface expression and glycosylation of 
the double mutant E1 protein by performing cell surface biotinylation and resolving the 
samples on an SDS-PAGE.  (Figure 4.4B).  We observed a ~17 kDa band for  
unglycosylated E1 and a band at ~20 kDa, corresponding to the monoglycosylated E1 
protein.  In the presence of Q1, we observed the typical slow migrating bands at 25 – 30 
kDa for mature monoglycosylated E1 protein that could also be detected on the cell 
surface.  Surprisingly, changing the serine of the second sequon to a threonine (S28T) 
was sufficient to overcome the N5Q phenotype (Figure 4.4B).  Moreover, we found that 
this change was enough to convert the internal post-translational glycosylation site on 
KCNE1 (N26) to a co-translational glycosylation site (Data not shown).    
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Figure 4.4:  Converting S28 to a threonine was sufficient to suppress N5Q 
phenotype.  (A)  The internal sequon (N26) was changed to a better glycosylation site by 
mutating the S28 to a threonine (Kasturi et al., 1997) via site-directed mutagenesis in 
N5Q background.  (B)  N5Q;S28T was expressed in CHO cells alone and with KCNQ1 
(Q1).  Cell surface biotinylation assay (Experimental Procedures) was performed after 48 
hours and the data was analyzed on a western blot.  ―1/5 of the input‖ lanes are showing 
the expression of the double mutant w and w/o Q1; ―Beads‖ lanes are showing the bead-
eluted proteins.  ~17 kDa band corresponds to unglycosylated E1 protein and ~20 kDa 
band shows monoglycosylated E1 protein.  In the presence of Q1, ~30 kDa band is 
indicative of mature monoglycosylated E1 proteins on the cell surface.  (This data is 
kindly generated by Yuan Gao).  
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DISCUSSION 
 
Previously, we have shown that the distruption of the N-terminal sequon (N5) and 
increasing its hydrophobicity had long range effects on the glycosylation of the internal 
sequon (N26) and prevented the efficient glycosylation of N26 (Figure 3.1A and Figure 
3.1B, Chapter III).  To date, there are no other identified sequence motifs that have long 
range effects on N-glycosylation efficiency (Gavel and von Heijne, 1990; Ben-Dor et al., 
2004).  In order to understand the structural requirements that determine the relative N-
glycosylation behavior of the two sites, N5 and N26, we changed the microenvironments 
of the two sequons on KCNE1.   
 
Structure-function deletion scans were not conclusive 
We performed structure-function deletion scans with two sets of mutants: N-
terminal truncation mutants and internal deletion mutants.  We wanted to see whether the 
relative position of the first glycosylation site (N5) to the N-terminus was responsible for 
the efficient glycosylation of this sequon.  To test this, we designed N-terminal 
truncations to bring the N-terminus closer to the internal sequon (N26) in order to rescue 
the N5Q phenotype.  Our results showed that none of the N-terminal truncation mutants, 
even the Δ(2-22) (in which N26 is four residues from M1) increased the glycosylation 
efficiency.  We concluded that the relative distance from the N-terminus did not 
significantly contribute to the N-linked glycosylation at N5.   
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We then tested the internal deletion mutants.  These mutants allowed us to 
systematically bring the first sequon (N5) closer to the transmembrane domain.  We have 
observed a slightly better glycosylation pattern with the internal deletion mutants 
compared to N-terminal truncation mutants, yet still we did not see a robust 
monoglycosylated protein expression as N26Q.  Only single or double amino acid 
deletions, Δ8 and Δ(8-9), allowed for an effective glycosylation at N5, suggesting a 
probable link between efficient glycosylation and the relative position of the sequon to 
the transmembrane domain.   
 
Positional glycosylation mutants suggest a positional periodicity for N-glycosylation 
Next, in a null glycosylation KCNE1 background (N5Q; N26Q) we changed the 
microenvironment of the internal sequon (N26) by repositioning it within the N-terminus.  
We moved the sequon at N26 closer to the N-terminus and away from the transmembrane 
domain in triplets in an effort to avoid distrupting helicity.  These positional 
glycosylation scans showed that bringing the glycosylation site to every other 9th residue, 
namely P0, P3, P6, resulted in glycosylation.  This suggested a periodicity for the 
efficient glycosylation of the sequon, which might be due to the accessibility of the 
sequon to the OST complex.  Interestingly, the N-terminally HA-tagged KCNE1 
introduces 9 amino acids between the residues Q22 and Q23, pushing the first 
glycosylation site 9 residues away from transmembrane domain.  Functionality and 
glycosylation efficiency of this tagged KCNE1 protein also favors the same glycosylation 
pattern.   
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The glycosylation pattern observed with these mutants is now being tested by 
Yuan Gao in collaboration with the Gilmore Lab, through 2 min pulse-chase radioactive 
labeling experiments.     
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EXPERIMENTAL PROCEDURES 
 
Plasmids and cDNAs.  Human Q1 and E1 were subcloned into pcDNA3.1(-) 
(Invitrogen).  E1 constructs (wild type and mutants) possessed a C-terminal HA 
(YPYDVPDYA) epitope tag (Appendix II).  To produce the positional glycosylation 
mutants, site-directed mutagenesis was performed using the QuikChange® system 
(Stratagene).  For deletion mutants a combination of PCR techniques, enzyme digestion 
and ligation procedures were utilized.  All the mutations were confirmed by DNA 
sequencing of the entire gene.   
Cell culture and transfections.  Chinese Hamster Ovary (CHO-K1) cells were 
cultured in F-12K nutrient mixture (Gibco – Invitrogen).  The media was supplemented 
with 10% fetal bovine serum (Hyclone) and 102 U/mL penicillin/streptomycin (Gibco – 
Invitrogen).  Cells were plated at 60 – 75 % confluency in 35 mm dishes for all 
experiments.  After 24 h, cells were transiently transfected at RT with Lipofectamine 
(Invitrogen) 8 μl per mL of Opti-MEMI (Gibco - Invitrogen) and returned to fresh media 
after 6 hr.  DNA ratios (in μg):  E1/empty pcDNA 3.1 plasmid: 1.25/1.25; Q1/E1 
(Western Blots).  Cells were used 48 h post-transfection for western blots.   
Cell lysis and Western Blot Analysis.  Cells were washed in ice-cold PBS (3 × 2 
mL) and lysed at 4°C in RIPKA buffer (in mM):  10 Tris·HCl, pH 7.4, 140 NaCl, 10 KCl, 
1 EDTA, and 1% Triton-X, 0.1% SDS, 1% sodium deoxycholate and supplemented with 
protease-inhibitors: 1 mM phenylmethylsulfonyl fluoride (PMSF) and 1 µg/mL each of 
leupeptin, pepstatin and aprotinin (LPA).  Lysates were diluted with SDS-PAGE loading 
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buffer containing 100 mM DTT, loaded on a 15% SDS-polyacrylamide gel, transferred to 
a nitrocellulose membrane, and blocked in western blocking buffer (5% nonfat dry milk 
in Tris-buffered saline containing 0.2% Tween-20 (TBS-T)) for 30 min at RT.  
Membranes were incubated overnight at 4°C with rat anti-HA (Roche) (1:750) in western 
blocking buffer and washed in TBS-T next day and incubated with goat anti-rat 
horseradish peroxidase (HRP)-conjugated antibody (Jackson Immunoresearch Labs, Inc.) 
(1:2000) in western blocking buffer for 45 min at RT.  Membranes were washed with 
TBS-T and incubated with SuperSignal West Dura Extended Duration Substrate (Pierce) 
for 5 min.  HRP-bound proteins were detected by chemiluminescence using Fujifilm 
LAS-3000 CCD camera and quantified using the Image Gauge V2.1 software (Fujifilm).   
Cell surface biotinylation.  Transfected cells were rinsed with ice-cold PBS2+ 
buffer (PBS containing 1 mM MgCl2, 0.1 mM CaCl2), incubated with 1 mg/mL sulfo-
NHS-SS-biotin (Pierce) in PBS2+ buffer for 2 × 15 min at 4°C.  The biotin reagent was 
quenched by washing with (3 × 2 mL) with quench solution (PBS2+ containing 100 mM 
glycine) and then incubated with quench solution for 2 × 15 min at 4°C.  Cells were lysed 
in RIPKA buffer and cell debris was removed by centrifugation.  For each sample, 75 µg 
of total protein was quantitated by BCA analysis and incubated with 25 µL of 
Immunopure® Immobilized streptavidin beads (Pierce) overnight at 4°C.  One-fifth of 
the input (37.5 µg of total protein) was saved as a control for each sample.  Beads were 
washed 3 X with 0.1% SDS buffer (500 µL) and biotinylated proteins were eluted first 
with 30 µl 2× SDS-PAGE and 200 µM DTT mix for 15 min at 55°C, then with 30 µl 200 
µM DTT for 5 min at 55°C and the two elutions were combined to achieve 60 µl final 
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volume.  1/5 of the input and bead-eluted proteins were separated by SDS-PAGE, 
analyzed by western blot analysis as described above. 
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CHAPTER V 
DISCUSSION 
 
CONCLUSIONS 
 
The work presented in this thesis investigated the importance of KCNE1 N-linked 
glycosylation on KCNQ1/KCNE1 channel complex assembly, trafficking and function.  
Our findings show that nonglycosylated KCNE1 proteins are K+ channel assembly 
incompetent and hypoglyosylated KCNE1 proteins are retained in the early secretory 
pathway.  The assembly inept KCNE1 proteins prevent KCNQ1/KCNE1 channel 
complex trafficking and lead to a pool of unpartnered KCNQ1 channels on the cell 
surface providing a biogenic mechanism for Long Q T Syndrome.  Moreover, we 
determined that the two consensus N-linked glycosylation sites on KCNE1 are 
glycosylated and show diverse biological properties.  The N-terminal sequon is a 
traditional co-translational glycosylation site and indispensible for KCNQ1/KCNE1 
assembly and function; whereas the internal sequon is a substrate for post-translational 
glycosylation machinery.  To date KCNE1 is the only full-length type I transmembrane 
protein shown to have distinct co- and post-translational N-linked glycosylation sites and 
I am very proud to be part of this finding.   
Chapter II laid the foundation for studying N-linked glycosylation of KCNE1.  
We showed KCNE1 peptides were N-glycosylated and we utilized glycan maturation as a 
tool for following KCNE1 trafficking through the secretory pathway.  We found that E1 
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glycan maturation and cell surface expression were dependent on Q1 subunit expression.  
We demonstrated that when E1 was expressed alone the majority of the unassembled E1 
peptides had immature N-linked glycans, were retained in the ER, and did not reach the 
cell surface.  Only in the presence of Q1 was the maturely glycosylated form of E1 
observed at the cell surface.  Our results supported the previous observation regarding 
Caenorhabditis elegans KCNE1 homolog, where Bianchi et al. (2003) showed that 
KCNE1 needs corresponding K+ channel subunit to reach cell surface.   
KCNE1 has two consensus N-linked glycosylation sites; an N-terminal sequon 
(N5) and an internal sequon (N26).  Both sequons in KCNE1 are conserved in all 
mammals and strikingly, the N-terminal sequon (N5) is conserved in all five KCNE 
family members (Figure 1.4, Chapter I).  In addition, the mutations that prevent 
glycosylation at the N-terminal sequon on both KCNE1 and KCNE2 lead to Long QT 
Syndrome (Schulze-Bahr et al., 1997; Sesti et al., 2000b; Park et al., 2003).  At this point 
I had enough background information to hypothesize that KCNE1 glycosylation at the N-
terminal sequon is important for KCNQ1/KCNE1 channel assembly and proper function.   
After showing KCNE1 was glycosylated and understanding the cellular 
machineries that ensure proper assembly and trafficking of KCNE-K+ channel complexes 
in Chapter II, I asked the following questions:  Does each consensus N-linked 
glycosylation site acquire glycans and is there anything special about the absolutely 
conserved N-terminal sequon?  Therefore, I performed extensive biochemical analysis 
and examined the kinetics and extent of N-linked glycosylation of the two E1 sequons 
individually in Chapter III.  I demonstrated that the unglycosylated E1 peptides do not 
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reach the cell surface with or without Q1 K+ channels.  I also showed that the two N-
linked consensus sites on E1 were handled differently in the ER.  The N-terminal sequon 
acquired glycans during translation, whereas the internal sequon acquired glycans mainly 
after translation.  Moreover, I found that without the co-translational site post-
translational glycosylation of E1 peptides was less efficient, resulting in the accumulation 
of unglycosylated KCNE1.  In addition, the post-translational glycosylation efficiency of 
some mutant E1 peptides was considerably reduced through co-assembly with Q1 
channel subunits.  Finally, I showed that mutations that inhibit co-translational N-
glycosylation reduced the population of functioning Q1/E1 complexes at the cell surface, 
which provided a biogenic mechanism for Long QT and Jervell-Lange Nielsen 
Syndromes.   
Next, I wanted to examine the differential glycosylation behavior of the two 
KCNE1 sequons:  I questioned the structural requirements that make the N-terminal 
sequon so indespensible and I wanted to find how disruption of the N-terminal sequon 
(N5) and/or increasing the hydrophobicity at this site had the observed unexpected long 
range effects on E1 glycosylation and how it reduced the glycosylation efficiency of the 
internal sequon (N26).  Therefore, in Chapter IV, in order to explain this observed long 
range hydrophobic effect and to understand the relative N-glycosylation behavior of the 
two N-linked glycosylation sites (N5 and N26), I systematically changed the 
microenvironment of the two sequons on KCNE1.  Our positional glycosylation scans 
showed that sliding the consensus N-glycosylation site to every other 9th residue from the 
N-terminal sequon resulted in glycosylation; just like the functional N-terminally HA-
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tagged KCNE1 that repositions the N-terminal sequon 9 residues away from the 
transmembrane domain.  This periodicity might give us a hint about N-terminal sequon 
being a traditional glycosylation site and the internal sequon being a post-translational 
glycosylation site, yet requires further investigation.  Figure 5.1 presents a likely pattern 
that could reflect the differential glycosylation of the two sequons on KCNE1.  The 
periodicity of the efficient glycosylation mutants fits to an α-helical presentation of the 
N-terminus, placing the glycosylation mutants on the same side or exact opposite side of 
the first glycosylation site.  At this stage, this hypothesis is quite premature and highly 
speculative, since the secondary structure of KCNE1 is still unknown.  But this 
hypothesis could allow us to brainstorm and design new experiments.  And if it is correct, 
this helical periodicity might be the reason why the first sequon is a traditional 
glycosylation site: by providing the correct interface for OST complex and by introducing 
the correct directionality for consensus N-linked glycosylation site recognition.  Briefly, 
as N5 is coming out the translocon it is available for OST complex for glycan transfer.  
However, the second glycosylation site (N26) does not fit to the same helical presentation 
with the effective glycosylation mutants (Po, P3, P6) (Figure 5.1).  Therefore, N26 is not 
presented to OST complex in optimal position and it can not get efficient co-translational 
glycosylation.  According to this hypothesis, following translation, N26 can be 
recognized by post-translational glycosylation machinery as an unoccupied consensus N-
linked glycosylation site and acquires glycans mainly post-translationaly.   
In Appendix II, I demonstrated the characterization of the C-terminally HA-
tagged KCNE1 that was used in the preceding chapters.  C-terminally HA-tagged 
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KCNE1 allowed us to study two previously unobserved features of E1 glycoprotein: 
KCNE1 bears an internal translational initiation site and a proprotein convertase 
recognition site.  In brief, I showed that KCNE1 has an internal translational start site, a 
methionine at position 27, in heterelogous expression systems.  This was not observed in 
the long-used N-terminally HA-tagged E1, since the tag was four amino acids upstream 
of the M27.  Therefore E1 protein that utilized M27 as the translation start site did not 
have a tag.  In addition, I found a proteolytic cleavage site at the arginine cluster spanning 
the residues 32 through 38, which also bears the two known Long QT mutations (R32H 
and R36H) (Splawski et al., 2000; Napolitano et al., 2005).  For the first time ever, we are 
showing that E1 has a proteolytic cleavage product that might be involved in 
KCNQ1/KCNE1 channel function; since mutations, indirectly preventing cleavage at this 
site, cause the Long QT Syndrome.   
In Appendix I, I described a suppressor genetic screen using two temperature 
sensitive alleles of mom-2/Wnt.  I designed these suppressor genetic screens to find 
additional components of the Wnt/Wingless signaling pathway that specify the endoderm 
tissue in C. elegans.  I identified five intragenic suppressors and three extragenic 
suppressors of mom-2/Wnt embryonic lethality.  We found a mutation in ifg-1, eIF4G 
homologue, as one of the extragenic suppressors, suggesting an intriguing connection 
between the Wnt signaling pathway and the translational machinery.   
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Figure 5.1:  The helical presentation of the two positional glycosylation mutants (P3 
and P6) compared to WT KCNE1.  The positional glycosylation scans showed that 
bringing the glycosylation site to every other 9th residue from the N-terminal sequon (P0, 
P3, P6) resulted in glycosylation (Figure 4.3, Chapter IV).  This periodicity could be 
fitted to an α-helical presentation of the N-terminus, placing the glycosylation mutants on 
the same side or exact opposite side of the first glycosylation site.  In WT, the letters of 
the first glycosylation site are centered in red circles (-NTT-), in mutants, P3 and P6, the 
letters corresponding to these exact amino acid positions are circled in blue (-QTT-), 
emphasizing the background mutation (N5Q).  The letters of the glycosylation sites in 
positional glycosylation mutants (P3 and P6) are placed in red circle.    
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Future Directions 
 
Chapter II and III: 
 
Does degradation of individual KCNE1 glycoforms (other than N26Q) play any role 
on observed glycosylation rates? 
Though we have shown that the protein decay rates of WT KCNE1, glycosylation 
mutants (N5Q, T7I and N26Q) and mono-glycosylated N26Q were similar (Table 3.1 and 
Figure 3.2, Chapter III), it would be a safe approach to recapitulate the glycosylation 
rates observed with kinetic experiments (2 min pulse) in the presence of proteosome 
inhibitors.  Inhibiting the ER-associated degradation (ERAD) pathway will help us to 
dissect glycosylation rates from the degradation rates of individual glycoforms.  In our 
lab, Yuan Gao is tackling this question.   
 
Do other members of the KCNE family acquire glycans co-translationally and/or 
post-translationally? 
With the exception of KCNE4, all KCNE family members have multiple 
consensus N-linked glycosylation sites in their N-terminus and moreover, the N-terminal 
sequon (N5) is absolutely conserved among all five KCNE family members (Figure 1.4, 
Chapter I).  Also, the distance between the N-terminal sequon and internal sequon is 
conserved (18-20 amino acids) in KCNE1, KCNE2, and KCNE5.  KCNE3 has an 
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additional sequon located midway between the N-terminal sequon and the internal 
sequon.   
It would be interesting to study the glycosylation sites on other KCNE family 
members through the same biochemical and functional approaches we used for KCNE1.  
The fact that the N-terminal sequon on KCNE1 is a traditional co-translational 
glycosylation site and the internal sequon is a substrate for post-translational 
glycosylation machinery raises the question whether the internal sequon(s) in other 
KCNE family members acquire glycans post-translationally.  In addition, knowing that 
the genetic mutations that target the N-terminal sequon in both KCNE1 and KCNE2 lead 
to Long QT Syndrome, it would be interesting to know whether the absolutely conserved 
N-terminal sequon in all KCNE family members is a traditional co-translational 
glycosylation site.  Consequently, KCNE peptides can be used as an invaluable tool to 
improve our knowledge of N-linked glycosylation.  Examining the glycosylation sites on 
KCNE family of proteins and the effects of glycosylation on K+ channel assembly and 
trafficking will help us understand the diseases related to hypoglycosylation of the 
channel subunits.   
 
Is STT3B responsible for the post-translational glycosylation of the KCNE1 internal 
sequon? 
Human coagulation factor VII (FVII) has two N-linked glycosylation sites: one of 
them acquires glycans co-translationally and the other post-translationally (Bolt et al., 
2005).  After this discovery, the Gilmore Lab demonstrated that STT3A is primarily 
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responsible for the co-translational glycosylation; whereas STT3B is important for both 
co-translational glycosylation and posttranslational glycosylation of FVII (Ruiz-Canada 
et al., 2009).   
Since post-translational glycosylation of proteins with intact glycosylation 
machinery is a newly emerging field, it would be of great interest to determine which 
OST isoform is responsible for post-translational glycosylation of the internal sequon on 
KCNE1.  In fact, our lab is pursuing this goal in collaboration with the Gilmore lab.  I 
participated in the initiation of this project.  We used RNA interference to knockdown the 
OST isoform of interest and performed 2 min pulse-chase radioactive analysis on WT 
KCNE1 to observe the changes in the KCNE1 glycosylation pattern.  The initial data was 
not conclusive and requires optimization of the RNAi technique.  Though, we are still in 
the early stages of this project, hopefully Yuan Gao will determine which OST isoform is 
responsible for post-translational glycosylation of the KCNE1 internal sequon.   
 
Are there other transmembrane glycopeptides that acquire glycans post-
translationally? 
In order to understand: 1. The functional importance of post-translational 
glycosylation 2. why at times post-translational glycosylation is preferred over co-
translational and vice versa, we need to create a database of glycoproteins that are post-
translationally glycosylated.  This hypothetical database might help us to deduce an 
algorithm that can identify the sequons that are substrates for co-translational and/or post-
translational machinery.  To achieve this goal, more proteins with post-translational N-
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linked glycosylation sites have to be discovered.  One way to overcome this caveat would 
be searching for proteins that exhibit sequence similarity to KCNE1 N-terminus.  With 
this approach we were able to find one candidate gene that has sequence homology to N-
terminus KCNE1: Homo sapiens transmembrane protein 10 (HTMP10).  HTMP10 is a 
novel human brain-specific gene encoding a putative transmembrane protein of 141 
amino acids.  Also, HTMP10 has two potential N-linked glycosylation sites that require 
further investigation.  It would be interesting to find similar proteins and analyze their N-
linked glycosylation behavior to find a pattern for predicting post-translational 
glycosylation.  
 
Chapter IV: 
 
What are the biochemical and functional properties of positional glycosylation 
mutants, P3 and P6?  
In order to make sure that the efficiently glycosylated positional glycosylation 
mutants are indeed behaving like WT KCNE1 and/or N26Q, we have to further 
characterize their biochemical and functional properties.  Enzymatic deglycosylation 
assays must be performed to identify the different glycoforms (immature N-linked and 
mature N-linked glycans) of these mutants when expressed alone and with Q1.  The cell 
surface expressions of P3 and P6 (co-expressed with Q1) should be tested through cell 
surface biotinylation assays.  Finally, electrophysiological studies have to be performed 
to see whether Q1/P3 and/or Q1/P6 will give rise to WT Q1/E1 currents.   
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Do efficiently N-glycosylated positional glycosylation mutants (P3 and P6) acquire 
glycans post-translationally or co-translationally?  
It would be interesting to know how P3 and P6 acquire glycans: co-translationally 
and/or post-translationally.  In our lab, Yuan Gao has started analyzing the positional 
glycosylation mutants (including P3 and P6) using 2 min pulse-chase analysis.  
Preliminary results suggest that P6 acquires glycans co-translationally and P3 acquires 
glycans primarily co-translationally.  If these findings are confirmed via upcoming 
experiments, it will be in favor of my periodicity–helical fit hypothesis (vide supra).  
These mutants acquire glycans co-translationally by attaining the optimal orientation 
during translation required for OST-complex recognition.   
 
How can we test the structural requirements for post-translational glycosylation?  
More structure-function studies will help us understand the requirements for post-
translational glycosylation.  By utilizing the differential behavior (co- vs post-) of the two 
N-linked glycosylation sites on KCNE1, following experiments can be designed:  1. 
Adding more amino acids between the transmembrane domain and the internal sequon 
(N26) can convert the post-translational glycosylation site (N26) to a co-translational 
glycosylation site (if the distance between the sequon and transmembrane domain has an 
effect on glycosylation).  2. Similarly, addition of transmembrane domains in tandem 
following E1 C-terminus might change the glycosylation behavior of the internal sequon 
(N26) by pushing this site out of the translocation channel and making it more accessible 
to OST-complex.  3. Transfering the two sequons on KCNE1 to a well-studied α-helical 
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type I transmembrane protein; placing them at the exact amino acid positions/distances 
relative to the N-terminus, transmembrane domain and each other and applying the 
positional glycosylation scans might allow us to examine the effect of protein secondary 
structure on glycosylation.   
 
Which post-translational modifications are responsible for the slower migrating 
bands observed on the SDS-PAGE of internal deletion mutants when co-expressed 
with Q1? 
When internal deletion mutants were co-expressed with KCNQ1 we observed 
slow migrating bands that require further characterization (data not shown).  Enzymatic 
deglycosylation assays must be performed to identify the different glycoforms (O-linked, 
immature N-linked and mature N-linked glycans) of these E1 mutants.   
 
Appendix II: 
 
What are the effects of single (R32A, R33A, R36A) and double (R33A;R36A) 
arganine mutants on KCNE1 cell surface expression and Q1/E1 channel function? 
The discovery of the proteolytic cleavage site spanning the residues that are prone 
to Long QT Syndrome on KCNE1 is quite promising and opens a new research direction.  
For starters, it would be interesting to know the biochemical properties of the single and 
double arganine mutants.  For instance cell surface expression of these mutants can be 
tested using the cell surface biotinylation assays.  If these mutants are expressed on the 
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plasma membrane, we can check the effect of these mutations on channel function 
through electrophysiological studies.  If all the biochemical and functional properties of 
the arganine mutants turn out to be WT KCNE1 like, then this might suggest that the 
cleavage product might have a regulatory role in KCNE1 function.  This brings up the 
next future direction: analyzing the E1 proteolytic cleavage product. 
 
What is the functional role of the proteolytic cleavage product? 
We can mimic the E1 cleavage product by designing an E1 mutant construct that 
removes the residues before and at the proteolytic cleavage cut site and introducing a new 
translational start site (methionine) before R36.  We can characterize this mutant protein 
and its assembly with K+ channel partner, KCNQ1 through biochemical analysis and test 
its role on KCNQ1/KCNE1 channel currents using electrophysiology.  This study will 
provide answers to the following questions: 1. Can the mutant protein assemble with 
KCNQ1 and traffic to the cell surface? 2. Are the KCNQ1/Mutant channel currents 
similar to KCNQ1/KCNE1 channel currents?  If the currents are not same, can this 
cleavage product be a negative regulator of KCNQ1/KCNE1 channels?  This work will 
enhance our knowledge about E1 cleavage product; hence improve our understanding in 
Long QT mutations that prevent the cleavage of E1 peptide.    
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Final Words 
 
To me the most amazing part of the work presented in this thesis was that it gave 
birth to many new ideas.  I really enjoyed working with KCNE1.  This small glycoprotein 
had/has a big story to tell us.   
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Appendix I 
My work in Dr Craig C Mello’s Lab – The first four years… 
Screening for the suppressors of mom-2/ Wnt embryonic lethality* 
 
 
Contributors to the work presented in Appendix I: 
 
The author of this thesis, Tuba Bas conducted suppressor screens of mom-2/Wnt; 
isolated five intragenic suppressors and three extragenic suppressors and initiated the 
mapping of one of the extragenic suppressors of mom-2/Wnt, ifg-1.  Dr Takao Ishidate 
helped conduct the suppressor screens.  Dr Soyoung Kim mapped and cloned ifg-1, one 
of the extragenic suppressors of mom-2/Wnt, and performed its genetic analysis.   
 
 
 
 
 
*  Kim S **, Bas T **, Ishidate T, Sharma R, Shirayama M, and Mello CC. (** equal contribution). 
Screening for the suppressors mom-2 embryonic lethality: A connection between the Wnt signaling 
pathway and the translational machinery in C. Elegans.  Manuscript in preparation.   
  
 178 
 
ABSTRACT 
 
The highly conserved Wnt/Wingless family of secreted glycoproteins regulates 
many aspects of animal development.  In 4-cell stage Caenorhabditis elegans embryos 
Wnt signaling specifies endoderm by controlling the fate of EMS blastomere daughters.  
In order to identify additional regulators of the Wnt/Wingless signaling pathway in 
endoderm specification, we performed suppressor genetic screens with two temperature-
sensitive alleles of mom-2/Wnt.  Among 20 million chromosomes screened, five 
intragenic and three semi-dominant extragenic suppressors were isolated.  Here, we 
report the identification of one extragenic suppressor as an allele of ifg-1, a homolog of 
eukaryotic translation initiation factor eIF4G.  The allele ifg-1(ne4271) is associated with 
a substitution, arginine 745 to cysteine, at a highly conserved residue in the middle third 
domain essential for the translational activity.  Genetic analyses using the ifg-1 deletion 
allele and ifg-1(RNAi) show that ifg-1(ne4271) acts as loss-of-function for suppressing 
the mom-2 phenotype.  Furthermore ifg-1(ne4271) suppresses other mutants in the 
pathway such as wrm-1/β-catenin, lit-1/MAPKKK, NEMO, and mom-4/MAPK, placing 
ifg-1 downstream of these molecules in the pathway.  Our results imply a potential 
connection between the Wnt signaling pathway and the translational machinery. 
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INTRODUCTION 
 
The Wnt signaling pathway is an evolutionarily conserved signal transduction 
pathway and consists of a protein network, where players take part in various stages of 
animal development including cell proliferation, cell fate specification, cell polarity and 
migration (Cadigan and Nusse, 1997; Wodarz and Nusse, 1998; Hobmayer et al., 2000; 
Moon et al., 2002; Nelson and Nusse, 2004).  Several of these proteins are oncogenes, 
and mutant proteins lead to colorectal, hepatic, breast and skin cancers (Peifer and 
Polakis, 2000; Polakis, 2000; Logan and Nusse, 2004).  In C. elegans, the Wnt signaling 
pathway acts early in development to specify endoderm (Rocheleau et al., 1997; Thorpe 
et al., 1997).  In 4-cell stage embryos signaling from the posteriormost P2 blastomere 
polarizes the EMS cell to produce one of the daughter cells known as the endoderm 
founder cell E. In the absence of P2/Wnt signal, E adopts the fate of the other EMS 
daughter, the MS blastomere, and becomes progenitor of the mesodermal tissues rather 
than endoderm. 
Previous genetic screens and studies using RNA-mediated genetic interference 
(RNAi) have identified a number of genes that are involved in P2/EMS signaling.  
Several of these genes define the components of the conserved Wnt/Wg signaling 
pathway, including mom-1 (Porcupine), mom-2 (Wnt/Wg), mom-5 (Frizzled), sgg-1 (gsk-
3), wrm-1 (β-catenin/Armadillo), apr-1 (adenomatous polypopsis coli, APC), and pop-1 
(TCF/LEF) (Lin et al., 1995; Rocheleau et al., 1997; Thorpe et al., 1997).  Genetic studies 
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also indicate that other signaling mechanisms contribute to the endoderm specification 
including the MAP kinase signaling factors, namely mom-4 (TAK1, MAP kinase kinase 
related) and lit-1 (Nemo, MAP kinase related) (Ishitani et al., 1999; Meneghini et al., 
1999; Rocheleau et al., 1999; Shin et al., 1999), and the Src-signaling pathway (Bei et al., 
2002).  Although the discovery of these components has been a great template in 
understanding Wnt signaling pathway; the picture is far from being complete.  So far, 
exactly how these pathways are orchestrated and what other players are involved remains 
a mystery. 
In order to look for new components of Wnt signaling pathway we have initiated 
suppressor genetic screens beginning with the most upstream component MOM-2/Wnt.  
For these screens we have utilized two temperature sensitive (Ts) alleles of mom-2/Wnt 
(ne834 and ne874), both exhibiting fully penetrant embryonic lethal phenotypes at 25oC.  
We used ENU (N-Ethylinitrosourea) as the mutagen and screened for suppression of 
embryonic lethality at the nonpermissive temperature.  For both alleles, suppressors were 
rare and we could isolate only five intragenic and three extragenic suppressors for the 20 
million chromosomes screened.  We identified one extragenic suppressor with a point 
mutation in ifg-1 gene, a homolog of eukaryotic translation initiation factor eIF4G known 
to play a key role in translation.  We also showed that the semi-dominant suppressor ifg-
1(ne4271) is a loss-of-function allele, and functions downstream of lit-1/MAPKKK, 
NEMO and wrm-1/β-catenin.  Our results reveal new insight into the function of Wnt 
signaling in endoderm specification, providing a link between the translational machinery 
and Wnt signaling pathway in early C. elegans embryos.   
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RESULTS 
 
 
Isolation of maternal-effect suppressors of mom-2/Wnt 
 
In order to screen for mom-2 suppressors, we utilized two mom-2/Wnt Ts alleles, 
ne834 and ne874, which were among the five alleles of mom-2 isolated in a previous 
large scale Ts screen Figure A1.1 (Nakamura et al., 2005).  Briefly, mom-2 suppressors 
were isolated through careful selection of viable embryos at the non-permissive 
temperature, 25°C.  After the ENU (N-Ethyl-N-Nitrosourea) mutagenesis of parent 
hermaphrodites (Po) of mom-2(ne834, ne874), dominant suppressors were collected in F1 
generation and recessive suppressors were isolated in F2 generation Figure A1.2.  
In ne874 screening, among five million worms that were mutagenized at the 
permissive temperature, five independent suppressors (TT1, TT2, TT3, TT4, TT5) were 
recovered at the non-permissive temperature in F1 screening, and none in F2 generation.  
In ne834 screening, we were unable to find any suppressors in the F1 generation.  
However, we were able to isolate three suppressors (TT10, TT11, TT12) among one 
million worms in the F2 generation (Table A1.1).  Isolated suppressors in ne834 
suppressor screen showed weak suppression at 25°C with ~ 5% viability.  When we 
lowered the temperature to 24 or 23 °C, we observed a significant increase in the 
suppression rate.    
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Figure A1.1:  The mom-2 alleles suppressed (ne834 and ne874) and the intragenic 
suppressors of mom-2(ne874).  Amino acid alignments of the two mom-2 homologs (C. 
elegans and human). Amino acid substitutions for each intragenic suppressors are shown 
in red letters above each black box. The mom-2(ne834) and mom-2(ne874) mutations are 
in green letters. The double amino acid substitution in TT5(ne3347) are highlighted by 
the blue letters of TT5. Conserved residues are in orange letters.   
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Figure A1.2:  Schematic diagram of the screen for maternal-effect suppressors of 
mom-2/Wnt.  Po mom-2(ne834 and ne874) animals in lin-11 Hawaiian (CB4856) 
background were mutagenized by ENU (N-Ethyl-N-Nitrosourea). After growing at 
permissive temperature (15°C), the F1 L4 stage animals were shifted to 25°C for 27 hrs 
then screened for worms with viable embryos, F1 suppressors. For F2 suppressors, the F2 
L4 stage animals were shifted to 25°C for 27 hrs to look for animals with viable embryos 
inside the mother worms. 
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Table A1.1:  Statistics of mom-2(ne874) and mom-2(ne834) suppressor screens 
 
Suppressor Screen Number of worms screened Chromosomal 
location 
TT1(ne3346) ne874 F1 screen 4 million V 
TT2(ne3343) ne874 F1 screen 4 million V 
TT3(ne3344) ne874 F1 screen 4 million V 
TT4(ne3345) ne874 F1 screen 4 million V 
TT5(ne3347) ne874 F1 screen 4 million V 
TT10 ne834 F2 screen 1 million V 
TT11 ne834 F2 screen 1 million X 
TT12 ne834 F2 screen 1 million II 
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To determine the chromosomal locations of the suppressors, we used linkage 
analysis combined with SNP (Single Nucleotide Polymorphism) mapping method.  The 
results showed that five suppressor strains from the ne874 screening contained mutations 
that were tightly linked to mom-2.  Whereas the three suppressors from ne834 screening 
did not appear to be linked to mom-2.  We further mapped these suppressors to determine 
their approximate chromosomal locations.  We found that TT10 was located far from the 
center of chromosome II, TT11 was on chromosome X, and TT12 was on the center of 
chromosome II.  In addition, during these initial mapping procedures we were able to 
determine if the suppressors were functioning in a dominant or recessive manner.  We 
showed that TT10, TT11 and TT12 were all weak dominant suppressors (semi-dominant).   
 
Identification of intragenic suppressors of mom-2(ne874)  
 
When we performed the linkage analysis on chromosome V, where mom-2 is 
located, we found that the five suppressors (TT1, TT2, TT3, TT4, TT5) from ne874 screen 
were tightly linked to the mom-2 locus and could not be separated.  In order to determine 
whether they were intragenic suppressors, we sequenced the mom-2 locus in these five 
strains and found at least one second site mutation in all of the five suppressors (Figure 
A1.1).  Surprisingly, TT5 had two amino acid substitutions; methionine 235 to leucine 
and aspartic acid 239 to asparagine.  Interestingly, we found that TT4 had a substitution 
in cysteine 167 to tyrosine, which was the same mutation as that of another Ts mom-2 
allele, namely ne834.  The two mom-2 mutant alleles, ne874 and ne834, replace cysteine   
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with tyrosine.  The fact that removal of both cysteines simultaneously resulted in the 
suppression of the mom-2 phenotype implies that both ne874 and ne834 eliminate a 
disulfide bond.   
 
TT12 is associated with an R745C substitution in ifg-1/eIF4G  
 
Linkage analyses and SNP assays showed that TT12 was located around the 
center of chromosome II.  In order to perform three-factor SNP mapping, we constructed 
a strain with unc-83(e1414) and rol-1(e19) in the mom-2(ne834) genetic background, 
which spanned the entire region from -2.98 to 6.65 on chromosome II.  After crossing 
this mapping strain with TT12 males, we isolated the recombinants in F2 generation, and 
tested for the suppression of mom-2 (ne834) and checked SNP loci to narrow down the 
location of the suppressor.  After testing approximately 700 recombinants, we were able 
to locate TT12 in a 9 cosmid interval on chromosome II (from T05H10 to Y1E3A).  This 
interval held about 30 genes.  Next, we sequenced the candidate genes to find the 
suppressor mutation.  We found a point mutation in ifg-1, a homolog of eukaryotic 
translation initiation factor eIF4G (Figure A1.3).  The ifg-1(ne4271) allele had an R745C 
substitution.  Arginine 745 is highly conserved and is located in the eIF4A and eIF3 
binding domain of eIF4G.   
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Figure A1.3:  The mom-2(ne834) suppressor, ifg-1 is a homolog of eIF4G.  Structure 
of eIF4G with the interaction domains for eIF4A (Lomakin et al., 2000; Morino et al., 
2000), eIF3 (Korneeva et al., 2001), Mnk1 (Morino et al., 2000), PABP & eIF4E 
(Gingras et al., 1999).  TT12 (ne4271) has a single amino acid change at Arginine 745 to 
Cysteine within the essential domain important for translational function and binding 
eIF4A and eIF3.   
 
  
ne4271
eIF4A eIF4A
PABP eIF4E eIF3 Mnk1
IRES-mediated translation
cap-dependent translation
essential domain
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DISCUSSION 
 
Wnt proteins are secreted glycoproteins that play essential roles during embryonic 
development.  Many players of Wnt signaling pathway such as Wnt, Frizzed/LRP, Axin, 
GSK3, APC, β-catenin, and TCF/LEF have been found through the extensive genetic 
screens performed in Wnt pathways of Drosophila and C. elegans.  Despite their 
undeniable role in identification of new components in Wnt signaling pathway, basic 
genetic screens have their weaknesses.  For example some pathway regulators may not 
have an obvious wnt-related phenotype of their own and can be missed in a basic genetic 
screen.  Also, using the same screening parameters over and over might lead to the 
saturation of a particular type of screen.  Here, we describe a suppressor genetic screen, a 
powerful genetic approach to overcome these shortcomings and identify new Wnt 
pathway regulators.  Another study that resulted in identification of new components was 
performed by DasGupta et al., where they used a genome-wide RNAi screening in 
Drosophila and found 238 candidate regulators of the Wnt signaling pathway, most of 
which had never been shown to be connected to Wnt signaling before (DasGupta et al., 
2005).   
In this study, we aimed to find additional components of the Wnt/Wingless 
signaling pathway to specify the endoderm tissue in C. elegans through suppressor 
genetic screen using two temperature sensitive alleles of mom-2/Wnt.  In our screen, we 
identified 8 new potential regulators of the Wnt signaling pathway.  When we 
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molecularly characterized the new loci, we found that five of them were intragenic 
suppressors and the rest were extragenic.  The locus of one extragenic suppressor 
corresponded to ifg-1, which encodes the eukaryotic translation initiation factor eIF4G.   
 
Intragenic suppressors 
 
Intragenic suppressors have extra mutations within the same gene that restore 
function of the original mutant gene products.  In our mom-2(ne874) (C139Y) suppressor 
screen, we identified five intragenic suppressors (TT1, TT2, TT3, TT4, TT5).  
Surprisingly, TT4 turned out to have a second site mutation in C167 to a tyrosine, the 
same mutation of the Ts allele mom-2(ne834) (C167Y).  Our suppressor screen allowed 
us to find out mom-2(ne834) itself acts as a suppressor of mom-2(ne874) in an allele 
specific manner.  This finding strongly implies that the cysteine residues at positions 139 
and 167 could be interacting with each other.  A high proportion of the conserved 
cysteine residues in Wnt proteins suggest that they may be critical determinants of the 
final structure of proteins through the formation of intramolecular disulfide bonds.   
Wnt proteins are highly hydrophobic.  This property of Wnt proteins renders them 
insoluble; therefore they are extremely difficult to isolate and characterize.  Well 
designed suppressor genetic screens might not only give us new Wnt regulators through 
extragenic suppressors, but might allow us to isolate intragenic suppressors that may help 
us understand the structural aspects of Wnt proteins in vivo.   
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Identification of the eukaryotic translational initiation factor eIF4G as a suppressor 
of wnt 
In our mom-2(ne834) suppressor screen, we isolated an eIF4G allele as a semi-
dominant suppressor of the wnt phenotype.  The eukaryotic initiation factor, eIF4G, is a 
large modular protein and a key component in promoting ribosome binding to mRNA 
through serving as a docking site for the initiation factors and proteins involved in RNA 
translation.  eIF4G is part of the eIF4F complex and acts as a scaffold for the other two 
members of this complex, namely eIF4E and eIF4A.  Thus, the central role of eIF4G in 
initiation makes it a valid target for modulation of translation.   
eIF4G has been isolated and cloned from many different species including the 
yeasts S. cerevisiae and S. pombe (Goyer et al., 1993), Drosophila (Zapata et al., 1994), 
wheat (Browning, 1996), and human (Yan et al., 1992; Gradi et al., 1998).  In C. elegans, 
two splice-variants of eIF4G, encoded by ifg-1, have been identified (Long et al., 2002; 
Kamath and Ahringer, 2003).  The eIF4G proteins of C. elegans and human exhibit 
moderate sequence conservation, yet overall they share similar biochemical functions.   
The mammalian eIF4GI can be divided into three regions; an amino-terminal 
third, which contains the poly(A) binding protein (PABP) and eIF4E binding sites; a 
middle third, which binds eIF4A and eIF3; and a carboxy-terminal third, which harbors a 
second site for eIF4A binding and a docking sequence for the Ser/Thr kinase Mnk1 
(Figure A1.3) (Morino et al., 2000).  The mutation in ifg-1 (ne4271) has a substitution at 
a highly conserved residue at position 745 from an arginine to a cysteine.  This point 
mutation lies in the middle third of the protein, which is the eIF4A and eIF3 binding 
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domain.  It has been previously shown that eIF4A and eIF3 binding domain is important 
for the cap-dependent translation (Morino et al., 2000).   
In earlier studies, mutational analysis was performed to elucidate the roles of 
some of the conserved residues in the middle third region of human eIF4GI (eIF4A and 
eIF3 binding domain) (Morino et al., 2000).  It was shown that the residues at Q533, 
K610, and F720 had no effect on eIF4A or eIF3 binding, yet mutations at Y273, F650, 
and F736 abolished binding to eIF4A and had no effect on eIF3 binding.  The role of 
R745, where ifg-1 (ne4271) has a mutation that suppresses the wnt phenotype, remains to 
be uncovered.  It would be interesting to see the role of R745C mutation on eIF4A and/or 
eIF3 binding and observe its ultimate effect on eIF4F, the translation initiation complex 
function.   
 
Novel regulator of the Wnt signaling pathway  
 
Up to date, a direct relation between the Wnt signaling pathway and the 
translational machinery has not been reported.  Thus, finding eIF4G, a key protein of a 
novel cellular mechanism, as a suppressor of mom-2 mutant was unanticipated.  Recently, 
similar unexpected functions of the translational machinery components have been 
identified in other cellular events.  Li et al isolated eIF4A, a component of the eIF4F 
complex, as a suppressor of dpp, a member of the superfamily of TGFβ (Transforming 
Growth Factor β) in Drosohpila (Li et al., 2005).  They showed that eIF4A acts as a 
specific inhibitor of Dpp signaling and mediates the degradation of Smad homologs for 
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signal activation (Li and Li, 2006a; Li and Li, 2006b).  Moreover, both human and 
Drosophila eIF4A-III are components of the exon-junction complex, which is formed 
during mRNA splicing (Ferraiuolo et al., 2004; Shibuya et al., 2004).  In mammals, the 
resulting complex is essential for nonsense-mediated mRNA decay.  Strikingly, eIF4A-III 
is also essential for the proper localization of oskar mRNA in the Drosophila embryos 
(Palacios et al., 2004).   
Even though more investigations need to be conducted to elucidate the 
mechanism underlying the connection between eIF4G and the Wnt signaling pathway, we 
can propose several possibilities to explain their association:  First, negative regulators of 
Wnt signaling may be sensitive to IFG-1 levels.  For example, it is possible that ifg-
1(ne4271) may act to reduce the POP-1 levels, since the heterozygote of hypomorphic 
pop-1 allele rescues the mom-2 phenotype (personal communication with Dr. Soyoung 
Kim).  Second, eIF4G itself may be a negative regulator of the Wnt signaling pathway.  
Third, the Wnt signaling pathway may directly regulate the translational machinery.  For 
example, the components of translational machinery might be phosphorylated by Wnt 
regulators.  eIF4G could also function completely independent of the Wnt signaling 
pathway, yet the two pathways may converge on the same targets with opposing effects.   
Our suppressor screen has provided brief structural information about Wnt 
proteins through intragenic suppressors. Through our screen we isolated ifg-1, a 
component of translational machinery, as a suppressor of Wnt signaling pathway in C. 
elegans gut development.  Our data suggests an intriguing connection between the Wnt 
signaling pathway and the translational machinery.  Future studies elucidating the 
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molecular mechanisms underlying this connection may shed light on this complex 
network of interactions.    
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EXPERIMENTAL PROCEDURES 
 
Genetics and Strains.  All strains were handled and cultured as described 
previously (Brenner, 1974).  ifg-1(ok1211) was obtained from CGC (Caenorhabditis 
Genetics Center).  Mutant strains used were: mom-2(ne834) (V), mom-2(ne874) (V), 
mom-4(ne1539) (I), wrm-1(ne1982) (III), lit-1(ne1991) (III), VC778 ifg-
1(ok1211)/mIn1[mIs14 dpy-10(e128)] (II).   
ENU mutagenesis screen for suppressors of mom-2 (ne834, ne874).  The Ts 
alleles of mom-2 (ne834, ne874), in the background of the Hawaiian CB4856-derived lin-
11(ne832) egg-laying deficient strain (WM59), were used for the suppressor screens.  L4 
worms were grown at 15°C.  Prior to mutagenesis worms were washed with 10 mL M9 
buffer. A final concentration of 1.00 mM ENU (N-Ethyl-N-Nitrosourea) in 4 mL of M9 
was used as mutagen.  Worms were M9-ENU incubated on rotating shaker set at 100 rpm 
for 4 hours at 15°C.  After mutagenesis worms were washed with 10 mL M9 buffer.  
Later, half of the F1 progenies were shifted to 25 °C at the L4 stage to select for the F1 
dominant suppressors, and the other half was maintained to produce F2 progeny.  In order 
to screen for the F2 recessive suppressors, L4 stage F2 animals were shifted to 25°C.   
RNAi assays. RNAi was performed by injecting dsRNA as described previously 
(Bei et al., 2002).  The ifg-1 dsRNA was prepared from full length genomic DNA.  
Embryos were collected 24 hr post injection and were scored for phenotypes at the 
appropriate temperature.    
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Appendix II 
Characterization of the C-terminally HA tagged KCNE1 
 
 
Contributors to the work presented in Appendix II: 
 
The author of this thesis, Tuba Bas, conducted all biochemical experiments.  Dr 
Trevor Morin, Dr Jessica Rochelau and Dr Steven Gage conducted the 
electrophysiological experiments.   
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ABSTRACT 
 
KCNE1 is the founding member of the KCNE family of proteins, modulatory β-
subunit of a number of hereromultimeric K+ channels, including KCNQ1.  KCNE1 and 
KCNQ1 are coexpressed in the heart and inner ear and mutations in either channel 
subunit lead to diseases such as Romano-Ward (autosomal dominant long-QT syndrome) 
and Jervell-Lange-Nielsen Syndrome (autosomal recessive long-QT syndrome 
accompanied with deafness).  KCNE1 has a single pass transmembrane domain with an 
N-terminus exposed to the exterior side of the membrane, which bears two N-linked 
glycosylation sides (N5 and N26) and a C-terminus facing the cytoplasm.  We wanted to 
investigate the effects of KCNE1 glycosylation on channel assembly and trafficking.  
Therefore, we constructed a C-terminally HA-tagged KCNE1 protein, which functions 
like WT KCNE1.  Here, I will present the characterization of the C-terminally HA tagged 
KCNE1 protein that we used throughout the experiments that are presented in Chapter II, 
Chapter III and Chapter IV.   
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INTRODUCTION 
 
KCNQ1 is a voltage-gated K+ channel identified in a linkage study looking at the 
genetic causes of sudden death from cardiac arrhythmia (Wang et al., 1996).  KCNQ1 
proteins form homotetramers and co-assemble with members of KCNE peptides 
achieving great channel diversity (Melman et al., 2002a; Melman et al., 2002b).  KCNE1, 
the founding member of KCNE gene family, and KCNQ1 are coexpressed in the heart 
and inner ear.  KCNE1 effects channel function by changing channel gating and by 
modulating ion selectivity, single channel conductance and drug interactions (Abbott and 
Goldstein, 1998; Trimmer, 1998; Pongs et al., 1999).  Mutations in either KCNE1 and/or 
KCNQ1 lead to chanellopathies such as Romano-Ward and Jervell-Lange-Nielsen 
Syndrome effecting more than 1 in every 5000 people.  Romano-Ward (autosomal 
dominant long-QT syndrome) is a heart disorder giving rise to cardiac arrhthymia and 
can be inherited or acquired.  Jervell-Lange-Nielsen Syndrome (autosomal recessive 
long-QT syndrome with deafness) is a form of long-QT syndrome accompanied with 
congenital deafness.  The endolymphatic space of these patients is collapsed due to loss 
of K+ homeostasis in the inner ear (Neyroud et al., 1997; Schulze-Bahr et al., 1997; 
Tyson et al., 1997; Splawski et al., 2000).  
KCNE1 is a type I membrane glycoprotein.  Type I proteins are integral 
membrane proteins with a single transmembrane stretch of hydrophobic residues.  The N-
terminal side of the transmembrane domain is exposed on the exterior side of the plasma 
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membrane and the C-terminus exposed on the cytoplasmic side of the cell.  KCNE1 has 
129 amino acids with two consensus N-linked glycosylation sites (sequons) at N5 and 
N26 on the N-terminal side of the transmembrane domain (Figure A2.1B).  These two N-
linked glycosylation sites are glycosylated in expression systems and native tissues 
(Chapter II and Chapter III) (Finley et al., 2002).   
Glycosylation is an important posttranslational modification.  In eukaryotes, N-
glycosylation starts with the transfer of a 14-sugar precursor to the asparagine residue of 
the consensus site on the protein (-NXT/S-, X cannot be proline), mostly cotranslationally 
and rarely post-tranlationally.  N-linked glycans can effect both the physico-chemical and 
biological functions of the proteins to which they are attached (Apweiler et al., 1999; 
Walsh, 2006).  Previous studies gave a small hint for the possible role of N-linked 
glycosylation of the two sequons on KCNE1 function; especially the sequon closer to the 
N-terminus (N5).  Deletion studies suggested truncations that remove the N-terminal 
sequon (N5) effected the electrophsiological properties of the KCNE1/KCNQ1 channel 
complex.  On the contrary the absence of the internal sequon (N26) did not have a 
significant effect on channel function.  These structure-function studies determined the 
minimal functional KCNE1 protein as being residues 1-9 and 40-94 including the 
transmembrane domain.  Moreover, T7I, a Jervell-Lange-Nielsen Syndrome (JLNS) 
mutation, eliminates glycosylation at N5 (Takumi et al., 1991; Schulze-Bahr et al., 1997; 
Abbott and Goldstein, 1998; Freeman et al., 2000).   
In order to investigate the two N-linked glycosylation sites, I constructed and 
characterized a C-terminally HA-tagged KCNE1 protein (E1-HAc).  Construction of the 
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tagged protein involved multiple steps: tagging the protein via PCR techniques; testing 
the expression of the candidate protein alone and in the presence of the channel partner 
KCNQ1; analyzing the ER-exit via enzymatic deglycosylation assays; checking the 
presence of the protein at the plasma membrane using a cell surface biotinylation assay 
and comparing the results with an established N-terminally HA-tagged KCNE1 construct 
(E1-HAn).  Finally, we performed functional analysis through the co-expression of E1-
HAc with Q1 and measuring currents through KCNE1/KCNQ1 channel complex.  While 
characterizing the C-terminally HA-tagged KCNE1 protein, we observed two interesting 
properties of the KCNE1 protein.  First, it has an internal start site at M27.  Second, it has 
a putative proteolytic cleavage site spanning the residues R32, R33, and R36, which 
requires further investigation.   
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RESULTS 
 
In order to study the two N-linked glycosylation sites on KCNE1, we constructed 
a panel of C-terminal tags using 2-Step PCR, gel purification, ligation and transformation 
techniques.  Seven tags were introduced at different locations on the KCNE1 C-terminus 
(Table A2.1).  All tagged KCNE1 derivatives were confirmed by sequencing and went 
through a series of biochemical and functional tests to ascertain whether they behave like 
WT KCNE1.  Among seven tags studied only the HA tag (-YPYDVPDYA) with a 
preceding spacer (-SGSG-) attached at the very end of the KCNE1 C-terminus (after 
P129) met all the WT KCNE1 criteria (Figure A2.1A) (vide infra).   
 
Epitope tag on KCNE1 C-terminal: Choosing the right tag and testing the protein 
expression 
After the addition of the epitope tag on C-terminus, we first tested the expression 
of the C-terminally HA-tagged protein (E1-HAc) in CHO cells (CHO cells lack 
endogenous K+ channels).  We transiently transfected CHO cells with E1-HAc alone or 
with KCNQ1.  The cells were lysed in RIPKA buffer with protease inhibitors and lysates 
were resolved on SDS-PAGE gel and probed for the HA-tag on E1 (Figure A2.1B).  
When E1 was expressed alone, we observed a doublet around ~15 kDa and a sigle band 
at ~25 kDa.  When E1 was coexpressed with Q1, E1 resolved to a higher molecular 
weight band above ~37 kDa.  These results compared favorably with those of an  
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Table A2.1:  The different C-terminally tagged versions of KCNE1 protein and their 
characterization.  
 
 Expression Mature Protein Cell Surface 
Expression 
Function 
Flag1 + None None N/D 
Flag2 + None None N/D 
Myc + None None N/D 
HA-Rep +++ + + Q1-like 
HA-End ++ ++ ++ Iks currents 
HA-Psp ++ + + N/D 
E1-HAc +++ +++ +++ Iks currents 
Epitope tags inserted in KCNE1 C-terminus are FLAG: -DYKDDDDK- ; Myc: -EQKLISEEDL- and HA: -YPYDVPDYA-. 
FLAG1 bears the insert between residues 91 and 92; FLAG2: 125-126; Myc: 118-119; HA-Rep: replaces the 8 residues 
103 through 110; HA-End: places the HA-tag at the very end of KCNE1 (after P129); HA-Psp: A linker, -PSP- is placed 
after P129, followed by the HA-tag; E1-HAc: A linker, -SGSG- is placed after P129, followed by the HA-tag.   
+, O.K; ++: good; +++: very good; N/D: Not determined. 
Q1-like: KCNQ1 currents; Iks currents: KCNQ1/ KCNE1 currents. 
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Figure A2.1:  C-terminally HA-tagged KCNE1 (E1-HAc).  (A) The amino acid 
sequence of hKCNE1, 1-40 and 126-142.  Green cylinder represents the transmembrane 
domain. First sequon (-NTT-) is underlined red, second sequon blue (-NMS-), arginine 
cluster (-RRSPR-) purple, linker (-SGSG-) orange, HA-tag (-YPYDVPDYA-) 
mahogany.  (B) The diagram of C-terminally HA-tagged KCNE1 with a single pass 
transmembrane domain.  The two consensus N-linked glycosylation sites (N5 and N26) 
are on N-terminus, facing the exterior side of the plasma membrane.  (C) Expression of 
E1-HAc alone and with Q1, 48 hours post-transfection.  When E1 was expressed alone 
the bands resolved to a doublet around ~15 kDa and a single band at ~25 kDa on an SDS-
PAGE.  When E1 was coexpressed with Q1, E1 resolved to a higher molecular weight 
band above ~37 kDa.  m: mature glycans on E1; imm: immature glycans on E1; doublet: 
the two bands resolving around ~15 kDa.  
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established and long used N-terminally HA-tagged KCNE1 protein (E1-HAn) (Figure 
A2.1B and Figure2.1, Chapter II).  However, E1-HAc construct also possessed an extra 
fast migrating band not observed with the E1-HAn construct.   
 
Determining the glycoforms of E1-HAc through enzymatic deglycosylation assays 
KCNE1 has two N-linked glycosylation sites at N5 and N26.  KCNE1 glycans 
allow us to follow trafficking of E1 through the secretory pathway (Chapter II) 
(Chandrasekhar et al., 2006).  ER resident proteins have immature N-linked glycans.  The 
ER uses these high mannose oligosaccharide handles to promote protein folding, 
oligomerization, quality control, retention and trafficking (Parodi, 2000b; Walsh, 2006).  
Once the proteins are correctly folded and assembled they are ready to leave the ER and 
migrate through medial- and trans-Golgi compartments.  While trafficking through 
secretory pathway, glycoproteins acquire complex modifications to their N-linked 
glycans and this process is known as glycan maturation (High et al., 2000; Parodi, 2000a; 
Trombetta, 2003; Walsh, 2006).  In order to distinguish between E1 glycoforms, we 
performed an enzymatic deglycosylation assay on E1-HAc to fully characterize the 
nature of all the bands observd on the western blot (Figure A2.2A).   
We used two glycosidases to differentiate between the unglycosylated E1 protein 
and the mature and immature glycoforms.  Endo H cleaves only high mannose and some 
hybrid N-linked glycans, removing immature glycans found in the ER and cis-Golgi 
forms of KCNE1 proteins.  PNGase F removes all N-linked glycans (high mannose, 
hybrid and complex).      
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Figure A2.2:  Only mature E1-HAc could reach cell membrane.  (A)  Immuboblot of 
enzymatic deglycosylation assay of E1-HAc from CHO cells transfected with E1 and 
E1/Q1 DNA.  The samples were left untreated (–), digested with Endo H (Hf) or PNGase 
F (Pf), and separated by SDS-PAGE (15%).  Expression of E1 alone resulted in a doublet 
at ~15 kDa, a faint 37 kDa band that was Hf resistant and a ~25 kDA band that collapsed 
to the upper band of the doublet (~17 kDa) upon Hf and Pf treatment.  Expression of E1 
with Q1 channel subunits resulted in robust expression of a ~37 kDa band that was 
identified as maturely glycosylated E1 after enzymatic deglycosylation. Mature (mature), 
immature (immature), and unglycosylated (unglyc) samples are indicated as determined 
by enzymatic deglycosylation. The ―?‖ denotes the lower, unknown band.  PNGase F 
digestion products that migrated slower than unglycosylated or immature E1 protein are 
different glycoforms of E1 due to O-linked glycosylation (personal communication with 
Kshama Chandrasakher).  (B)  Immunoblot of a cell surface biotinylation assay of E1-
HAc expressed in CHO cells with and without Q1 channel subunits.  Transfected cells 
were labeled with a membrane-impermeant biotin reagent and subsequently lysed 
(Experimental Procedures).  The isolated biotinylated proteins (Beads) and half of the 
input (1/2 Input) were separated on an SDS-PAGE (15%).  Mature (m), immature (im), 
and unglycosylated (un) samples are indicated as determined by the enzymatic 
deglycosylation assay above. The ―?‖ denotes the lower unknown band.    
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Therefore, cell lysates were treated with PNGase F (Pf) or Endo H (Hf) and resolved by 
SDS-PAGE (Figure A2.2A). 
When E1 was expressed alone, both enzymes collapsed the band running at ~25 
kDa to the top band resolving at ~17 kDa.  This identified the larger ~17 kDa band as 
unglycosylated E1 and the ~25 kDa species as the immaturely glycosylated E1 protein 
(Figure A2.2A).  With Q1 co-expression, we primarily observed a ~37 kDa band, 
resistant to Endo-H treatment.  This band collapsed to lower molecular weight bands 
upon PNGase-F treatment, indicating that the higher molecular band was maturely 
glycosylated E1.  The identity of the lowest band, which resolved to smaller ~16 kDa and 
was missing in the N-terminally HA-tagged E1, was analyzed further (vide infra).   
 
Measuring membrane protein levels by cell surface biotinylation assay 
Previously, cell surface biotinylation assay showed that maturely glycosylated E1-
HAn proteins were found at the cell surface.  Hence, we tested whether the cell surface 
expression of E1-HAc was the same as E1-HAn.  We expressed E1-HAc alone and with 
Q1 in CHO cells.  We labeled the proteins with a membrane impermeant, amine reactive 
biotin derivative at 4oC to stop membrane recycling and pulled down biotinylated cell 
surface proteins using streptavidin beads (Experimental Procedures).  The samples were 
resolved by an SDS-PAGE and probed for the HA tag.  Consistent with E1-HAn, our 
results showed that E1-HAc requires Q1 to reach cell surface and only the mature 
glycoform is detected at the cell surface (Figure A2.2B and Figure 2.4A, Chapter II).    
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Q1/E1-HAn            Q1/E1-HAc 
 
 
 
 
Figure A2.3:  Q1/E1-HAc currents were like Q1/E1-HAn currents.  Representative 
families of traces were recorded from Xenopus laevis oocytes.  Oocytes were 
microinjected with KCNQ1 (Q1) and with KCNE1 (E1-HAn or E1-HAc) RNA 
(Experimental Procedures).  The currents were evoked by holding oocytes at −80 mV and 
pulsing to a command potential of -100 mV to + 60 mV in 20 mV increments.   
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Functional analysis of E1-HAc: E1-HAc and KCNQ1 channels give IKs currents 
With the exception of a single, faster migrating band on a western blot, E1-HAc 
seemed to behave like E1-HAn.  Therefore, we wanted to test E1-HAc for native function 
by analyzing E1-HAc/KCNQ1 channel currents.  KCNE1/KCNQ1 channels give rise to 
cardiac IKs currents in native tissues.  Figure A2.3 shows two electrode voltage clamp 
recordings from Xenopus oocytes injected with Q1/E1-HAn or Q1/E1-HAc.  Both E1-
HAn/KCNQ1 and E1-HAc/KCNQ1 channels gave rise to slowly activating cardiac IKs 
like currents.  Therefore, the placement of this HA-tag in KCNE1 C-terminus does not 
distrupt E1 function.   
 
Investigation of the lower band 
Each C-terminally tagged KCNE1 construct possessed an extra band below the 
unglycosylated band (~17 KDa).  Since we were not able to see the truncated protein in 
the western blots of the N-terminally tagged E1, we wanted to be certain this band was 
not an artifact of the C-terminal HA-tag.  Therefore, we probed E1-HAn immunoblots 
with native KCNE1 antibody (rabbit α-KCNE1).  We observed the presence of the lower, 
band with E1-HAn (Figure A2.4A), demonstrating that this putative post-translational 
modification was also present in N-terminally HA-tagged KCNE1.   
This gave us the biggest clue as to why we were not able to see this truncated 
protein with E1-HAn.  We hypothesized that a proteolytic cleavage was occurring 
downstream of the HA tag, which was located between the residues 22 and 23.  Once the   
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Figure A2.4:  The unknown band was membrane associated and also detected wih 
E1-HAn when probed with native antibody.  (A)  Immunoblots of N-terminally HA-
tagged KCNE1 (E1-HAn) and C-terminally HA-tagged KCNE1 (E1-HAc) from 
solubilized CHO cells transfected with E1 and E1/Q1 DNA.  The samples were separated 
by SDS-PAGE (15%).  Immuboblots were probed with α-KCNE1 (native antibody).  For 
both constructs expression of E1 alone resulted in a doublet at ~15 kDa (the fast 
migrating, unknown band was present in E1-HAn and E1-HAc) and a ~25 kDa band.  
Expression of E1-HAn with Q1 channel subunits resulted in expression of a 37 kDa band, 
corresponding to the maturely glycosylated E1 protein, and it was not observed with E1-
HAc.  This was not a surprise since we knew that the native antibody was raised against 
the C-terminus, and the 9 amino acid HA tag with the 4 amino acid linker might interfere 
with antibody binding to this segment.  (B)  Immuboblot from solubilized CHO cells 
transfected with E1-HAc DNA.  CHO cells were hypotonically lysed; membrane was 
pelleted, washed, and solubilized in 1.5% RIPKA solution.  The resuspended membrane 
proteins were separated by SDS-PAGE (15%) and probed for the HA tag.  A doublet at 
~15 kDa, a ~25 kDa band and an extra band below 37 kDa band was observed (O-
glycosylated E1 glycoform could be membrane associated). The fast migrating - 
unknown band, which was running below the ~17 kDa band (unglycosylated E1), was 
membrane associated.   
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N-terminus was partially cleaved we were losing the tag on N-terminus; whereas with 
E1-HAc, the tag on the C-terminus stayed intact and allowed us to observe this 
previously unobserved post-translational modification.  Later, autoradiographs of 
metabolically labeled E1-HAn also showed the presence of the lower band below the 
unglycosylated E1-HAn protein, consistent with our hypothesis (data not shown).   
In order to further analyze this truncated protein, we asked whether (a) it was 
membrane associated, (b) it was a degradation product, or (c) whether phosphorylation – 
dephosphorylation had an effect on electrophoretic mobility.   
I used different protease inhibitor cocktails to inhibit probable degradation 
pathways.  Phenylmethylsulfonyl fluoride (PMSF) and leupeptin, pepstatin and aprotinin 
(LPA) are the protease inhibitors regularly used to prevent proteolysis during cell lysis.  
In addition to these inhibitors, I supplemented the lysates with additional Protease 
Inhibitor Cocktails (Experimental Procedures).   
Deoxymannojirimycin (DMJ) was used to check whether the lower unidentified 
band was due to ER based degradation.  DMJ inhibits the action of ER mannosidases 1 
and 2, preventing the removal of the outermost mannose residues on the core 
oligosaccharides, thereby blocking ER assisted degradation (Helenius and Aebi, 2001).  
NH4Cl and chloroquine were used to prevent lysosomal degradation (Experimental 
Procedures).  NH4Cl and chloroquine are both weak bases that inhibit lysosomal 
hydrolysis by reducing the acidification of the endosomal/lysosomal compartments.  
ALLN, lactacystin and MG132 were used to inhibit proteosomal degradation 
(Experimental Procedures).  With the exception of one lysosomal inhibitor, none of the 
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inhibitors or reagents tested resulted in any observable difference on the expression of the 
lower band (data not shown).  With the lysosomal inhibitor, chloroquine, we saw an 
increase in the signal of the lower band, which suggested that this cleavage product was 
degraded in the lysosomal compartments.  However, this did not indicate how and where 
the 15 kDa band was made.   
Next, I tested whether the band shift might be due to phoshorylation.  Calf 
intestinal alkaline phosphatase (CIP) is an enzyme that releases the phosphate group from 
phosphorylated tyrosine (Y), serine (S) and threonine (T) residues.  The cell lysates were 
treated with CIP for 1 hour at 37oC.  I used endogenous protein kinase C (PKC, a known 
phosphorylated protein) as a positive control.  Both CIP treated and untreated samples 
were compared on SDS-PAGE.  The western blot was probed with α-HA and α-phospho 
PKC.  CIP treatment had no effect on the intensity or migration pattern of the unknown 
KCNE1 band (data not shown).   
Finally, I asked whether this truncated protein was membrane associated or 
soluble.  To test this, cells were hypotonically lysed to release cytoplasmic proteins.  The 
membrane was pelleted, washed, and then solubilized in 1.5% RIPKA solution.  The 
resuspended membrane proteins were resolved on SDS-PAGE and probed for the HA 
tag.  The western blots showed that the KCNE1 truncated protein was membrane 
associated (Figure A2.4B).    
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Finding an internal translation start site at M27 
Next, we tested the presence of an internal translation start site, since KCNE1 has 
a methionine at M27.  We also knew that the unknown band was not observed with E1-
HAn where the N-terminal tag was placed before the 23rd residue, preceding the internal 
methionine.  Therefore, I made a panel of start site mutants, M1L, M27L and M27V, to 
find out the contribution of the internal start site (M27) on protein expression.   
When I mutated the first methionine to a leucine (M1L), we were still able to see 
the lower band (Figure A2.5A).  This suggested that in the absence of M1, M27 could act 
as a translational start site.  Yet, it was not clear whether the lower band was solely due to 
the presence of an internal translational start site.  Therefore, I mutated the methionine at 
27 to a leucine (M27L).  M27L reduced the overall signal for the KCNE1 glycoforms on 
a western blot, and we still could see the lower band (Figure A2.5A).  Since M27L did 
not completely abolish the lower band, this KCNE1 isoform might not be solely due to 
the presence of an internal translational start site.   
This second start site (M27) happens to be the variable amino acid at the center of 
the internal sequon (-NMS-) and it is conserved in rat, human and pig homologues of E1 
protein.  Yet, mouse has a valine instead of a methionine (Figure1.4B, Chapter I). Since, 
the point mutation from Met to Leu resulted in reduced protein expression of KCNE1 
glycoforms, I decided to mutate the internal translation start site to another conserved 
residue, valine (M27V).  M27V improved overall KCNE1 expression, but still yielded 
the unknown band (Figure A2.5A).    
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Figure A2.5:  M27 on KCNE1 is an internal translational start site.  Immunoblots of 
WT (E1-HAc), the start site mutants (M1L, M27L, M27V), and the E1-HAc with the 
Kozak site.  E1-HAc proteins were expressed alone and with Q1.  WT (E1-HAc) was 
used as a positive control.  (A)  M1L abolished the start site and resulted in a robust 
expression from the internal start site (M27) resolving as the unknown, fast migrating 
lower band (~15 kDa) on an SDS-PAGE (15%).  Both M27L and M27V partially 
reduced the unknown, fast migrating lower band (~15 kDa).  With M27L appeared an 
extra band below the unknown band.  Co-expression of M27V with Q1 resulted in an 
abundance of the maturely glycosylated proteins (~37 kDa), whereas with M27L the 
signal was significantly low, suggesting a reduction in glycan maturation in the case of 
M27L.  (B)  Kozak site (GCC GCC (A/G)CC ATG) partially disrupted the unknown, fast 
migrating lower band (~15 kDa).  Co-expression with Q1 resulted in an abundance of 
maturely glycosylated proteins (~37 kDa).   
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In order to prevent the internal start site from complicating the future results, an 
optimal translation initiation site (Kozak site; -GCC GCC (A/G)CC ATG-) was 
engineered into all our expression vectors, which has been reported to improve 
translation initiation in higher eukaryotes (Kozak, 1989).  In our expression vectors, the 
Kozak sites improved overall KCNE1 expression (Figure A2.5B).  All E1-HAc 
constructs used in Chapters II, III, and IV possess the optimal translation initiation site.   
 
A probable proprotein convertase site on E1 
KCNE1 protein has a potential proprotein convertase recognition site that starts 
with R32 and ends with S38 (--RRSPRSS--) according to the propeptide cleavage site 
prediction program, ProPv.1.0b.  Therefore we wanted to test whether the lower band 
observed in our western blots was the proteolytic cleavage product of a proprotein 
convertase (PC).  The proprotein convertases are a family of calcium-dependent, 
subtisilin-like serine endoproteases that cleave the proprotein substrates at the carboxy 
terminal side of doublets or clusters of basic amino acids, (-Arg/Lys)- (X)n-(Arg/Lys)- ↓ .  
Moreover, two arginines within this consensus cleavage site, R32H and R36H, are Long 
QT mutations (Splawski et al. 2000 and Napolitano et al. 2005).  R36 also scored high as 
PC cleavage site in silico.   
Furin is the most studied member of PCs.  First, I used furin inhibitors to see 
whether they could prevent formation of the unknown band.  Two different furin 
inhibitors were used: furin Inhibitor I (Decanoyl-Arg-Val-Lys-Arg-CMK) and furin 
Inhibitor II, (H(D)Arg-Arg-Arg-Arg-Arg-NH2).  Neither of the inhibitors had an effect on 
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the lower band, indicating that the probable proprotein convertase cleavage site is not a 
substrate for furin or other known proprotein convertases that are sensitive to furin 
inhibitors (data not shown).   
Next, I introduced point mutations and changed the arginines at the potential 
proprotein convertase recognition site to alanines: R32A, R33A, R36A.  Individual 
alanine mutants did not result in a significant reduction of the lower band.  However, we 
did observe a better expression of E1 alone and with Q1, especially with the two Long 
QT mutants: R33A and R36A (Figure A2.6A).  Then, I designed a double arginine 
mutant (R33A; R36A), disrupting the entire recognition site (Figure A2.6B).  With the 
double arginine mutants, expression of immature E1 increased significantly and 
unglycosylated glycoform was almost abolished, but the lower band was still present.  
Finally, the double mutant (R33A; R36A) in the Kozak plasmid resulted in almost 
complete loss of the lower band (Figure A2.6B), suggesting a role for R33 and R36 (R32 
and R36 are the residues prone to Long QT mutations) in proteolytic cleavage of KCNE1 
proteins.    
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Figure A2.6:  The basic residues residing between 32-36 are partially responsible for 
the unknown band.  (A)  The amino acid sequence of hKCNE1, 1-40 and 126-142.  
Green cylinder represents transmembrane domain. First sequon (-NTT-) is underlined in 
red, second sequon in blue (-NMS-), linker (-SGSG-) in orange, HA-tag (-
YPYDVPDYA-) in mahogany, arganine cluster (-RRSPR-) bearing R32, R33 and R36 in 
purple.  (B)  Immunoblots of WT (E1-HAc) and the arginine mutants (R32A, R33A, 
R36A, R33A;R36A; R33A;R36A with Kozak site).  WT and mutant proteins were 
expressed alone and with Q1.  WT (E1-HAc) was used as a positive control.  With single 
arganine mutants (R32A, R33A, R36A) and R33A;R36A the bands resolved on an 15 % 
SDS-PAGE were like WT protein: the doublet around ~15 kDa (unglycosylated band and 
the unknown species); ~25 kDa (immaturely glycosylated protein); ~37 kDa (maturely 
glycosylated protein in the presence of Q1).  Whereas with R33A;R36A with the Kozak 
site, the unknown band was significantly reduced, almost abolished.   
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DISCUSSION 
 
KCNE1 has two glycosylation sites at N5 and N26; N5 acquires glycans co-
translationally, and N26 acquires glycans post-translationally (Chapter II).  KCNE1 also 
has an O-linked glycosylation site (personal communication with Kshama 
Chandrasekhar).  The need for building a C-terminally tagged KCNE1 protein for 
studying the two glycosylation sites on N-terminus led to the investigation of two 
previously unobserved features of this glycoprotein.  We now know that KCNE1 has an 
internal translation start site, a methionine at position 27 that gives rise to a fast migrating 
band below the unglycosylated E1 protein on a western blot.  This lower band was not 
observed in the long-used N-terminally tagged E1, since the tag was between the residues 
Q22 and Q23, four amino acids upstream of the M27.   
We also found a putative proteolytic cleavage site at the arginine cluster spanning 
the residues 32 through 38 contributing to the signal of fast migrating band on an SDS-
PAGE.  This region of KCNE1 bears strong sequence homology to a potential proprotein 
convertase cleavage site, (-Arg/Lys)- (X)n-(Arg/Lys)- ↓.  The potential importance of this 
putative proteolytic cleavage site may be highlighted by two known Long QT mutations 
(R32H and R36H) (Splawski et al., 2000; Napolitano et al., 2005).  Yet, inhibitors 
targeting the known proprotein convertases did not have an effect on the expression of 
the lower band.  This leaves the door open for finding the enzyme that is responsible for 
the cleavage of the KCNE1 protein.  More importantly, the functional significance of this 
 221 
membrane associated post-translationally modified KCNE1 form has to yet be 
discovered.   
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EXPERIMENTAL PROCEDURES 
 
Plasmids and cDNAs.  Human Q1 and E1 were subcloned into pcDNA3.1(-) 
(Invitrogen).  Two hemagglutinin A (HA)-tagged versions of E1 were used.  For 
comparison purposes, a well established extracellular HA tag (YPYDVPDYA) was 
incorporated in the E1 N terminus between residues 22 and 23.  The C-terminally epitope 
tagged KCNE1 had an HA tag (YPYDVPDYA) appended to the E1 C terminus via an 
SGSG linker through PCR techniques.  All E1 constructs (wild type and mutants) 
possessed this C-terminal HA epitope tag.  To produce the M1L, M27L, R32A, R33A, 
R36A, (R33A;R36A) mutants and Kozak site (GCC GCC (A/G)CC ATG) site-directed 
mutagenesis was performed using the QuikChange system (Stratagene) and the mutations 
were confirmed by DNA sequencing of the entire gene.   
Cell culture and transfections.  Chinese Hamster Ovary (CHO-K1) cells were 
cultured in F-12K nutrient mixture (Gibco – Invitrogen).  The media was supplemented 
with 10% fetal bovine serum (Hyclone) and 102 U/mL penicillin/streptomycin (Gibco – 
Invitrogen).  Cells were plated at 60 – 75 % confluency in 35 mm dishes for all 
experiments.  After 24 h, cells were transiently transfected at RT with Lipofectamine 
(Invitrogen) 8 μl per mL of Opti-MEMI (Gibco - Invitrogen) and returned to fresh media 
after 6 hr.  DNA ratios (in μg):  E1/empty pcDNA 3.1 plasmid: 1.25/1.25; Q1/E1 
(western blots).  Cells were used 48 h post-transfection for western blots.   
Cell lysis and Western Blot Analysis.  Cells were washed in ice-cold PBS (3 × 2 
mL) and lysed at 4°C in RIPKA buffer (in mM):  10 Tris·HCl, pH 7.4, 140 NaCl, 10 KCl, 
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1 EDTA, and 1% Triton-X, 0.1% SDS, 1% sodium deoxycholate and supplemented with 
protease-inhibitors: 1 mM phenylmethylsulfonyl fluoride (PMSF) and 1 µg/mL each of 
leupeptin, pepstatin and aprotinin (LPA).  Lysates were diluted with SDS-PAGE loading 
buffer containing 100 mM DTT, loaded on a 15% SDS-polyacrylamide gel, transferred to 
a nitrocellulose membrane, and blocked in western blocking buffer (5% nonfat dry milk 
in Tris-buffered saline containing 0.2% Tween-20 (TBS-T)) for 30 min at RT.  
Membranes were incubated overnight at 4°C with rat anti-HA (Roche) (1:750) in western 
blocking buffer and washed in TBS-T next day and incubated with goat anti-rat 
horseradish peroxidase (HRP)-conjugated antibody (Jackson Immunoresearch Labs, Inc.) 
(1:2000) in western blocking buffer for 45 min at RT.  Membranes were washed with 
TBS-T and incubated with SuperSignal West Dura Extended Duration Substrate (Pierce) 
for 5 min.  HRP-bound proteins were detected by chemiluminescence using Fujifilm 
LAS-3000 CCD camera and quantified using the Image Gauge V2.1 software (Fujifilm).   
Ezymatic deglycosylation assay.  NP-40, BME, and reaction buffer (G5 for Endo 
H; G7 for PNGase F) were added to the cell lysates (20 µL), which were diluted with 
water to a final concentration of 1% NP40 and 1% BME.  Endo Hf (2 µL) or PNGase F 
(1 µL) (New England BioLabs, Inc.) were added to the samples and incubated at 37°C for 
30 min.  The samples were brought to a final concentration of 100 mM DTT and 1.3% 
SDS and were separated on an SDS-PAGE (15% gel) and analyzed by western blot as 
described above.   
Cell surface biotinylation.  Transfected cells were rinsed with ice-cold PBS2+ 
buffer (PBS containing 1 mM MgCl2, 0.1 mM CaCl2), incubated with 1 mg/mL sulfo-
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NHS-SS-biotin (Pierce) in PBS2+ buffer for 2 × 15 min at 4°C.  The biotin reagent was 
quenched by washing with (3 × 2 mL) with quench solution (PBS2+ containing 100 mM 
glycine) and then incubated with quench solution for 2 × 15 min at 4°C.  Cells were lysed 
in RIPKA buffer and cell debris was removed by centrifugation.  For each sample, 75 µg 
of total protein was quantitated by BCA analysis and incubated with 25 µL of 
Immunopure® Immobilized streptavidin beads (Pierce) overnight at 4°C.  One-half of the 
input (37.5 µg of total protein) was saved as a control for each sample.  Beads were 
washed 3 X with 0.1% SDS buffer (500 µL) and biotinylated proteins were eluted first 
with 30 µl 2× SDS-PAGE and 200 µM DTT mix for 15 min at 55°C, then with 30 µl 200 
µM DTT for 5 min at 55°C and the two elutions were combined to achieve 60 µl final 
volume.  Half of the input and bead-eluted proteins were separated by SDS-PAGE, 
analyzed by Western Blot as described above. 
cRNA Preparation; Oocyte Preparation and cRNA Injection.  KCNE1 and 
KCNQ1 plasmids were linearized with MluI, and RNA synthesized by run-off 
transcription using SP6 (Promega).  Mature oocytes were surgically extracted from 
anesthetized Xenopus laevis; isolated and prepared for injection as described in (Gage 
and Kobertz, 2004).  Oocytes were microinjected with RNA approximately 24 hours after 
extraction with 36 nL total volume of cRNA solution.  Oocytes were injected with Q1 (10 
ng/oocyte) and E1 (5 ng/oocyte) at RT.  After 3–6 days, currents were measured using 
two-electrode voltage clamp, TEVC (OC-725-C; Warner Instrument Corp.) and data 
acquired with Digidata 1322A (Axon Instruments) using pClamp 8 or 9 (Axon 
Instruments) at RT.  Electrodes were filled with 3 M KCl, 5 mM EGTA, 10 mM HEPES, 
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pH 7.6, and had resistance between 0.2 and 1 MΩ.  For each experiment, oocytes were 
held at −80 mV in ND96 (in mM): 96 NaCl, 2 KCl, 0.3 CaCl2, 1 MgCl2, 5 HEPES, pH 
7.4, and pulsed to a command potential of + 60 mV in 20 mV increments.   
Additional Enzyme Assays and Inhibitors used:  We used rabbit α-KCNE1 (1:600) 
from Alomone Labs.  The 30 µl of cell lysates were treated with 1 µl of calf intestinal 
alkaline phosphatase, CIP, (New England BioLabs), 4 µl of 10 X NEBuffer 3 (New 
England BioLabs) and brought up to a final volume of 40 µl with H2O and incubated for 
1 hour at 37oC.  CIP treated and untreated samples were resolved on a western blot and 
analyzed as described above.  We used endogeneous protein kinase C, PKC, as a positive 
control and probed the blots with (1:1000) rabbit α-phospho-PKCδ antibody (Cell 
Signaling Technology) as 1o antibody and (1:2000) donkey α-rabbit IgG, HRP (Promega) 
as 2o antibody.  In addition to the protease inhibitor mix LPA and PMSF, we used Roche 
Complete, EDTA-free protease inhibitor tablets (each tablet was dissolved in 500 µl H2O 
to obtain 100X solution) and Protease Inhibitor Cocktail (Sigma).  1 µl of each protease 
inhibitor was used for 100 µl final volume.  To test ER based degradation 1 mM 
deoxymannojirimycin, DMJ (Toronto Research Chemicals, Inc.) was used. To prevent 
lysosomal degradation 50 mM NH4Cl and 50 µM chloroquine (Sigma) were used.  To 
test proteosomal degradation 50 µM ALLN (Calbiochem), 25 µM lactacystin 
(Calbiochem) and 10 µM MG132 (Calbiochem) were used.  To check proteolytic 
cleavage by furin we used 25 µM furin inhibitor I (Decanoyl-Arg-Val-Lys-Arg-CMK) 
and 25 µM furin inhibitor II, (H(D)Arg-Arg-Arg-Arg-Arg-NH2) from Calbiochem.  Cells 
were incubated with the media containing inhibitors for 24 hours to 48 hours.    
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